Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Breast Cancer

Free Subscription Articles published in Ann Surg Oncol Retrieve available abstracts of 946 articles: HTML format

Single Articles

June 2024
1. CHAUHAN H, Ashrafian H, Takats Z, Leff DR, et al
   ASO Author Reflections: The Impact of DCIS on Positive Margin Rates.
   Ann Surg Oncol. 2024;31:3948-3949.
   PubMed    
   
   
   
2. CHAUHAN H, Jiwa N, Nagarajan VR, Thiruchelvam P, et al
   Clinicopathological Predictors of Positive Resection Margins in Breast-Conserving Surgery.
   Ann Surg Oncol. 2024;31:3939-3947.
   PubMed     Abstract available
   
   
   
3. CARROLL MC, Yen RW, Leech M, Barth RJ Jr, et al
   A Systematic Review and Meta-analysis of the Role of Preoperative MRI in In-breast Tumor Recurrence After Breast-Conserving Surgery.
   Ann Surg Oncol. 2024;31:3926-3938.
   PubMed     Abstract available
   
   
   
4. VINGAN PS, Serafin J, Boe L, Zhang KK, et al
   Reducing Disparities: Regional Anesthesia Blocks for Mastectomy with Reconstruction Within Standardized Regional Anesthesia Pathways.
   Ann Surg Oncol. 2024;31:3684-3693.
   PubMed     Abstract available
   
   
   
5. GONZALEZ L, Johnson NC, Jones VC, Taylor L, et al
   An Observational Cohort Study Comparing Positive Margin Rates Using an Electromagnetic Navigational System Versus Wire Localization in Breast Conservation Surgery.
   Ann Surg Oncol. 2024;31:3669-3671.
   PubMed    
   
   
   
6. KIM Y, Ganduglia-Cazaban C, Tamirisa N, Lucci A, et al
   Contemporary Analysis of Reexcision and Conversion to Mastectomy Rates and Associated Healthcare Costs for Women Undergoing Breast-Conserving Surgery.
   Ann Surg Oncol. 2024;31:3649-3660.
   PubMed     Abstract available
   
   
   May 2024
7. NGUYEN CL, Cui R, Zhou M, Ali F, et al
   ASO Visual Abstract: Cost-Effectiveness of Radar Localization Versus Wire Localization for Wide Local Excision of Non-palpable Breast Cancer.
   Ann Surg Oncol. 2024 May 9. doi: 10.1245/s10434-024-15383.
   PubMed    
   
   
   
8. LEE EG, Lee DE, Jung SY, Han JH, et al
   Clinical Application of Multimodal Sentinel Lymph Node Mapping Method in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: An Interim Analysis.
   Ann Surg Oncol. 2024 May 8. doi: 10.1245/s10434-024-15317.
   PubMed     Abstract available
   
   
   
9. HAMID SA, Schultz KS, Greenup RA
   ASO Author Reflections: "Peace of Mind" After Surgery for Breast Cancer: Implications for Preference-Sensitive Shared Decision Making.
   Ann Surg Oncol. 2024 May 7. doi: 10.1245/s10434-024-15408.
   PubMed    
   
   
   
10. PFOB A, Kokh DB, Surovtsova I, Riedel F, et al
    Oncologic Outcomes for Different Axillary Staging Techniques in Patients with Nodal-Positive Breast Cancer Undergoing Neoadjuvant Systematic Treatment: A Cancer Registry Study.
    Ann Surg Oncol. 2024 May 6. doi: 10.1245/s10434-024-15292.
    PubMed     Abstract available
    
    
    
11. NIJVELDT JJ, Rajan KK, Boersma K, Noorda EM, et al
    ASO Visual Abstract: Implementation of the Targeted Axillary Dissection Procedure in Clinically Node-Positive Breast Cancer-A Retrospective Analysis.
    Ann Surg Oncol. 2024 May 6. doi: 10.1245/s10434-024-15375.
    PubMed    
    
    
    
12. MUNCK F, Jensen MB, Vejborg I, Gerlach MK, et al
    Residual Axillary Metastases in Node-Positive Breast Cancer Patients After Neoadjuvant Treatment: A Register-Based Study.
    Ann Surg Oncol. 2024 May 4. doi: 10.1245/s10434-024-15354.
    PubMed     Abstract available
    
    
    
13. JUNG JJ, Cheun JH, Kang E, Shin I, et al
    Survival After Contralateral Axillary Metastasis in Breast Cancer.
    Ann Surg Oncol. 2024 May 2. doi: 10.1245/s10434-024-15370.
    PubMed     Abstract available
    
    
    
14. GREENE AJE, Davis J, Moon J, Dubin I, et al
    Determination of Factors Associated with Upstage in Atypical Ductal Hyperplasia to Identify Low-Risk Patients Where Active Surveillance May be an Alternative.
    Ann Surg Oncol. 2024;31:3177-3185.
    PubMed     Abstract available
    
    
    
15. CHU JJ, Tadros AB, Vingan PS, Assel MJ, et al
    Remote Symptom Monitoring with Clinical Alerts Following Mastectomy: Do Early Symptoms Predict 30-Day Surgical Complications.
    Ann Surg Oncol. 2024;31:3377-3386.
    PubMed     Abstract available
    
    
    April 2024
16. KAUFMAN C, Sarantou T, Donovan C, Kamali Polat A, et al
    ASO Author Reflections: Increasing Time of Diagnosis to Breast Cancer Surgery.
    Ann Surg Oncol. 2024 Apr 29. doi: 10.1245/s10434-024-15295.
    PubMed    
    
    
    
17. ROACH EA, Weil CR, Cannon G, Grant J, et al
    The Role of Axillary Lymph Node Dissection versus Sentinel Lymph Node Dissection in Breast Cancer Patients with Clinical N2b-N3c Disease Who Receive Adjuvant Radiotherapy.
    Ann Surg Oncol. 2024 Apr 22. doi: 10.1245/s10434-024-15280.
    PubMed     Abstract available
    
    
    
18. PARVEZ E, Bogach J, Kirkwood D, Pond G, et al
    Immigration Status and Breast Cancer Surgery Quality of Care Metrics: A Population-Level Analysis.
    Ann Surg Oncol. 2024 Apr 18. doi: 10.1245/s10434-024-15250.
    PubMed     Abstract available
    
    
    
19. XIONG M, Young AT, Fernandez A, Jones JS, et al
    Understanding Breast Cancer Surgery Through Tiktok: an Analysis of Video Content and Viewer Engagement.
    Ann Surg Oncol. 2024 Apr 9. doi: 10.1245/s10434-024-15268.
    PubMed     Abstract available
    
    
    
20. QIU M, Liang F, Xie Y, Yang H, et al
    Clinical Outcomes of Transaxillary Reverse-Sequence Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Prepectoral Breast Reconstruction: A Prospective Study of Initial 68 Procedures.
    Ann Surg Oncol. 2024;31:2777-2785.
    PubMed     Abstract available
    
    
    
21. WESTENEND P, Meurs C, van Bekkum S, van Rosmalen J, et al
    ASO Author Reflections: What Can Prediction Models for Upstaging of DCIS Diagnosed on Biopsy Tell Us About DCIS Surveillance Trials?
    Ann Surg Oncol. 2024;31:2272-2273.
    PubMed    
    
    
    
22. EVERIDGE SA, Sun J, Teshome M, Tamirisa N, et al
    ASO Visual Abstract: Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy-Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management.
    Ann Surg Oncol. 2024;31:2276-2277.
    PubMed    
    
    
    
23. SINGH P, Agnese D, Amin M, Barrio AV, et al
    Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks.
    Ann Surg Oncol. 2024;31:2212-2223.
    PubMed     Abstract available
    
    
    
24. RUBENSTEIN RN, Kim M, Plotsker EL, Chu JJ, et al
    Early Complications in Prepectoral Tissue Expander-Based Breast Reconstruction.
    Ann Surg Oncol. 2024;31:2766-2776.
    PubMed     Abstract available
    
    
    
25. QIU M, Liang F, Xie Y, Yang H, et al
    ASO Author Reflections: A Novel Technique of Transaxillary Reverse-Sequence Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Prepectoral Breast Reconstruction.
    Ann Surg Oncol. 2024;31:2791-2792.
    PubMed    
    
    
    
26. POLIDORIO N, Montagna G, Sevilimedu V, Le T, et al
    Do HER2-Low Tumors Have a Distinct Clinicopathologic Phenotype?
    Ann Surg Oncol. 2024;31:2231-2243.
    PubMed     Abstract available
    
    
    
27. QIU M, Liang F, Xie Y, Yang H, et al
    ASO Visual Abstract: Clinical Outcomes of Transaxillary Reverse-Sequence Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Prepectoral Breast Reconstruction-A Prospective Study of Initial 68 Procedures.
    Ann Surg Oncol. 2024;31:2794-2795.
    PubMed    
    
    
    
28. EVERIDGE SA, Sun J, Teshome M, Tamirisa N, et al
    Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management.
    Ann Surg Oncol. 2024;31:2224-2230.
    PubMed     Abstract available
    
    
    
29. WIENER AA, Schumacher JR, Perlman SB, Wilke LG, et al
    A Four-Arm Randomized Clinical Trial of Topical Pain Control for Sentinel Node Radiotracer Injections in Patients with Breast Cancer.
    Ann Surg Oncol. 2024 Apr 1. doi: 10.1245/s10434-024-15235.
    PubMed     Abstract available
    
    
    March 2024
30. SCODARI BT, Schaefer AP, Kapadia NS, Brooks GA, et al
    The Association Between Oncology Outreach and Timely Treatment for Rural Patients with Breast Cancer: A Claims-Based Approach.
    Ann Surg Oncol. 2024 Mar 27. doi: 10.1245/s10434-024-15195.
    PubMed     Abstract available
    
    
    
31. NIJVELDT JJ, Rajan KK, Boersma K, Noorda EM, et al
    Implementation of the Targeted Axillary Dissection Procedure in Clinically Node-Positive Breast Cancer: A Retrospective Analysis.
    Ann Surg Oncol. 2024 Mar 24. doi: 10.1245/s10434-024-15182.
    PubMed     Abstract available
    
    
    
32. NGUYEN CL, Cui R, Zhou M, Ali F, et al
    Cost-Effectiveness of Radar Localisation Versus Wire Localisation for Wide Local Excision of Non-palpable Breast Cancer.
    Ann Surg Oncol. 2024 Mar 12. doi: 10.1245/s10434-024-15142.
    PubMed     Abstract available
    
    
    
33. CHUNG AP, Dang CM, Karlan SR, Amersi FF, et al
    ASO Visual Abstract: A Prospective Study of Sentinel Node Biopsy Omission in Women Age >/= 65 with ER+ Breast Cancer.
    Ann Surg Oncol. 2024 Mar 6. doi: 10.1245/s10434-024-15137.
    PubMed    
    
    
    
34. CARTER MM, Whitrock JN, Pratt CG, Shaughnessy EA, et al
    ASO Visual Abstract: Nationwide Analysis of Locoregional Management for Ductal Carcinoma In Situ (DCIS) in Males-An NCDB Analysis of the Surgical Approach to DCIS in Males.
    Ann Surg Oncol. 2024;31:1663-1664.
    PubMed    
    
    
    
35. VORSTENBOSCH J, Ghione P, Plitas G, Horwitz S, et al
    Surgical Management and Long-Term Outcomes of BIA-ALCL: A Multidisciplinary Approach.
    Ann Surg Oncol. 2024;31:2032-2040.
    PubMed     Abstract available
    
    
    
36. PALMQUIST E, Sevilimedu V, Garcia P, Le T, et al
    Patient-Reported Outcomes in Patients Undergoing Lumpectomy With and Without Defect Closure.
    Ann Surg Oncol. 2024;31:1615-1622.
    PubMed     Abstract available
    
    
    
37. SPIEKERMAN VAN WEEZELENBURG MA, Bakens MJAM, Daemen JHT, Aldenhoven L, et al
    Prevention of Seroma Formation and Its Sequelae After Axillary Lymph Node Dissection: An Up-to-Date Systematic Review and Guideline for Surgeons.
    Ann Surg Oncol. 2024;31:1643-1652.
    PubMed     Abstract available
    
    
    
38. GOLDHABER N, O'Keefe T, Blair S
    Reply to: "Is Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70 Years of Age? A National Cancer Database Analysis of Sentinel Node Practice Patterns.
    Ann Surg Oncol. 2024;31:1669-1670.
    PubMed    
    
    
    
39. CARTER MM, Whitrock JN, Pratt CG, Shaughnessy EA, et al
    Nationwide Analysis of Locoregional Management for Ductal Carcinoma In Situ in Males: An NCDB Analysis of the Surgical Approach to DCIS in Males.
    Ann Surg Oncol. 2024;31:1599-1607.
    PubMed     Abstract available
    
    
    
40. ROLDAN-VASQUEZ E, Bharani T, Mitri S, Flores R, et al
    Expanding Access to Immediate Lymphatic Reconstruction Through an Axillary Surgery Referral Program: A 6-Year Single-Center Experience.
    Ann Surg Oncol. 2024;31:2025-2031.
    PubMed     Abstract available
    
    
    
41. COSTARELLI L, Arienzo F, Broglia L, La Pinta M, et al
    Clipping a Positive Lymph Node Improves Accuracy of Nodal Staging After Neoadjuvant Chemotherapy for Breast Cancer Patients, but Does It Drive Management Changes?
    Ann Surg Oncol. 2024 Mar 1. doi: 10.1245/s10434-024-15052.
    PubMed     Abstract available
    
    
    February 2024
42. JAKUB JW, Advani P, Maxwell R, Vallow L, et al
    SOUND (Sentinel Node Versus Observation After Axillary Ultrasound) Trial: Are We Ready to Change the Tune of Our Breast Cancer Practice?
    Ann Surg Oncol. 2024 Feb 28. doi: 10.1245/s10434-024-15111.
    PubMed    
    
    
    
43. CHUNG A
    ASO Author Reflections: Considerations in the Debate on Sentinel Node Biopsy in Older Patients with ER+/Her2- Breast Cancer.
    Ann Surg Oncol. 2024 Feb 21. doi: 10.1245/s10434-024-15095.
    PubMed    
    
    
    
44. BARKER VR, Naffouje SA, Mallory MA, Hoover SA, et al
    ASO Visual Abstract: Surgical Management of the Axilla in HR+/HER2-Breast Cancer in the Z1071 Era: A Propensity-Score Matched Analysis of the National Cancer Database.
    Ann Surg Oncol. 2024 Feb 19. doi: 10.1245/s10434-024-15063.
    PubMed    
    
    
    
45. CHUN JW, Kang E, Kim HK, Lee HB, et al
    Oncological Safety of Skipping Axillary Lymph Node Dissection in Patients with Clinical N0, Sentinel Node-Positive Breast Cancer Undergoing Total Mastectomy.
    Ann Surg Oncol. 2024 Feb 17. doi: 10.1245/s10434-024-15049.
    PubMed     Abstract available
    
    
    
46. LAWS A, Leonard S, Hershey E, Stokes S, et al
    ASO Visual Abstract: Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions.
    Ann Surg Oncol. 2024 Feb 16. doi: 10.1245/s10434-024-15067.
    PubMed    
    
    
    
47. CORTINA CS, Lloren JI, Rogers C, Johnson MK, et al
    ASO Visual Abstract: Does Neoadjuvant Chemotherapy in Clinical T1-T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery?
    Ann Surg Oncol. 2024 Feb 15. doi: 10.1245/s10434-024-15037.
    PubMed    
    
    
    
48. SCHWARTZ T
    At the Speed of SOUND: The Pace of Change for Axillary Management in Breast Cancer.
    Ann Surg Oncol. 2024 Feb 12. doi: 10.1245/s10434-024-15010.
    PubMed    
    
    
    
49. CHUNG AP, Dang CM, Karlan SR, Amersi FF, et al
    A Prospective Study of Sentinel Node Biopsy Omission in Women Age >/= 65 Years with ER+ Breast Cancer.
    Ann Surg Oncol. 2024 Feb 12. doi: 10.1245/s10434-024-15000.
    PubMed     Abstract available
    
    
    
50. CORTINA CS, Rogers CC, Teshome M
    ASO Author Reflections: Neoadjuvant Systemic Therapy and Nodal Management in cT1-2 N0 Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2024 Feb 10. doi: 10.1245/s10434-024-15020.
    PubMed    
    
    
    
51. CHO JH, Park JM, Park HS, Kim HJ, et al
    ASO Visual Abstract: Oncologic Outcomes in Nipple-Sparing Mastectomy with Immediate Reconstruction and Total Mastectomy with Immediate Reconstruction in Women with Breast Cancer: A Machine Learning Analysis.
    Ann Surg Oncol. 2024 Feb 8. doi: 10.1245/s10434-024-14982.
    PubMed    
    
    
    
52. BHATIA MB, Kisilu N, Kiptoo S, Limenik I, et al
    Breast Health Awareness: Understanding Health-Seeking Behavior in Western Kenya.
    Ann Surg Oncol. 2024;31:1190-1199.
    PubMed     Abstract available
    
    
    
53. APOSTOLOVA C, Ferroum A, Alhassan B, Prakash I, et al
    ASO Visual Abstract: Surgical Decision Making in Genetically High-Risk Women-Quantifying Postoperative Complications and Long-Term Risks of Supplemental Surgery After Risk-Reducing Mastectomy.
    Ann Surg Oncol. 2024;31:1018-1019.
    PubMed    
    
    
    
54. MYERS SP, Bayard S, Tadros AB, Sevilimedu V, et al
    ASO Visual Abstract: Examining Race and Patient-Reported Outcomes After Contralateral Prophylactic Mastectomy with Reconstruction.
    Ann Surg Oncol. 2024;31:1023-1024.
    PubMed    
    
    
    
55. MYERS SP, Bayard S, Tadros AB, Sevilimedu V, et al
    Examining Race and Patient-Reported Outcomes After Contralateral Prophylactic Mastectomy with Reconstruction.
    Ann Surg Oncol. 2024;31:966-973.
    PubMed     Abstract available
    
    
    
56. HERSH EH, Minami CA, Weiss A, King TA, et al
    Opportunities for De-Escalation of Axillary Surgery in Patients with Ductal Carcinoma in Situ with Microinvasion.
    Ann Surg Oncol. 2024;31:726-728.
    PubMed    
    
    
    
57. LOHANI KR, Hoskin TL, Day CN, Yasir S, et al
    ASO Author Reflections: Toward Individualized Management of Heterogenous Mixed Invasive Ductolobular Breast Cancers.
    Ann Surg Oncol. 2024;31:1008-1009.
    PubMed     Abstract available
    
    
    
58. TOKITA HK, Assel M, Simon BA, Lin E, et al
    ASO Visual Abstract: Regional Blocks Benefit Patients Undergoing Bilateral Mastectomy with Immediate Implant-Based Reconstruction, Even After Discharge.
    Ann Surg Oncol. 2024;31:1014-1015.
    PubMed    
    
    
    
59. KANTOR O, King TA, Jones A, Glass C, et al
    ASO Visual Abstract: Racial and Ethnic Disparities in Outcomes after Breast-Conserving Therapy and Endocrine Therapy for DCIS-A Post Hoc Analysis of the NSABP B-35 Randomized, Clinical Trial.
    Ann Surg Oncol. 2024;31:1010-1011.
    PubMed    
    
    
    
60. KLASSEN CL, Viers LD, Ghosh K
    Following the High-Risk Patient: Breast Cancer Risk-Based Screening.
    Ann Surg Oncol. 2024 Feb 1. doi: 10.1245/s10434-024-14957.
    PubMed     Abstract available
    
    
    January 2024
61. CHOI S, Borowsky PA, Morgan O, Kwon D, et al
    A Multi-institutional Analysis of Factors Influencing the Rate of Positive MRI Biopsy Among Women with Early-Stage Breast Cancer.
    Ann Surg Oncol. 2024 Jan 29. doi: 10.1245/s10434-024-14954.
    PubMed     Abstract available
    
    
    
62. NG TP, Loo BYK, Yong N, Chia CLK, et al
    Review: Implant-Based Breast Reconstruction After Mastectomy for Breast Cancer: A Meta-analysis of Randomized Controlled Trials and Prospective Studies Comparing Use of Acellular Dermal Matrix (ADM) Versus Without ADM.
    Ann Surg Oncol. 2024 Jan 29. doi: 10.1245/s10434-024-14943.
    PubMed     Abstract available
    
    
    
63. CORTINA CS, Lloren JI, Rogers C, Johnson MK, et al
    Does Neoadjuvant Chemotherapy in Clinical T1-T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery?
    Ann Surg Oncol. 2024 Jan 25. doi: 10.1245/s10434-024-14914.
    PubMed     Abstract available
    
    
    
64. HIGGINS T, Kantor O, Harrison B, Giordano J, et al
    ASO Visual Abstract: Defining the Biology of Estrogen Receptor-Low Positive Breast Cancer.
    Ann Surg Oncol. 2024 Jan 24. doi: 10.1245/s10434-024-14921.
    PubMed    
    
    
    
65. LAWS A, Leonard S, Hershey E, Stokes S, et al
    Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions.
    Ann Surg Oncol. 2024 Jan 23. doi: 10.1245/s10434-024-14947.
    PubMed     Abstract available
    
    
    
66. KOBZEVA-HERZOG A, O'Shea T, Young S, Kenzik K, et al
    ASO Visual Abstract: Breast Cancer Screening and BI-RADS Scoring Trends Before and During the COVID-19 Pandemic in an Academic Safety-Net Hospital.
    Ann Surg Oncol. 2024 Jan 22. doi: 10.1245/s10434-024-14896.
    PubMed    
    
    
    
67. KIM HS, Noh YK, Min KW, Kim DH, et al
    ASO Visual Abstract: Cancer-Associated Fibroblasts Together with a Decline in CD8+ T Cells Predict a Worse Prognosis for Breast Cancer Patients.
    Ann Surg Oncol. 2024 Jan 17. doi: 10.1245/s10434-024-14889.
    PubMed    
    
    
    
68. BRAHMBHATT P, Look Hong NJ, Sriskandarajah A, Alavi N, et al
    A Feasibility Randomized Controlled Trial of Prehabilitation During Neoadjuvant Chemotherapy for Women with Breast Cancer: A Mixed Methods Study.
    Ann Surg Oncol. 2024 Jan 13. doi: 10.1245/s10434-023-14851.
    PubMed     Abstract available
    
    
    
69. LAWS A, Lagendijk M, Grossmith S, Hughes M, et al
    ASO Visual Abstract: Long-Term Patient-Reported Arm Symptoms in Breast Cancer Survivors.
    Ann Surg Oncol. 2024 Jan 11. doi: 10.1245/s10434-023-14868.
    PubMed    
    
    
    
70. WOODFIN AA, Yam C, Teshome M, Kuerer HM, et al
    ASO Visual Abstract: Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2024 Jan 11. doi: 10.1245/s10434-023-14842.
    PubMed    
    
    
    
71. CHENG O, Postlewait LM
    De-Escalation of Multidisciplinary Breast Cancer Care with Cryoablation Therapy: Navigating Novel Therapeutics, Ethics, and Outcomes.
    Ann Surg Oncol. 2024 Jan 7. doi: 10.1245/s10434-023-14784.
    PubMed    
    
    
    
72. KOBZEVA-HERZOG A, O'Shea T, Young S, Kenzik K, et al
    Breast Cancer Screening and BI-RADS Scoring Trends Before and During the COVID-19 Pandemic in an Academic Safety-Net Hospital.
    Ann Surg Oncol. 2024 Jan 4. doi: 10.1245/s10434-023-14787.
    PubMed     Abstract available
    
    
    
73. HARAVU PN, Shakir A, Jackson K, Alva D, et al
    Establishment and Feasibility of an Immediate Lymphatic Reconstruction Program in a Community Health System.
    Ann Surg Oncol. 2024;31:672-680.
    PubMed     Abstract available
    
    
    
74. SUYDAM C, Chibane F, Brown N, Schlafly M, et al
    Are There More HER2 FISH in the Sea? An Institution's Experience in Identifying HER2 Positivity Using Fluorescent In Situ Hybridization in Patients with HER2 Negative Immunohistochemistry.
    Ann Surg Oncol. 2024;31:376-381.
    PubMed     Abstract available
    
    
    
75. MAGOON R, Suresh V
    Comparing Pre- and Post-mastectomy Regional Blocks: An Anesthesiologist's Perspective.
    Ann Surg Oncol. 2024;31:403-404.
    PubMed    
    
    
    
76. HASSAN AM, Paidisetty P, Ray N, Govande JG, et al
    Frail but Resilient: Frailty in Autologous Breast Reconstruction is Associated with Worse Surgical Outcomes but Equivalent Long-Term Patient-Reported Outcomes.
    Ann Surg Oncol. 2024;31:659-671.
    PubMed     Abstract available
    
    
    
77. MUKHTAR RA, Huppert L, Ramalingam K
    Letter to the Editor of Annals of Surgical Oncology concerning "Is Choosing Wisely Wise for Lobular Carcinoma in Patients over 70 Years of Age? A National Cancer Database Analysis of Sentinel Node Practice Patterns".
    Ann Surg Oncol. 2024;31:401-402.
    PubMed    
    
    
    
78. HASSAN AM, Mericli AF, Selber JC
    The Impact of Frailty on Surgical and Patient-Reported Outcomes of Autologous Breast Reconstruction.
    Ann Surg Oncol. 2024;31:386-387.
    PubMed    
    
    
    
79. PARMESHWAR N, Dugan CL, Barnes LL, Cheng JK, et al
    ASO Visual Abstract: Nipple-Sparing Mastectomies in Patients over the Age of 60 Years: Factors Associated with Surgical Outcomes.
    Ann Surg Oncol. 2024;31:398-399.
    PubMed    
    
    
    
80. APOSTOLOVA C, Ferroum A, Alhassan B, Prakash I, et al
    Surgical Decision Making in Genetically High-Risk Women: Quantifying Postoperative Complications and Long-Term Risks of Supplemental Surgery After Risk-Reducing Mastectomy.
    Ann Surg Oncol. 2024;31:356-364.
    PubMed     Abstract available
    
    
    
81. ONG C, Blue CM, Khan J, Deng X, et al
    Luminal A Versus B After Choosing Wisely: Does Lymph Node Surgery Affect Oncologic Outcomes?
    Ann Surg Oncol. 2024;31:335-343.
    PubMed     Abstract available
    
    
    
82. TOKITA HK, Assel M, Simon BA, Lin E, et al
    Regional Blocks Benefit Patients Undergoing Bilateral Mastectomy with Immediate Implant-Based Reconstruction, Even After Discharge.
    Ann Surg Oncol. 2024;31:316-324.
    PubMed     Abstract available
    
    
    December 2023
83. HIGGINS T, Kantor O, Harrison B, Giordano J, et al
    Defining the Biology of Estrogen Receptor-Low-Positive Breast Cancer.
    Ann Surg Oncol. 2023 Dec 31. doi: 10.1245/s10434-023-14835.
    PubMed     Abstract available
    
    
    
84. CHEN JC, Handley D, Elsaid MI, Plascak JJ, et al
    ASO Visual Abstract: The Implications of Racialized Economic Segregation and Allostatic Load on Mortality in Patients with Breast Cancer.
    Ann Surg Oncol. 2023 Dec 29. doi: 10.1245/s10434-023-14788.
    PubMed    
    
    
    
85. RAUZI A, Powell LE, White M, Prathibha S, et al
    ASO Visual Abstract: Readability Analysis of Online Breast Cancer Surgery Patient Education Materials from National Cancer Institute-Designated Cancer Centers Compared with Top Internet Search Results.
    Ann Surg Oncol. 2023 Dec 28. doi: 10.1245/s10434-023-14832.
    PubMed    
    
    
    
86. MENG X, Wang N, Qin P, Jia Q, et al
    ASO Author Reflections: Refining Radiotherapy Decisions in T3N0M0 Breast Cancer: A Nomogram-Based Approach.
    Ann Surg Oncol. 2023 Dec 23. doi: 10.1245/s10434-023-14818.
    PubMed    
    
    
    
87. KIM HS, Min KW
    ASO Author Reflections: Cancer-Associated Fibroblasts with Decreased CD8+ T Cells are Associated with a Poor Prognosis in the Treatment of Breast Cancer Patients.
    Ann Surg Oncol. 2023 Dec 23. doi: 10.1245/s10434-023-14817.
    PubMed    
    
    
    
88. KHATTAK MN, Chichura AM, Lang JE
    Adjuvant Trastuzumab Emtansine Versus Paclitaxel and Trastuzumab in Stage I HER2-Positive Breast Cancer: The ATEMPT Trial.
    Ann Surg Oncol. 2023 Dec 21. doi: 10.1245/s10434-023-14766.
    PubMed     Abstract available
    
    
    
89. BHATIA MB, Hunter-Squires JL, Busakhala N
    ASO Author Reflections: Breast Cancer Early Detection: If You Build It, She Will Come.
    Ann Surg Oncol. 2023 Dec 14. doi: 10.1245/s10434-023-14719.
    PubMed    
    
    
    
90. KIM HS, Noh YK, Min KW, Kim DH, et al
    Cancer-Associated Fibroblasts Together with a Decline in CD8+ T Cells Predict a Worse Prognosis for Breast Cancer Patients.
    Ann Surg Oncol. 2023 Dec 13. doi: 10.1245/s10434-023-14715.
    PubMed     Abstract available
    
    
    
91. PFOB A, Cai L, Schneeweiss A, Rauch G, et al
    ASO Visual Abstract: Minimally-Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment-A New Concept.
    Ann Surg Oncol. 2023 Dec 13. doi: 10.1245/s10434-023-14747.
    PubMed    
    
    
    
92. MENG X, Wang N, Qin P, Jia Q, et al
    Nomogram-Based Risk Stratification to Identify Patients with T3N0M0 Breast Cancer with Survival Benefit from Postmastectomy Radiotherapy.
    Ann Surg Oncol. 2023 Dec 12. doi: 10.1245/s10434-023-14723.
    PubMed     Abstract available
    
    
    
93. HERNANDEZ AE, Goel N
    ASO Author Reflections: Translational Epidemiology in Breast Cancer Research: Integrating Social and Biological Data to Understand Disparities.
    Ann Surg Oncol. 2023 Dec 10. doi: 10.1245/s10434-023-14661.
    PubMed    
    
    
    
94. EDEN CM, Ju T, Newman LA, Malik M, et al
    ASO Author Reflections: Disparities Among the Disaggregated Asian American Breast Cancer Population in New York City.
    Ann Surg Oncol. 2023 Dec 10. doi: 10.1245/s10434-023-14777.
    PubMed    
    
    
    
95. LAWS A, Lagendijk M, Grossmith S, Hughes M, et al
    Long-Term Patient-Reported Arm Symptoms in Breast Cancer Survivors.
    Ann Surg Oncol. 2023 Dec 10. doi: 10.1245/s10434-023-14711.
    PubMed     Abstract available
    
    
    
96. HERNANDEZ AE, Westrick AC, Stoler J, Kesmodel SB, et al
    ASO Visual Abstract: Associations Between Neighborhood-Level Income and Triple-Negative Breast Cancer in a Majority-Minority Population.
    Ann Surg Oncol. 2023 Dec 10. doi: 10.1245/s10434-023-14666.
    PubMed    
    
    
    
97. EDEN CM, Syrnioti G, Johnson J, Fasano G, et al
    ASO Visual Abstract: Breast Cancer Incidence Among Asian American Women in New York City-Disparities in Screening and Presentation.
    Ann Surg Oncol. 2023 Dec 10. doi: 10.1245/s10434-023-14750.
    PubMed    
    
    
    
98. ALHASSAN B, Rjeily MB, Villareal-Corpuz V, Prakash I, et al
    ASO Visual Abstract: Awareness and Candidacy for Endocrine Prevention and Risk-Reducing Mastectomy of Unaffected High-Risk Women Referred for Breast Cancer Risk Assessment.
    Ann Surg Oncol. 2023 Dec 7. doi: 10.1245/s10434-023-14671.
    PubMed    
    
    
    
99. JAMES TA, Roldan E
    ASO Author Reflections: Advancing Surgical Care in Breast Cancer: Insights from an Axillary Surgery Referral Program.
    Ann Surg Oncol. 2023 Dec 6. doi: 10.1245/s10434-023-14718.
    PubMed    
    
    
    
100. EDEN CM, Syrnioti G, Johnson J, Fasano G, et al
     Breast Cancer Incidence Among Asian American Women in New York City: Disparities in Screening and Presentation.
     Ann Surg Oncol. 2023 Dec 6. doi: 10.1245/s10434-023-14640.
     PubMed     Abstract available
     
     
     
101. NEWMAN LA
     Top Breast Oncology Articles from 2021 to Inform Your Cancer Practice.
     Ann Surg Oncol. 2023;30:8296-8301.
     PubMed     Abstract available
     
     
     
102. HAGLICH K, Stern C, Graziano FD, Shamsunder MG, et al
     Missing Data in Patient-Reported Outcomes Research: Utilizing Multiple Imputation to Address an Unavoidable Problem.
     Ann Surg Oncol. 2023;30:8074-8082.
     PubMed     Abstract available
     
     
     
103. KANTOR O, King TA, Jones A, Glass C, et al
     Racial and Ethnic Disparities in Outcomes After Breast-Conserving Therapy and Endocrine Therapy for DCIS: A Post-Hoc Analysis of the NSABP B-35 Randomized Clinical Trial.
     Ann Surg Oncol. 2023;30:8404-8411.
     PubMed     Abstract available
     
     
     
104. PARMESHWAR N, Piper M
     ASO Author Reflections: Evaluating Nipple-Sparing Mastectomies in Patients Over Age 60.
     Ann Surg Oncol. 2023;30:8462-8463.
     PubMed    
     
     
     
105. VAN OLMEN JP, Beerthuizen AWJ, Bekers EM, Viegen I, et al
     ASO Visual Abstract: Management of Benign Phyllodes Tumors: A Dutch Population-Based Retrospective Cohort Between 1989 and 2022.
     Ann Surg Oncol. 2023;30:8486.
     PubMed    
     
     
     
106. SETO A, Pass A, Babkowski R, Volpicelli ER, et al
     ASO Visual Abstract: Routine Use of a Standardized, Mastectomy Diagram by Surgeons Improves Accuracy and Timeliness of the Final Pathological Report.
     Ann Surg Oncol. 2023;30:8483.
     PubMed    
     
     
     
107. NASH AL, Bloom DL, Chapman BM, Wheeler SB, et al
     ASO Visual Abstract: Contralateral Prophylactic Mastectomy Decision Making-The Partners' Perspective.
     Ann Surg Oncol. 2023;30:8481-8482.
     PubMed    
     
     
     
108. PARMESHWAR N, Dugan CL, Barnes LL, Cheng JK, et al
     Nipple-Sparing Mastectomies in Patients over the Age of 60 Years: Factors Associated with Surgical Outcomes.
     Ann Surg Oncol. 2023;30:8428-8435.
     PubMed     Abstract available
     
     
     
109. MILLEN JC, Jackson K, Stern SL, Orozco JIJ, et al
     ASO Visual Abstract: Simultaneous Symmetry Procedure in Patients Undergoing Oncoplastic Breast-Conserving Surgery: An Evaluation of Patient Desire and Revision Rates.
     Ann Surg Oncol. 2023;30:8475.
     PubMed    
     
     
     
110. CHAMPION NT, Mooney B, Kim Y, Whiting J, et al
     ASO Visual Abstract: Surgeon and Radiologist Evaluation of Electromagnetic Chip Localization for Benign and Malignant Breast Lesions.
     Ann Surg Oncol. 2023;30:8478.
     PubMed    
     
     
     
111. CAIRNS A, Howard-McNatt M
     ASO Author Reflections: Preoperative MRI Utilization Relating to Margin Status in Breast-Conserving Surgery (BCS): SHAVE Trial Data.
     Ann Surg Oncol. 2023;30:8459.
     PubMed    
     
     
     
112. YOUN S, Lee E, Peiris L, Olson D, et al
     ASO Visual Abstract: Spare the Nipple: A Systematic Review of Tumor Nipple-Distance and Oncologic Outcomes in Nipple-Sparing Mastectomy.
     Ann Surg Oncol. 2023;30:8473.
     PubMed    
     
     
     
113. FLORES R, Roldan E, Pardo JA, Beight L, et al
     ASO Visual Abstract: Discordant Breast and Axillary Pathologic Response to Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2023;30:8467-8468.
     PubMed    
     
     
     
114. VAN OLMEN JP, Beerthuizen AWJ, Bekers EM, Viegen I, et al
     Management of Benign Phyllodes Tumors: A Dutch Population-Based Retrospective Cohort Between 1989 and 2022.
     Ann Surg Oncol. 2023;30:8344-8352.
     PubMed     Abstract available
     
     
     
115. VAN OLMEN JP, Bartels SAL, van Duijnhoven FH
     ASO Author Reflections: The Management of Benign Phyllodes Tumors.
     Ann Surg Oncol. 2023;30:8457-8458.
     PubMed    
     
     
     
116. YOUN S, Lee E, Peiris L, Olson D, et al
     Spare the Nipple: A Systematic Review of Tumor Nipple-Distance and Oncologic Outcomes in Nipple-Sparing Mastectomy.
     Ann Surg Oncol. 2023;30:8381-8388.
     PubMed     Abstract available
     
     
     
117. FLORES R, Roldan E, Pardo JA, Beight L, et al
     Discordant Breast and Axillary Pathologic Response to Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2023;30:8302-8307.
     PubMed     Abstract available
     
     
     November 2023
118. BEAULIEU-JONES BR, Ha EJ, Fefferman A, Wang J, et al
     Association of Race, Ethnicity, Language, and Insurance with Time to Treatment Initiation Among Women with Breast Cancer at an Urban, Academic, Safety-Net Hospital.
     Ann Surg Oncol. 2023 Nov 28. doi: 10.1245/s10434-023-14612.
     PubMed     Abstract available
     
     
     
119. SCHULZE AK, Hoskin TL, Moldoveanu D, Sturz JL, et al
     ASO Visual Abstract: Tumor Characteristics of Bilateral Breast Cancer Compared with Unilateral Breast Cancer.
     Ann Surg Oncol. 2023 Nov 25. doi: 10.1245/s10434-023-14588.
     PubMed    
     
     
     
120. SHELTON C, Nielsen SM
     ASO Author Reflections: Impact of Universal Germline Genetic Testing on Clinical Management in Rural Breast Cancer Patients.
     Ann Surg Oncol. 2023 Nov 23. doi: 10.1245/s10434-023-14510.
     PubMed    
     
     
     
121. LOHANI KR, Hoskin TL, Day CN, Yasir S, et al
     ASO Visual Abstract: Lobular-Like Features and Outcomes of Mixed Invasive Ductolobular Breast Cancer (MIDLC): Insights from 54,403 Stage I-III MIDLC Patients.
     Ann Surg Oncol. 2023 Nov 20. doi: 10.1245/s10434-023-14589.
     PubMed    
     
     
     
122. MINAMI CA, Jin G, Freedman RA, Schonberg MA, et al
     ASO Visual Abstract: Trends in Locoregional Therapy in Older Women with Early-Stage Hormone Receptor-Positive Breast Cancer by Frailty and Life Expectancy.
     Ann Surg Oncol. 2023 Nov 20. doi: 10.1245/s10434-023-14600.
     PubMed    
     
     
     
123. SHELTON C, Ruiz A, Shelton L, Montgomery H, et al
     ASO Visual Abstract: Universal Germline Genetic Testing for Breast Cancer: Implementation in a Rural Practice and Impact on Shared Decision Making.
     Ann Surg Oncol. 2023 Nov 17. doi: 10.1245/s10434-023-14596.
     PubMed    
     
     
     
124. HERNANDEZ AE, Westrick AC, Stoler J, Kesmodel SB, et al
     Associations Between Neighborhood-Level Income and Triple-Negative Breast Cancer in a Majority-Minority Population.
     Ann Surg Oncol. 2023 Nov 17. doi: 10.1245/s10434-023-14517.
     PubMed     Abstract available
     
     
     
125. ALHASSAN B, Rjeily MB, Villareal-Corpuz V, Prakash I, et al
     Awareness and Candidacy for Endocrine Prevention and Risk Reducing Mastectomy in Unaffected High-Risk Women Referred for Breast Cancer Risk Assessment.
     Ann Surg Oncol. 2023 Nov 16. doi: 10.1245/s10434-023-14566.
     PubMed     Abstract available
     
     
     
126. WOODFIN AA, Yam C, Teshome M, Kuerer HM, et al
     Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer.
     Ann Surg Oncol. 2023 Nov 16. doi: 10.1245/s10434-023-14541.
     PubMed     Abstract available
     
     
     
127. JOHNSON JA, Newman LA
     ASO Author Reflections: Using the Cancer Genome Atlas to Investigate the Role of Genetics in Breast Cancer Disparities.
     Ann Surg Oncol. 2023 Nov 15. doi: 10.1245/s10434-023-14296.
     PubMed    
     
     
     
128. WEBER WP, Heidinger M, Hayoz S, Matrai Z, et al
     ASO Visual Abstract: Impact of Imaging-Guided Localization on Performance of Tailored Axillary Surgery in Patients with Clinically Node-Positive Breast Cancer: Prospective Cohort Study Within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
     Ann Surg Oncol. 2023 Nov 13. doi: 10.1245/s10434-023-14489.
     PubMed    
     
     
     
129. CHU C, Smith CE, Gorski J, Smolkin M, et al
     ASO Visual Abstract: Decision Aid for High Risk Breast Screening-Implementation of a Novel Patient Decision Aid for Women with Elevated Breast Cancer Risk Considering MRI Screening-A Pilot Study.
     Ann Surg Oncol. 2023 Nov 10. doi: 10.1245/s10434-023-14530.
     PubMed    
     
     
     
130. PFOB A, Cai L, Schneeweiss A, Rauch G, et al
     Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept.
     Ann Surg Oncol. 2023 Nov 10. doi: 10.1245/s10434-023-14551.
     PubMed     Abstract available
     
     
     
131. CORTINA CS, Siegel EL, Polovneff A, Sahyouni G, et al
     Current Insurance Policy Coverage for Screening Mammography in Transgender and Gender-Diverse Individuals.
     Ann Surg Oncol. 2023;30:6978-6980.
     PubMed    
     
     
     
132. CHOI KY, Hao Q, Carlisle K, Hollenbeak CS, et al
     ASO Visual Abstract: Cost-Effectiveness of [(99m)Tc]Tilmanocept Relative to [(99m)Tc]Sulfur Colloid for Sentinel Lymph Node Biopsy in Early Stage Oral Cavity Cancer.
     Ann Surg Oncol. 2023;30:7699.
     PubMed    
     
     
     
133. MYERS SP, Tadros AB, Sevilimedu V, Nelson JA, et al
     Satisfaction and Well-Being After Contralateral Prophylactic Mastectomy Among BRCA Mutation Carriers and Noncarriers: A Longitudinal Analysis of BREAST-Q Domains.
     Ann Surg Oncol. 2023;30:7116-7123.
     PubMed     Abstract available
     
     
     
134. CHEN KA, Kirchoff KE, Butler LR, Holloway AD, et al
     Analysis of Specimen Mammography with Artificial Intelligence to Predict Margin Status.
     Ann Surg Oncol. 2023;30:7107-7115.
     PubMed     Abstract available
     
     
     
135. PAK LM, Matar-Ujvary R, Verdial FC, Haglich KA, et al
     Long-Term Patient-Reported Outcomes Comparing Oncoplastic Breast Surgery and Conventional Breast-Conserving Surgery: A Propensity Score-Matched Analysis.
     Ann Surg Oncol. 2023;30:7091-7098.
     PubMed     Abstract available
     
     
     
136. CHAMPION NT, Mooney B, Kim Y, Whiting J, et al
     Surgeon and Radiologist Evaluation of Electromagnetic Chip Localization for Benign and Malignant Breast Lesions.
     Ann Surg Oncol. 2023;30:7081-7090.
     PubMed     Abstract available
     
     
     
137. ZAVERI S, Kuerer HM
     ASO Author Reflections: The Importance of a Multidisciplinary Approach to Axillary Management in the Upfront Mastectomy Patient.
     Ann Surg Oncol. 2023;30:7131-7132.
     PubMed    
     
     
     
138. XU C, Pfob A, Sidey-Gibbons C
     ASO Author Reflections: Enhancing Surgical Decision-Making for Breast Reconstruction-Machine Learning-Driven Prediction of Postoperative Quality of Life.
     Ann Surg Oncol. 2023;30:7135-7136.
     PubMed    
     
     
     
139. CHE BAKRI NA, Kwasnicki RM, Giannas E, Tenang L, et al
     The Use of Wearable Activity Monitors to Measure Upper Limb Physical Activity After Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy.
     Ann Surg Oncol. 2023;30:7036-7045.
     PubMed     Abstract available
     
     
     
140. CHE BAKRI NA, Kwasnicki RM, Giannas E, Tenang L, et al
     ASO Author Reflections: Objective Outcome Measure of Upper Limb Function Following Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy.
     Ann Surg Oncol. 2023;30:7133-7134.
     PubMed    
     
     
     October 2023
141. SCHULZE AK, Hoskin TL, Moldoveanu D, Sturz JL, et al
     Tumor Characteristics of Bilateral Breast Cancer Compared with Unilateral Breast Cancer.
     Ann Surg Oncol. 2023 Oct 31. doi: 10.1245/s10434-023-14451.
     PubMed     Abstract available
     
     
     
142. KHAN MMM, Munir MM, Pawlik TM
     ASO Author Reflections: Disparities in Breast Cancer Screening Rates Among Adults With and Without Intellectual and Developmental Disabilities.
     Ann Surg Oncol. 2023 Oct 31. doi: 10.1245/s10434-023-14505.
     PubMed    
     
     
     
143. WEBER WP, Heidinger M, Hayoz S, Matrai Z, et al
     Impact of Imaging-Guided Localization on Performance of Tailored Axillary Surgery in Patients with Clinically Node-Positive Breast Cancer: Prospective Cohort Study Within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101).
     Ann Surg Oncol. 2023 Oct 30. doi: 10.1245/s10434-023-14404.
     PubMed     Abstract available
     
     
     
144. LOHANI KR, Hoskin TL, Day CN, Yasir S, et al
     Lobular-Like Features and Outcomes of Mixed Invasive Ductolobular Breast Cancer (MIDLC): Insights from 54,403 Stage I-III MIDLC Patients.
     Ann Surg Oncol. 2023 Oct 23. doi: 10.1245/s10434-023-14455.
     PubMed     Abstract available
     
     
     
145. CHEN JC, Handley D, Elsaid MI, Plascak JJ, et al
     The Implications of Racialized Economic Segregation and Allostatic Load on Mortality in Patients with Breast Cancer.
     Ann Surg Oncol. 2023 Oct 22. doi: 10.1245/s10434-023-14431.
     PubMed     Abstract available
     
     
     
146. FARLEY C, Hwang RF
     ASO Author Reflections: Preoperative Assessment of Nodal Burden in Breast Cancer.
     Ann Surg Oncol. 2023 Oct 20. doi: 10.1245/s10434-023-14326.
     PubMed    
     
     
     
147. KHAN MMM, Waqar U, Munir MM, Woldesenbet S, et al
     Disparities in Breast Cancer Screening Rates Among Adults With and Without Intellectual and Developmental Disabilities.
     Ann Surg Oncol. 2023 Oct 19. doi: 10.1245/s10434-023-14425.
     PubMed     Abstract available
     
     
     
148. HALIMA A, Fane L, Parker S, Obi E, et al
     Intraoperative Radiation Therapy for Early-Stage Breast Cancer: Updated Outcomes from a Single-Institution Experience.
     Ann Surg Oncol. 2023 Oct 19. doi: 10.1245/s10434-023-14448.
     PubMed     Abstract available
     
     
     
149. ONG C, Blue CM, McGuire KP
     ASO Author Reflections: Changes in Breast Cancer Management with Advances in Tumor Biology Over Time.
     Ann Surg Oncol. 2023 Oct 19. doi: 10.1245/s10434-023-14459.
     PubMed    
     
     
     
150. MINAMI CA, Jin G, Freedman RA, Schonberg MA, et al
     Trends in Locoregional Therapy in Older Women with Early-Stage Hormone Receptor-Positive Breast Cancer by Frailty and Life Expectancy.
     Ann Surg Oncol. 2023 Oct 18. doi: 10.1245/s10434-023-14446.
     PubMed     Abstract available
     
     
     
151. WILSON B, Mendez J, Newman L, Lum S, et al
     Addressing Data Aggregation and Data Inequity in Race and Ethnicity Reporting and the Impact on Breast Cancer Disparities.
     Ann Surg Oncol. 2023 Oct 15. doi: 10.1245/s10434-023-14432.
     PubMed     Abstract available
     
     
     
152. JAMES TA, Roldan E
     ASO Author Reflections: Exploring Discordant Response to Neoadjuvant Therapy in Breast Cancer: Insights into the Clinical and Biological Implications of Persistent Lymph Node Metastasis.
     Ann Surg Oncol. 2023 Oct 11. doi: 10.1245/s10434-023-14398.
     PubMed    
     
     
     
153. KHAN SY, Cole J, Habrawi Z, Melkus MW, et al
     ASO Visual Abstract: Cryoablation Allows the Ultimate De-escalation of Surgical Therapy in Select Breast Cancer Patients.
     Ann Surg Oncol. 2023 Oct 11. doi: 10.1245/s10434-023-14381.
     PubMed    
     
     
     
154. MYERS SP, Sevilimedu V, Barrio AV, Tadros AB, et al
     ASO Visual Abstract: Mutational Status is Associated with Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer.
     Ann Surg Oncol. 2023 Oct 10. doi: 10.1245/s10434-023-14390.
     PubMed    
     
     
     
155. SHELTON C, Ruiz A, Shelton L, Montgomery H, et al
     Universal Germline-Genetic Testing for Breast Cancer: Implementation in a Rural Practice and Impact on Shared Decision-Making.
     Ann Surg Oncol. 2023 Oct 9. doi: 10.1245/s10434-023-14394.
     PubMed     Abstract available
     
     
     
156. GRIFFIN C, Fairhurst K, Stables I, Brunsden S, et al
     ASO Visual Abstract: Outcomes in Women Undergoing Mastectomy for Unilateral Breast Cancer Who Elect to Undergo Contralateral Mastectomy for Symmetry-A Systematic Review.
     Ann Surg Oncol. 2023 Oct 6. doi: 10.1245/s10434-023-14389.
     PubMed    
     
     
     
157. MYERS SP, Sevilimedu V, Barrio AV, Tadros AB, et al
     Mutational Status is Associated with a Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer.
     Ann Surg Oncol. 2023 Oct 5. doi: 10.1245/s10434-023-14319.
     PubMed     Abstract available
     
     
     
158. PERRY LM, Keegan THM, Li Q, Bold RJ, et al
     ASO Visual Abstract: Survival After Contralateral Secondary Breast Cancer by Age Group in California.
     Ann Surg Oncol. 2023 Oct 3. doi: 10.1245/s10434-023-14371.
     PubMed    
     
     
     
159. BLUMENCRANZ P, Habibi M, Shivers S, Acs G, et al
     ASO Visual Abstract: The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2023 Oct 3. doi: 10.1245/s10434-023-14317.
     PubMed    
     
     
     
160. CAI S
     The Breast Surgeon's Role in Risk-Reducing Medication Uptake.
     Ann Surg Oncol. 2023;30:5962-5964.
     PubMed     Abstract available
     
     
     
161. GOLDHABER NH, O'Keefe T, Kang J, Douglas S, et al
     ASO Visual Abstract: Is Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70? A National Cancer Database (NCDB) Analysis of Sentinel Node Practice Patterns.
     Ann Surg Oncol. 2023;30:6033.
     PubMed    
     
     
     
162. LIZARRAGA IM, Huang K, Yalamuru B, Mott SL, et al
     ASO Visual Abstract: A Randomized Single-Blinded Study Comparing Pre- and Post-Mastectomy PECS Block for Postoperative Pain Management in Bilateral Mastectomy With Immediate Reconstruction.
     Ann Surg Oncol. 2023;30:6022-6023.
     PubMed    
     
     
     
163. NASH AL, Bloom DL, Chapman BM, Wheeler SB, et al
     Contralateral Prophylactic Mastectomy Decision-Making: The Partners' Perspective.
     Ann Surg Oncol. 2023;30:6268-6274.
     PubMed     Abstract available
     
     
     
164. ROTHSCHILD HT, Clelland EN, Mujir F, Record H, et al
     ASO Visual Abstract: Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy.
     Ann Surg Oncol. 2023;30:6007.
     PubMed    
     
     
     
165. SATTAR AK, Masroor T, Martins RS, Zahid N, et al
     ASO Visual Abstract: Impact of Postoperative, Antibiotic Prophylaxis on Surgical Site Infection Rates After Mastectomy with Drains but Without Immediate Reconstruction-A Multicenter, Double-Blinded, Randomized, Control Superiority Trial.
     Ann Surg Oncol. 2023;30:5974-5975.
     PubMed    
     
     
     
166. O'CONNELL RL, Sharma B, El-Sharkawi D, Wotherspoon A, et al
     ASO Visual Abstract: Oncological Outcomes After Multidisciplinary Management of Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
     Ann Surg Oncol. 2023;30:6176-6177.
     PubMed    
     
     
     
167. JACKSON KM, Grumley JG
     ASO Author Reflections: Considerations for the Contralateral Breast in Patients Undergoing Oncoplastic Breast-Conserving Surgery.
     Ann Surg Oncol. 2023;30:6168-6169.
     PubMed    
     
     
     
168. MILLEN JC, Grumley J
     ASO Author Reflections: Patient Interest and Outcomes with Simultaneous Symmetry Procedures in Oncoplastic Breast-Conserving Surgery.
     Ann Surg Oncol. 2023;30:6140.
     PubMed    
     
     
     
169. MILLEN JC, Jackson KM, Stern SL, Orozco JIJ, et al
     Simultaneous Symmetry Procedure in Patients Undergoing Oncoplastic Breast-Conserving Surgery: An Evaluation of Patient Desire and Revision Rates.
     Ann Surg Oncol. 2023;30:6135-6139.
     PubMed     Abstract available
     
     
     
170. CAIRNS A, Chagpar AB, Dupont E, Levine EA, et al
     ASO Visual Abstract: Does Preoperative MRI Reduce Positive Margins After Breast Conserving Surgery?
     Ann Surg Oncol. 2023;30:6059-6060.
     PubMed    
     
     
     
171. JACKSON KM, Millen JC, Orozco JIJ, Stern SL, et al
     A Look at the Other Side: High-Risk Lesions and Occult Contralateral Malignancy in Symmetry Procedures for Patients Undergoing Oncoplastic Breast-Conserving Surgery.
     Ann Surg Oncol. 2023;30:6159-6166.
     PubMed     Abstract available
     
     
     
172. KENNARD K, Israel I, Naaseh A, Saini R, et al
     Lymph Node Positivity: Indication for Preoperative MRI?
     Ann Surg Oncol. 2023;30:6188-6197.
     PubMed     Abstract available
     
     
     
173. FERRUCCI M, Milardi F, Marchet A
     ASO Author Reflections: Is the Era of Blind Breast Surgery Coming to an End? IOUS (Intra-Operative Ultrasound-guided Surgery).
     Ann Surg Oncol. 2023;30:6217-6218.
     PubMed    
     
     
     
174. LIZARRAGA IM, Huang K, Yalamuru B, Mott SL, et al
     A Randomized Single-Blinded Study Comparing Preoperative with Post-Mastectomy PECS Block for Post-operative Pain Management in Bilateral Mastectomy with Immediate Reconstruction.
     Ann Surg Oncol. 2023;30:6010-6021.
     PubMed     Abstract available
     
     
     
175. BENOLKEN MM, McLaughlin S, Piltin M, Mrdutt M, et al
     ASO Visual Abstract: Lymph Node Positivity of Axillary Reverse Mapping Lymph Nodes at Time of Axillary Lymph Node Dissection, 2 Site Prospective Trial.
     Ann Surg Oncol. 2023;30:6050.
     PubMed    
     
     
     
176. JOHNSON HM, Teshome M, Singh P, Mitchell KB, et al
     ASO Visual Abstract: Lactation Education for Surgeons-American Society of Breast Surgeons (ASBrS) Survey Demonstrates Strong Member Interest in Expanded Training.
     Ann Surg Oncol. 2023;30:6133-6134.
     PubMed    
     
     
     
177. CAIRNS A, Chagpar AB, Dupont E, Levine EA, et al
     Does Preoperative MRI Reduce Positive Margins after Breast-Conserving Surgery?
     Ann Surg Oncol. 2023;30:6053-6058.
     PubMed     Abstract available
     
     
     
178. ROJAS K, Spring LM, O'Riordan L, Weiss A, et al
     Endocrine Therapy for Surgeons: Practical Pearls for Managing Menopausal, Bone Loss and Sexual Adverse Effects.
     Ann Surg Oncol. 2023;30:5951-5961.
     PubMed     Abstract available
     
     
     
179. BECK AC, Bayard S, Plitas G, Sevilimedu V, et al
     Does Non-Classic Lobular Carcinoma In Situ at the Lumpectomy Margin Increase Local Recurrence?
     Ann Surg Oncol. 2023;30:6061-6069.
     PubMed     Abstract available
     
     
     
180. GOLDHABER NH, O'Keefe T, Kang J, Douglas S, et al
     Is Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70 Years of Age? A National Cancer Database Analysis of Sentinel Node Practice Patterns.
     Ann Surg Oncol. 2023;30:6024-6032.
     PubMed     Abstract available
     
     
     
181. BENOLKEN MM, Jakub JW
     ASO Author Reflections: Axillary Reverse Mapping: Where Do We Go from Here?
     Ann Surg Oncol. 2023;30:6051-6052.
     PubMed    
     
     
     
182. MARTINS RS, Sattar AK
     ASO Author Reflections: Demystifying the Drain Dilemma-Antibiotic Prophylaxis After Mastectomy with Indwelling Drains.
     Ann Surg Oncol. 2023;30:5976-5977.
     PubMed    
     
     
     
183. BENOLKEN MM, McLaughlin S, Piltin M, Mrdutt M, et al
     Lymph Node Positivity of Axillary Reverse Mapping Lymph Nodes at the Time of Axillary Lymph Node Dissection: Two-Site Prospective Trial.
     Ann Surg Oncol. 2023;30:6042-6049.
     PubMed     Abstract available
     
     
     
184. ROTHSCHILD HT, Clelland EN, Mujir F, Record H, et al
     Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy.
     Ann Surg Oncol. 2023;30:5999-6006.
     PubMed     Abstract available
     
     
     
185. SATTAR AK, Masroor T, Martins RS, Zahid N, et al
     Impact of Postoperative Antibiotic Prophylaxis on Surgical Site Infections Rates After Mastectomy with Drains but Without Immediate Reconstruction: A Multicenter, Double-Blinded, Randomized Control Superiority Trial.
     Ann Surg Oncol. 2023;30:5965-5973.
     PubMed     Abstract available
     
     
     
186. ROTHSCHILD HT, Mukhtar RA
     ASO Author Reflections: Patient, Tumor, and Treatment Characteristics Predict Early Versus Late Recurrence in Patients with Invasive Lobular Carcinoma of the Breast.
     Ann Surg Oncol. 2023;30:6008-6009.
     PubMed    
     
     
     
187. O'CONNELL RL, Sharma B, El-Sharkawi D, Wotherspoon A, et al
     Oncological Outcomes After Multidisciplinary Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
     Ann Surg Oncol. 2023;30:6170-6175.
     PubMed     Abstract available
     
     
     
188. MENEVEAU MO, Crawford MP, Turkheimer LM, Millard TA, et al
     The POWER-PAK Score Characterizes Tumor Response to 3 Months of Preoperative Endocrine Therapy.
     Ann Surg Oncol. 2023;30:6034-6040.
     PubMed     Abstract available
     
     
     
189. JOHNSON HM, Teshome M, Singh P, Mitchell KB, et al
     Lactation Education for Surgeons: American Society of Breast Surgeons (ASBrS) Survey Demonstrates Strong Member Interest in Expanded Training.
     Ann Surg Oncol. 2023;30:6125-6132.
     PubMed     Abstract available
     
     
     
190. LAPKUS M, Horowitz B, Sauer C, Victorson D, et al
     Exploring Breast Surgeons' Attitudes on Universal Genetic Testing: A Qualitative Study.
     Ann Surg Oncol. 2023;30:6108-6116.
     PubMed     Abstract available
     
     
     
191. BAKER JL
     The Era of Flat Closure Mastectomy (Is Still Here). Are You Ready?
     Ann Surg Oncol. 2023;30:6293-6295.
     PubMed    
     
     
     
192. LOUIE AD, Rosenberger LH
     Phyllodes Tumors of the Breast: Addressing the Gaps in Consensus Recommendations for Clinical Management.
     Ann Surg Oncol. 2023;30:6296-6298.
     PubMed    
     
     
     
193. BOGACH J, Sriskandarajah A, Wright FC, Hong NL, et al
     ASO Visual Abstract: Phyllodes Tumors of the Breast: Canadian National Consensus Document Using Modified Delphi Methodology.
     Ann Surg Oncol. 2023;30:6400.
     PubMed    
     
     
     
194. BOGACH J, Sriskandarajah A, Wright FC, Look Hong N, et al
     Phyllodes Tumors of the Breast: Canadian National Consensus Document Using Modified Delphi Methodology.
     Ann Surg Oncol. 2023;30:6386-6397.
     PubMed     Abstract available
     
     
     
195. MANIK R, Fayanju OM
     ASO Author Reflections: The Case for Using Response to Neoadjuvant Chemotherapy to Guide Administration of Post-mastectomy Radiation.
     Ann Surg Oncol. 2023;30:6516-6517.
     PubMed    
     
     
     
196. SERIO F, Manna E, La Pinta M, Arienzo F, et al
     ASO Visual Abstract: Intraoperative Examination of Retro-areolar Margin is Not Routinely Necessary During Nipple Sparing Mastectomy for Cancer.
     Ann Surg Oncol. 2023;30:6497-6498.
     PubMed    
     
     
     
197. JOHNSON MK, Cortina CS, Hsu TL, Huang S, et al
     ASO Visual Abstract: National Trends in "Going Flat" After Mastectomy.
     Ann Surg Oncol. 2023;30:6385.
     PubMed    
     
     
     
198. SERGESKETTER AR, Tian WM, Barrow BE, Morris MX, et al
     ASO Visual Abstract: Air or Saline? A Propensity Score-Matched Analysis on the Effect of Tissue Expander Fill on Complications in Immediate Breast Reconstruction.
     Ann Surg Oncol. 2023;30:6556-6557.
     PubMed    
     
     
     
199. JOHNSON MK, Cortina CS, Hsu TL, Huang S, et al
     National Trends in "Going Flat" After Mastectomy.
     Ann Surg Oncol. 2023;30:6374-6382.
     PubMed     Abstract available
     
     
     
200. BOGACH J, Sriskandarajah A, Wright FC, Look Hong N, et al
     ASO Author Reflections: Development of Canadian National Consensus Statements on Phyllodes Tumors of the Breast.
     Ann Surg Oncol. 2023;30:6398-6399.
     PubMed    
     
     
     
201. LANGER S, Xu Y, Kong S, Puddy J, et al
     Investigating Factors Associated with Postmastectomy Emergency Department Visits: A Population-Based Analysis.
     Ann Surg Oncol. 2023;30:6499-6505.
     PubMed     Abstract available
     
     
     
202. JOHNSON MK, Cortina CS, Kong AL
     ASO Author Reflections: The Potential Impact of the "Going Flat" Movement on National Rates of Post-Mastectomy Breast Reconstruction.
     Ann Surg Oncol. 2023;30:6383-6384.
     PubMed    
     
     
     
203. KIM L, Coman M, Pusztai L, Park TS, et al
     ASO Visual Abstract: Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancers-Catching up with the Rest.
     Ann Surg Oncol. 2023;30:6452-6453.
     PubMed    
     
     
     
204. MONTAGNA G, El-Tamer MB
     Staging of the Axilla After Neoadjuvant Chemotherapy: Which Technique is Better? The Endless Debate.
     Ann Surg Oncol. 2023;30:6290-6292.
     PubMed    
     
     
     
205. SERIO F, Manna E, La Pinta M, Arienzo F, et al
     Intraoperative Examination of Retro-Areolar Margin is not Routinely Necessary During Nipple-Sparing Mastectomy for Cancer.
     Ann Surg Oncol. 2023;30:6488-6496.
     PubMed     Abstract available
     
     
     
206. MUNCK F, Kroman N, Tvedskov T
     ASO Author Reflections: Comparison of Two-Step Methods for Targeted Axillary Dissection in Denmark.
     Ann Surg Oncol. 2023;30:6370-6371.
     PubMed    
     
     
     
207. KIM L, Coman M, Pusztai L, Park TS, et al
     Neoadjuvant Immunotherapy in Early, Triple-Negative Breast Cancers: Catching Up with the Rest.
     Ann Surg Oncol. 2023;30:6441-6449.
     PubMed     Abstract available
     
     
     
208. SERGESKETTER AR, Tian WM, Barrow BE, Morris MX, et al
     Air or Saline? A Propensity Score-Matched Analysis on the Effect of Tissue Expander Fill on Complications in Immediate Breast Reconstruction.
     Ann Surg Oncol. 2023;30:6545-6553.
     PubMed     Abstract available
     
     
     
209. SERGESKETTER AR, Phillips BT
     ASO Author Reflections: Initial Tissue Expander Fill with Air Reduces Complications in Immediate Breast Reconstruction.
     Ann Surg Oncol. 2023;30:6554-6555.
     PubMed    
     
     
     
210. SHAH C, Vicini F
     Adjuvant Radiation Therapy for Ductal Carcinoma In Situ of the Breast: A Clinician's Dilemma.
     Ann Surg Oncol. 2023;30:6281-6283.
     PubMed    
     
     
     September 2023
211. KHAN SY, Cole J, Habrawi Z, Melkus MW, et al
     Cryoablation Allows the Ultimate De-escalation of Surgical Therapy for Select Breast Cancer Patients.
     Ann Surg Oncol. 2023 Sep 28. doi: 10.1245/s10434-023-14332.
     PubMed     Abstract available
     
     
     
212. FASOLA CE, Sharp HJ, Clavin NW, Sha W, et al
     ASO Visual Abstract: Effect of Delayed Oncoplastic Reduction Mammoplasty on Radiation Treatment Delay Following Breast-Conserving Surgery for Breast Cancer.
     Ann Surg Oncol. 2023 Sep 27. doi: 10.1245/s10434-023-14310.
     PubMed    
     
     
     
213. GLASS CC, Pride RM, Freedman RA, Mayer EL, et al
     ASO Visual Abstract: Racial Disparities in Locoregional Recurrence in Postmenopausal Patients with Stage I-III, Hormone Receptor-Positive Breast Cancer Enrolled in the NSABP B-42 Clinical Trial.
     Ann Surg Oncol. 2023 Sep 27. doi: 10.1245/s10434-023-14313.
     PubMed    
     
     
     
214. MCNEELY ML, Courneya KS, Al Onazi MM, Wharton S, et al
     Upper Limb Morbidity in Newly Diagnosed Individuals After Unilateral Surgery for Breast Cancer: Baseline Results from the AMBER Cohort Study.
     Ann Surg Oncol. 2023 Sep 27. doi: 10.1245/s10434-023-14316.
     PubMed     Abstract available
     
     
     
215. MELKUS MW, Khan SY, Cole J, Layeequr Rahman R, et al
     ASO Author Reflections: Achieving Surgical De-Escalation of Breast Cancer Through Cryoablation.
     Ann Surg Oncol. 2023 Sep 27. doi: 10.1245/s10434-023-14335.
     PubMed    
     
     
     
216. RAUZI A, Powell LE, White M, Prathibha S, et al
     ASO Author Reflections: The Readability of Patient-Facing Breast Cancer Surgery Educational Materials.
     Ann Surg Oncol. 2023 Sep 27. doi: 10.1245/s10434-023-14327.
     PubMed    
     
     
     
217. GRIFFIN C, Fairhurst K, Stables I, Brunsden S, et al
     Outcomes of Women Undergoing Mastectomy for Unilateral Breast Cancer Who Elect to Undergo Contralateral Mastectomy for Symmetry: A Systematic Review.
     Ann Surg Oncol. 2023 Sep 25. doi: 10.1245/s10434-023-14294.
     PubMed     Abstract available
     
     
     
218. WANG T, Weed C, Tseng J, Chung A, et al
     ASO Visual Abstract: De-Implementation of Low-Value Care in Women >/= 70 Years with Low-Risk Breast Cancer During the COVID-19 Pandemic.
     Ann Surg Oncol. 2023 Sep 21. doi: 10.1245/s10434-023-14329.
     PubMed    
     
     
     
219. ZHANG JQ, Dos Anjos CH, Sevilimedu V, Crown A, et al
     ASO Visual Abstract: Association of Moderate-Risk Breast Cancer Genes with Contralateral Prophylactic Mastectomy and Bilateral Disease.
     Ann Surg Oncol. 2023 Sep 20. doi: 10.1245/s10434-023-14280.
     PubMed    
     
     
     
220. SHEN A, Qiang W, Zhang L, Bian J, et al
     Risk Factors for Breast Cancer-Related Lymphedema: An Umbrella Review.
     Ann Surg Oncol. 2023 Sep 19. doi: 10.1245/s10434-023-14277.
     PubMed     Abstract available
     
     
     
221. FASANO GA, Bayard S, Chen Y, Marti J, et al
     ASO Visual Abstract: Survival Outcomes in Women with Unilateral Triple Negative Breast Cancer Correlated with Contralateral Prophylactic Mastectomy.
     Ann Surg Oncol. 2023 Sep 15. doi: 10.1245/s10434-023-13136.
     PubMed    
     
     
     
222. RAUZI A, Powell LE, White M, Prathibha S, et al
     Readability Analysis of Online Breast Cancer Surgery Patient Education Materials from National Cancer Institute-Designated Cancer Centers Compared with Top Internet Search Results.
     Ann Surg Oncol. 2023 Sep 14. doi: 10.1245/s10434-023-14279.
     PubMed     Abstract available
     
     
     
223. FASOLA CE, Hadzikadic-Gusic L
     ASO Author Reflections: Oncoplastic Reduction Mammoplasty Appears Safe for Patients with Early-Stage Breast Cancer Albeit with Delays > 8 Weeks to Adjuvant Radiation.
     Ann Surg Oncol. 2023 Sep 13. doi: 10.1245/s10434-023-14260.
     PubMed    
     
     
     
224. JEFFERS EJ, Wagner JL, Korentager SS, Larson KE, et al
     ASO Visual Abstract: Breast Cancer-Related Lymphedema (BCRL) and Bioimpedance Spectroscopy: Long-Term Follow-Up, Surveillance Recommendations, and Multidisciplinary Risk Factors.
     Ann Surg Oncol. 2023 Sep 8. doi: 10.1245/s10434-023-14170.
     PubMed    
     
     
     
225. HALFTECK GG, Polychronopoulou YE, Haque W, Weiser R, et al
     De-escalation of Post-mastectomy Irradiation in Hormone Receptor-Positive Breast Cancer with One to Three Positive Nodes.
     Ann Surg Oncol. 2023 Sep 7. doi: 10.1245/s10434-023-14155.
     PubMed     Abstract available
     
     
     
226. FRANCO I, Alshalalfa M, Hernandez A, Mahal BA, et al
     ASO Visual Abstract: Genomic Characterization of Aggressive Breast Cancer in Younger Women.
     Ann Surg Oncol. 2023 Sep 5. doi: 10.1245/s10434-023-14227.
     PubMed    
     
     
     
227. GLASS CC, Pride RM, Freedman RA, Mayer EL, et al
     Racial Disparities in Locoregional Recurrence in Postmenopausal Patients with Stage I-III, Hormone Receptor-Positive Breast Cancer Enrolled in the NSABP B-42 Clinical Trial.
     Ann Surg Oncol. 2023 Sep 5. doi: 10.1245/s10434-023-14220.
     PubMed     Abstract available
     
     
     
228. FARLEY C, Bassett R, Meric-Bernstam F, Bedrosian I, et al
     To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer?
     Ann Surg Oncol. 2023 Sep 5. doi: 10.1245/s10434-023-14245.
     PubMed     Abstract available
     
     
     
229. ZHANG JQ, Dos Anjos CH, Sevilimedu V, Crown A, et al
     Association of Moderate-Risk Breast Cancer Genes with Contralateral Prophylactic Mastectomy and Bilateral Disease.
     Ann Surg Oncol. 2023 Sep 3. doi: 10.1245/s10434-023-14141.
     PubMed     Abstract available
     
     
     
230. MIAH PA, Pourkey N, Marmer A, Sevdalis A, et al
     ASO Visual Abstract: Results of Magnetic Resonance Imaging Screening in Patients at High Risk for Breast Cancer.
     Ann Surg Oncol. 2023 Sep 2. doi: 10.1245/s10434-023-14211.
     PubMed    
     
     
     
231. WEED C, Wang T, Fat SC, Chung A, et al
     Surveillance Strategies Following Prophylactic Nipple-Sparing Mastectomy in BRCA Mutation Carriers.
     Ann Surg Oncol. 2023;30:5335-5336.
     PubMed    
     
     
     
232. VEMURU SR, Bronsert M, Vossler K, Huynh VD, et al
     Postoperative Outcomes After Staged Versus Coordinated Breast Surgery and Bilateral Salpingo-Oophorectomy.
     Ann Surg Oncol. 2023;30:5667-5680.
     PubMed     Abstract available
     
     
     
233. HASSAN AM, Ray N, Govande JG, Paidisetty P, et al
     ASO Visual Abstract: Long-Term Surgical and Patient-Reported Outcomes Comparing Skin-Preserving, Staged Versus Delayed Microvascular Breast Reconstruction.
     Ann Surg Oncol. 2023;30:5725-5726.
     PubMed    
     
     
     
234. YANG L, Liu Y, Han D, Fu S, et al
     ASO Visual Abstract: Clinical Genetic Features and Neoadjuvant Chemotherapy Response in HER2-Low Breast Cancers-A Retrospective, Multicenter Cohort Study.
     Ann Surg Oncol. 2023;30:5665-5666.
     PubMed    
     
     
     
235. MATAR-UJVARY R, Haglich K, Flanagan MR, Fuzesi S, et al
     ASO Visual Abstract: The Impact of Breast-Conserving Surgery Re-excision on Patient-Reported Outcomes Using the BREAST-Q.
     Ann Surg Oncol. 2023;30:5350-5351.
     PubMed    
     
     
     
236. VEMURU SR, Bronsert M, Vossler K, Huynh VD, et al
     ASO Visual Abstract: Postoperative Outcomes After Staged Versus Coordinated Breast Surgery and Bilateral Salpingo-oophorectomy.
     Ann Surg Oncol. 2023;30:5683-5684.
     PubMed    
     
     
     
237. SHUKLA S, Hariharan N
     Intraoperative Margin Assessment in Breast Conservation Surgery: A Necessity or a Luxury?
     Ann Surg Oncol. 2023;30:5314-5315.
     PubMed    
     
     
     
238. MATAR-UJVARY R, Haglich K, Flanagan MR, Fuzesi S, et al
     The Impact of Breast-Conserving Surgery Re-excision on Patient-Reported Outcomes Using the BREAST-Q.
     Ann Surg Oncol. 2023;30:5341-5349.
     PubMed     Abstract available
     
     
     
239. HASSAN AM, Ray N, Govande JG, Paidisetty P, et al
     Long-term Surgical and Patient-Reported Outcomes Comparing Skin-Preserving, Staged Versus Delayed Microvascular Breast Reconstruction.
     Ann Surg Oncol. 2023;30:5711-5722.
     PubMed     Abstract available
     
     
     
240. NARAYANAN S, Rao R
     To Radiate or Not to Radiate After Breast-Conserving Surgery-Endocrine Therapy is the Question.
     Ann Surg Oncol. 2023;30:5309-5311.
     PubMed    
     
     
     
241. VEMURU S, Tevis SE
     ASO Author Reflections: In Which Patients Should We Coordinate Breast Surgery and Bilateral Salpingo-oophorectomy?
     Ann Surg Oncol. 2023;30:5681-5682.
     PubMed    
     
     
     
242. HASSAN AM, Selber JC
     ASO Author Reflections: Skin-Preserving Staged Microvascular Breast Reconstruction Results in Surgical and Patient-Reported Outcomes Comparable to Delayed Reconstruction.
     Ann Surg Oncol. 2023;30:5723-5724.
     PubMed    
     
     
     
243. YANG L
     ASO Author Reflections: Genetic Heterogeneity in HER2-Low Breast Cancers Reflects Different Treatment Responses.
     Ann Surg Oncol. 2023;30:5663-5664.
     PubMed    
     
     
     
244. YANG L, Liu Y, Han D, Fu S, et al
     Clinical Genetic Features and Neoadjuvant Chemotherapy Response in HER2-Low Breast Cancers: A Retrospective, Multicenter Cohort Study.
     Ann Surg Oncol. 2023;30:5653-5662.
     PubMed     Abstract available
     
     
     
245. BLUMENCRANZ P, Habibi M, Shivers S, Acs G, et al
     The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to Have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2023 Sep 1. doi: 10.1245/s10434-023-14027.
     PubMed     Abstract available
     
     
     
246. KEEGAN G, Crown A, DiMaggio C, Joseph KA, et al
     Insufficient Reporting of Race and Ethnicity in Breast Cancer Clinical Trials.
     Ann Surg Oncol. 2023 Sep 1. doi: 10.1245/s10434-023-14201.
     PubMed     Abstract available
     
     
     August 2023
247. CAVALCANTE FP, Zerwes FP, Millen EC, Garcia GN, et al
     Nipple-Sparing Mastectomy for Early Breast Cancer: Less is More?
     Ann Surg Oncol. 2023 Aug 30. doi: 10.1245/s10434-023-14210.
     PubMed    
     
     
     
248. HSIEH YC, Guo KW, Wang MW, Su SP, et al
     ASO Visual Abstract: A Novel Injection Protocol Using Voluven(R)-Assisted Indocyanine Green with Improved Near-Infrared Fluorescence Guidance in Breast Cancer Sentinel Lymph Node Mapping: A Translational Study.
     Ann Surg Oncol. 2023 Aug 29. doi: 10.1245/s10434-023-14235.
     PubMed    
     
     
     
249. TUTTLE TM, Hui JYC
     Breast Cancer Genes and Contralateral Prophylactic Mastectomy: Beyond BRCA.
     Ann Surg Oncol. 2023 Aug 26. doi: 10.1245/s10434-023-14161.
     PubMed    
     
     
     
250. RAMALINGAM K, Clelland E, Rothschild H, Mujir F, et al
     ASO Visual Abstract: Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment.
     Ann Surg Oncol. 2023 Aug 25. doi: 10.1245/s10434-023-14226.
     PubMed    
     
     
     
251. WANG T, Weed C, Tseng J, Chung A, et al
     De-Implementation of Low-Value Care for Women 70 Years of Age or Older with Low-Risk Breast Cancer During the COVID-19 Pandemic.
     Ann Surg Oncol. 2023 Aug 25. doi: 10.1245/s10434-023-14156.
     PubMed     Abstract available
     
     
     
252. ZAVERI S, Everidge S, FitzSullivan E, Hwang R, et al
     ASO Visual Abstract: Extremely Low Incidence of Local-Regional Recurrences Observed among T1-2N1 (one or two Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy without Completion Axillary Node Dissection.
     Ann Surg Oncol. 2023 Aug 23. doi: 10.1245/s10434-023-14088.
     PubMed    
     
     
     
253. JEFFERS EJ, Wagner JL, Kilgore LJ
     ASO Author Reflections: Breast Cancer-Related Lymphedema (BCRL) Surveillance Recommendations with Bioimpedance Spectroscopy.
     Ann Surg Oncol. 2023 Aug 23. doi: 10.1245/s10434-023-14099.
     PubMed    
     
     
     
254. BARKER VR, Naffouje SA, Mallory MA, Hoover SA, et al
     Surgical Management of the Axilla in HR+/HER2- Breast Cancer in the Z1071 Era: A Propensity Score-Matched Analysis of the National Cancer Database.
     Ann Surg Oncol. 2023 Aug 23. doi: 10.1245/s10434-023-14029.
     PubMed     Abstract available
     
     
     
255. ADESOYE T, Lucci A
     ASO Author Reflections: Low Rates of Local-Regional Recurrence in Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy.
     Ann Surg Oncol. 2023 Aug 23. doi: 10.1245/s10434-023-14159.
     PubMed    
     
     
     
256. FERRUCCI M, Milardi F, Passeri D, Mpungu LF, et al
     Intraoperative Ultrasound-Guided Conserving Surgery for Breast Cancer: No More Time for Blind Surgery.
     Ann Surg Oncol. 2023 Aug 22. doi: 10.1245/s10434-023-13900.
     PubMed     Abstract available
     
     
     
257. HSIEH YC, Guo KW, Wang MW, Su SP, et al
     A Novel Injection Protocol Using Voluven(R)-Assisted Indocyanine Green with Improved Near-Infrared Fluorescence Guidance in Breast Cancer Sentinel Lymph Node Mapping-A Translational Study.
     Ann Surg Oncol. 2023 Aug 21. doi: 10.1245/s10434-023-14129.
     PubMed     Abstract available
     
     
     
258. FASOLA CE, Sharp HJ, Clavin NW, Sha W, et al
     Effect of Delayed Oncoplastic Reduction Mammoplasty on Radiation Treatment Delay Following Breast-Conserving Surgery for Breast Cancer.
     Ann Surg Oncol. 2023 Aug 21. doi: 10.1245/s10434-023-14177.
     PubMed     Abstract available
     
     
     
259. AL-HILLI Z, Noss R, Dickard J, Wei W, et al
     ASO Visual Abstract: A Randomized Trial Comparing the Effectiveness of Pre-test Genetic Counseling Using an Artificial Intelligence Automated Chatbot and Traditional In-person Genetic Counseling in Women Newly Diagnosed with Breast Cancer.
     Ann Surg Oncol. 2023 Aug 21. doi: 10.1245/s10434-023-13989.
     PubMed    
     
     
     
260. XU C, Pfob A, Mehrara BJ, Yin P, et al
     ASO Visual Abstract: Enhanced Surgical Decision-Making Tools in Breast Cancer-Predicting 2-Year Postoperative Physical, Sexual, and Psychosocial Well-Being Following Mastectomy and Breast Reconstruction (INSPiRED 004).
     Ann Surg Oncol. 2023 Aug 19. doi: 10.1245/s10434-023-14095.
     PubMed    
     
     
     
261. LUCCI A, Kim LS, Golshan M, King TA, et al
     Great Debate: The Surgeon's Role in Locoregional Management of Stage IV Breast Cancer.
     Ann Surg Oncol. 2023 Aug 19. doi: 10.1245/s10434-023-14134.
     PubMed    
     
     
     
262. CHO JH, Park JM, Park HS, Kim HJ, et al
     Oncologic Outcomes in Nipple-sparing Mastectomy with Immediate Reconstruction and Total Mastectomy with Immediate Reconstruction in Women with Breast Cancer: A Machine-Learning Analysis.
     Ann Surg Oncol. 2023 Aug 16. doi: 10.1245/s10434-023-13963.
     PubMed     Abstract available
     
     
     
263. JOHNSON JA, Moore BJ, Syrnioti G, Eden CM, et al
     Landmark Series: The Cancer Genome Atlas and the Study of Breast Cancer Disparities.
     Ann Surg Oncol. 2023 Aug 16. doi: 10.1245/s10434-023-13866.
     PubMed     Abstract available
     
     
     
264. ADESOYE T, Everidge S, Chen J, Sun SX, et al
     ASO Visual Abstract: Low Rates of Local-Regional Recurrence in Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy.
     Ann Surg Oncol. 2023 Aug 14. doi: 10.1245/s10434-023-14066.
     PubMed    
     
     
     
265. HUANG K, Jakub J, Gabriel E, Moreno-Aspitia A, et al
     ASO Visual Abstract: Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node-Negative T1 Triple-Negative Breast Cancer.
     Ann Surg Oncol. 2023 Aug 14. doi: 10.1245/s10434-023-14097.
     PubMed    
     
     
     
266. AL-HILLI Z, Noss R, Dickard J, Wei W, et al
     A Randomized Trial Comparing the Effectiveness of Pre-test Genetic Counseling Using an Artificial Intelligence Automated Chatbot and Traditional In-person Genetic Counseling in Women Newly Diagnosed with Breast Cancer.
     Ann Surg Oncol. 2023 Aug 11. doi: 10.1245/s10434-023-13888.
     PubMed     Abstract available
     
     
     
267. MEURS CJC, van Bekkum S, van Rosmalen J, Menke-Pluijmers MBE, et al
     ASO Visual Abstract: Validation and Clinical Utility of a Prediction Model for the Risk of Upstaging to Invasive Breast Cancer After a Biopsy Diagnosis of Ductal Carcinoma In Situ.
     Ann Surg Oncol. 2023 Aug 11. doi: 10.1245/s10434-023-14090.
     PubMed    
     
     
     
268. HUANG K, Jakub JW, McLaughlin SA
     ASO Author Reflections: Sequence of Treatment in Clinically Node-Negative T1 Triple-Negative Breast Cancer.
     Ann Surg Oncol. 2023 Aug 11. doi: 10.1245/s10434-023-14122.
     PubMed    
     
     
     
269. FERRUCCI M, Milardi F, Passeri D, Mpungu LF, et al
     ASO Visual Abstract: Intraoperative Ultrasound-Guided Conserving Surgery for Breast Cancer-No More Time for Blind Surgery.
     Ann Surg Oncol. 2023 Aug 10. doi: 10.1245/s10434-023-14004.
     PubMed    
     
     
     
270. RAMALINGAM K, Clelland E, Rothschild H, Mujir F, et al
     Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment.
     Ann Surg Oncol. 2023 Aug 10. doi: 10.1245/s10434-023-14075.
     PubMed     Abstract available
     
     
     
271. MIAH PA, Pourkey N, Marmer A, Sevdalis A, et al
     Results of Magnetic Resonance Imaging (MRI) Screening in Patients at High Risk for Breast Cancer.
     Ann Surg Oncol. 2023 Aug 10. doi: 10.1245/s10434-023-14052.
     PubMed     Abstract available
     
     
     
272. FRANCO I, Alshalalfa M, Hernandez A, Mahal BA, et al
     Genomic Characterization of Aggressive Breast Cancer in Younger Women.
     Ann Surg Oncol. 2023 Aug 7. doi: 10.1245/s10434-023-14080.
     PubMed     Abstract available
     
     
     
273. PRIDE RM, Glass CC, Nakhlis F, Laws A, et al
     ASO Visual Abstract: Intraoperative Pathology Assessment May Lead to Overtreatment of the Axilla in Clinically Node-Negative Breast Cancer Patients Undergoing Upfront Mastectomy.
     Ann Surg Oncol. 2023 Aug 5. doi: 10.1245/s10434-023-14000.
     PubMed    
     
     
     
274. MEURS CJC, van Bekkum S, van Rosmalen J, Menke-Pluijmers MBE, et al
     Validation and Clinical Utility of a Prediction Model for the Risk of Upstaging to Invasive Breast Cancer After a Biopsy Diagnosis Ductal Carcinoma In Situ.
     Ann Surg Oncol. 2023 Aug 4. doi: 10.1245/s10434-023-13929.
     PubMed     Abstract available
     
     
     
275. HE J, Chen S, Xu R
     ASO Author Reflections: A More Effective Radiotherapy Modality for Early Breast Cancer: Intraoperative Radiotherapy as a Tumour Bed Boost Combined with Whole Breast Irradiation.
     Ann Surg Oncol. 2023 Aug 4. doi: 10.1245/s10434-023-14057.
     PubMed    
     
     
     
276. RECORD SM, Thomas SM, Tori Chanenchuk, Baker JA, et al
     ASO Visual Abstract: Breast Cancer Risk Assessment and Screening Practices Reported via an Online Survey.
     Ann Surg Oncol. 2023 Aug 3. doi: 10.1245/s10434-023-14043.
     PubMed    
     
     
     
277. GO J, Ahn JH, Park JM, Choi SB, et al
     Distinct Prognosis of Minimal Residual Disease According to Breast Cancer Subtype in Patients with Breast or Nodal Pathologic Complete Response After Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2023 Aug 3. doi: 10.1245/s10434-023-13938.
     PubMed     Abstract available
     
     
     
278. BOUGHEY JC, Yu H, Dugan CL, Piltin MA, et al
     ASO Visual Abstract: Changes in Surgical Management of the Axilla Over 11 Years-Report on Over 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial.
     Ann Surg Oncol. 2023 Aug 3. doi: 10.1245/s10434-023-14017.
     PubMed    
     
     
     
279. CHUNG SH, Romatoski KS, Rasic G, Beaulieu-Jones BR, et al
     ASO Visual Abstract: Impact of the COVID-19 Pandemic on Delays to Breast Cancer Surgery-Ripples or Waves?
     Ann Surg Oncol. 2023 Aug 3. doi: 10.1245/s10434-023-13986.
     PubMed    
     
     
     
280. JEFFERS EJ, Wagner JL, Korentager SS, Larson KE, et al
     Breast Cancer-Related Lymphedema (BCRL) and Bioimpedance Spectroscopy: Long-Term Follow-Up, Surveillance Recommendations, and Multidisciplinary Risk Factors.
     Ann Surg Oncol. 2023 Aug 3. doi: 10.1245/s10434-023-13956.
     PubMed     Abstract available
     
     
     
281. BRYAN AF, Castillo-Angeles M, Minami C, Laws A, et al
     ASO Visual Abstract: Value of Ambulatory Modified Radical Mastectomy.
     Ann Surg Oncol. 2023;30:4646-4647.
     PubMed    
     
     
     
282. SHARON CE, Wang M, Tortorello GN, Perry NJ, et al
     ASO Visual Abstract: Impact of Patient Comorbidities on Presentation Stage of Breast and Colon Cancers.
     Ann Surg Oncol. 2023;30:4629-4630.
     PubMed    
     
     
     
283. GOMEZ AB, Calvo NM, Boria F, Manzour N, et al
     ASO Visual Abstract: SUCCOR Nodes: May Sentinel Node Biopsy Determine the Need for Adjuvant Treatment?
     Ann Surg Oncol. 2023;30:4986-4987.
     PubMed    
     
     
     
284. HOSSEINI O, Wang J, Lee O, Pulliam N, et al
     ASO Visual Abstract: Menstrual Phase and Menopausal Status Classification of Benign Breast Tissue Using Hormone-Regulated Gene Expression and Histomorphology: A Validation Study.
     Ann Surg Oncol. 2023;30:5225-5226.
     PubMed    
     
     
     
285. SHARON CE, Wang M, Tortorello GN, Perry NJ, et al
     Impact of Patient Comorbidities on Presentation Stage of Breast and Colon Cancers.
     Ann Surg Oncol. 2023;30:4617-4626.
     PubMed     Abstract available
     
     
     
286. LUDWIG KK
     Choice of Hospital Setting for Modified Radical Mastectomy: Difference in Value?
     Ann Surg Oncol. 2023;30:4564-4565.
     PubMed    
     
     
     
287. BRYAN AF, Castillo-Angeles M, Minami C, Laws A, et al
     Value of Ambulatory Modified Radical Mastectomy.
     Ann Surg Oncol. 2023;30:4637-4643.
     PubMed     Abstract available
     
     
     
288. SHARON CE, Miura JT, Karakousis GC
     ASO Author Reflections: Evaluating the Relationship Between Patient Comorbidities and Stage at Diagnosis for Breast and Colon Cancers.
     Ann Surg Oncol. 2023;30:4627-4628.
     PubMed    
     
     
     
289. BRYAN AF, Jarman MP, Weiss A
     ASO Author Reflections: It's Time to Get the Patient Perspective on Same-Day Mastectomy.
     Ann Surg Oncol. 2023;30:4644-4645.
     PubMed    
     
     
     
290. RYAN JF, Lesniak DM, Cordeiro E, Campbell SM, et al
     ASO Visual Abstract: Surgeon Factors Influencing Breast Surgery Outcomes-A Scoping Review to Define the Modern Breast Surgical Oncologist.
     Ann Surg Oncol. 2023;30:4714.
     PubMed    
     
     
     
291. RYAN JF, Lesniak DM, Cordeiro E, Campbell SM, et al
     Surgeon Factors Influencing Breast Surgery Outcomes: A Scoping Review to Define the Modern Breast Surgical Oncologist.
     Ann Surg Oncol. 2023;30:4695-4713.
     PubMed     Abstract available
     
     
     
292. HOSSEINI O, Wang J, Lee O, Pulliam N, et al
     Menstrual Phase and Menopausal Status Classification of Benign Breast Tissue Using Hormone-Regulated Gene Expression and Histomorphology: A Validation Study.
     Ann Surg Oncol. 2023;30:5215-5224.
     PubMed     Abstract available
     
     
     
293. DONOVAN CA, Kaufman CS, Thomas KA, Polat AK, et al
     Timeliness of Breast Diagnostic Imaging and Biopsy in Practice: 15 Years of Collecting, Comparing, and Defining Quality Breast Cancer Care.
     Ann Surg Oncol. 2023 Aug 1. doi: 10.1245/s10434-023-13905.
     PubMed     Abstract available
     
     
     
294. CHUNG SH, Romatoski KS, Rasic G, Beaulieu-Jones BR, et al
     Impact of the COVID-19 Pandemic on Delays to Breast Cancer Surgery: Ripples or Waves?
     Ann Surg Oncol. 2023 Aug 1. doi: 10.1245/s10434-023-13878.
     PubMed     Abstract available
     
     
     July 2023
295. JONCZYK MM, Karamchandani M, Zaccardelli A, Bahadur A, et al
     ASO Visual Abstract: External Validation of the Breast Cancer Surgery Risk Calculator (BCSRc): A Predictive Model for Postoperative Complications.
     Ann Surg Oncol. 2023 Jul 31. doi: 10.1245/s10434-023-14044.
     PubMed    
     
     
     
296. OGIYA A, Nagura N, Shimo A, Nogi H, et al
     ASO Visual Abstract: Long-Term Outcomes of Breast Cancer Patients with Local Recurrence After Mastectomy Undergoing Immediate Breast Reconstruction-A Retrospective, Multi-institutional Study of 4153 Cases.
     Ann Surg Oncol. 2023 Jul 30. doi: 10.1245/s10434-023-14019.
     PubMed    
     
     
     
297. VASILYEVA E, Hamm J, Nichol A, Isaac KV, et al
     ASO Visual Abstract: Breast-Conserving Therapy is Associated with Improved Survival without an Increased Risk of Locoregional Recurrence Compared to Mastectomy in Both Clinically Node Positive and Node Negative Breast Cancer Patients.
     Ann Surg Oncol. 2023 Jul 30. doi: 10.1245/s10434-023-13876.
     PubMed    
     
     
     
298. MILLER KN, Thomas SM, Record SM, Rosenberger LH, et al
     ASO Visual Abstract: Neoadjuvant Chemotherapy and Endocrine Therapy for Older Patients with Estrogen Receptor Positive Breast Cancer-Comparison of Approaches.
     Ann Surg Oncol. 2023 Jul 30. doi: 10.1245/s10434-023-14010.
     PubMed    
     
     
     
299. MOLDOVEANU D, Hoskin TL, Day CN, Schulze AK, et al
     ASO Visual Abstract: Clinical Behavior, Management, and Treatment Response of Estrogen Receptor-Low (1-10%) Breast Cancer.
     Ann Surg Oncol. 2023 Jul 30. doi: 10.1245/s10434-023-13998.
     PubMed    
     
     
     
300. XU C, Pfob A, Mehrara BJ, Yin P, et al
     Enhanced Surgical Decision-Making Tools in Breast Cancer: Predicting 2-Year Postoperative Physical, Sexual, and Psychosocial Well-Being following Mastectomy and Breast Reconstruction (INSPiRED 004).
     Ann Surg Oncol. 2023 Jul 30. doi: 10.1245/s10434-023-13971.
     PubMed     Abstract available
     
     
     
301. CHU CD, Smith CE, Gorski J, Smolkin M, et al
     Implementation of a Novel Patient Decision Aid for Women with Elevated Breast Cancer Risk Who Are Considering MRI Screening: A Pilot Study.
     Ann Surg Oncol. 2023 Jul 28. doi: 10.1245/s10434-023-13901.
     PubMed     Abstract available
     
     
     
302. HE J, Chen S, Ye L, Sun Y, et al
     Intraoperative Radiotherapy as a Tumour-Bed Boost Combined with Whole Breast Irradiation Versus Conventional Radiotherapy in Patients with Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.
     Ann Surg Oncol. 2023 Jul 28. doi: 10.1245/s10434-023-13955.
     PubMed     Abstract available
     
     
     
303. NGUYEN CL, Zhou M, Easwaralingam N, Seah JL, et al
     ASO Visual Abstract: Novel Dual Tracer Indocyanine Green and Radioisotope Versus Gold Standard Sentinel Lymph Node Biopsy in Breast Cancer-The GREENORBLUE Trial.
     Ann Surg Oncol. 2023 Jul 27. doi: 10.1245/s10434-023-13997.
     PubMed    
     
     
     
304. JONCZYK MM, Chatterjee A
     ASO Author Reflections: Enhancing Preoperative Decision-Making by Using the BCSRc to Predict Breast Cancer Surgery Complications.
     Ann Surg Oncol. 2023 Jul 25. doi: 10.1245/s10434-023-14025.
     PubMed    
     
     
     
305. HUANG K, Jakub J, Gabriel E, Moreno-Aspitia A, et al
     Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node Negative T1 Triple Negative Breast Cancer.
     Ann Surg Oncol. 2023 Jul 25. doi: 10.1245/s10434-023-13977.
     PubMed     Abstract available
     
     
     
306. MOLDOVEANU D, Goetz MP, Boughey JC
     ASO Author Reflections: Low Estrogen Receptor (ER) Expression Breast Cancer Behaves More like ER Negative Disease and Influences Management.
     Ann Surg Oncol. 2023 Jul 24. doi: 10.1245/s10434-023-13985.
     PubMed    
     
     
     
307. SILVERSTEIN MJ, Kim B, Lin K, Lloyd S, et al
     ASO Visual Abstract: Risk-Adapted Intraoperative Radiation Therapy (IORT) for Breast Cancer-Novel Analysis.
     Ann Surg Oncol. 2023 Jul 22. doi: 10.1245/s10434-023-13980.
     PubMed    
     
     
     
308. HORAN J, Reid C, Boland MR, Daly GR, et al
     Assessing Mode of Recurrence in Breast Cancer to Identify an Optimised Follow-Up Pathway: 10-Year Institutional Review.
     Ann Surg Oncol. 2023 Jul 21. doi: 10.1245/s10434-023-13885.
     PubMed     Abstract available
     
     
     
309. ADESOYE T, Everidge S, Chen J, Sun SX, et al
     Low Rates of Local-Regional Recurrence Among Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy.
     Ann Surg Oncol. 2023 Jul 21. doi: 10.1245/s10434-023-13906.
     PubMed     Abstract available
     
     
     
310. PARK TS, Pusztai L
     ASO Author Reflections: Immunotherapy and Breast Cancer-Spotlight on Early Stage TNBC.
     Ann Surg Oncol. 2023 Jul 20. doi: 10.1245/s10434-023-13957.
     PubMed    
     
     
     
311. NGUYEN CL, Zhou M, Easwaralingam N, Seah JL, et al
     ASO Author Reflections: Indocyanine Green Fluorescence Sentinel Lymph Node Biopsy in Breast Cancer-An Alternative to Blue Dye?
     Ann Surg Oncol. 2023 Jul 20. doi: 10.1245/s10434-023-13951.
     PubMed    
     
     
     
312. MUNCK F, Jepsen P, Zeuthen P, Carstensen L, et al
     ASO Visual Abstract: Comparing Methods for Targeted Axillary Dissection in Breast Cancer Patients: A Nationwide, Retrospective Study.
     Ann Surg Oncol. 2023 Jul 19. doi: 10.1245/s10434-023-13852.
     PubMed    
     
     
     
313. MILLER KN, Thomas SM, Record SM, Rosenberger LH, et al
     Neoadjuvant Chemotherapy and Endocrine Therapy for Older Patients with Estrogen Receptor Positive Breast Cancer: Comparison of Approaches.
     Ann Surg Oncol. 2023 Jul 19. doi: 10.1245/s10434-023-13880.
     PubMed     Abstract available
     
     
     
314. SILVERSTEIN MJ, Kim B, Lin K, Lloyd S, et al
     Risk-Adapted Intraoperative Radiation Therapy (IORT) for Breast Cancer: A Novel Analysis.
     Ann Surg Oncol. 2023 Jul 18. doi: 10.1245/s10434-023-13897.
     PubMed     Abstract available
     
     
     
315. MOLDOVEANU D, Hoskin TL, Day CN, Schulze AK, et al
     Clinical Behavior, Management, and Treatment Response of Estrogen Receptor Low (1-10%) Breast Cancer.
     Ann Surg Oncol. 2023 Jul 17. doi: 10.1245/s10434-023-13846.
     PubMed     Abstract available
     
     
     
316. MANIK R, Grady CB, Elmore LC, Fieber JH, et al
     Temporal Trends and Factors Associated with Receipt of Post-mastectomy Radiation After Neoadjuvant Chemotherapy in Women with cT3 Breast Cancer.
     Ann Surg Oncol. 2023 Jul 17. doi: 10.1245/s10434-023-13730.
     PubMed     Abstract available
     
     
     
317. THALJI SZ, Cortina CS, Frebault J, Cho Y, et al
     ASO Visual Abstract: Associations Between Hospital Volume on Overall Survival After Surgery in Older Patients with Breast Cancer.
     Ann Surg Oncol. 2023 Jul 17. doi: 10.1245/s10434-023-13921.
     PubMed    
     
     
     
318. RECORD SM, Thomas SM, Chanenchuk T, Baker JA, et al
     Breast Cancer Risk Assessment and Screening Practices Reported Via an Online Survey.
     Ann Surg Oncol. 2023 Jul 17. doi: 10.1245/s10434-023-13903.
     PubMed     Abstract available
     
     
     
319. JONCZYK MM, Karamchandani M, Zaccardelli A, Bahadur A, et al
     External Validation of the Breast Cancer Surgery Risk Calculator (BCSRc): A Predictive Model for Postoperative Complications.
     Ann Surg Oncol. 2023 Jul 17. doi: 10.1245/s10434-023-13904.
     PubMed     Abstract available
     
     
     
320. PERRY LM, Keegan THM, Li Q, Bold RJ, et al
     Survival After Contralateral Secondary Breast Cancer by Age Group in California.
     Ann Surg Oncol. 2023 Jul 17. doi: 10.1245/s10434-023-13902.
     PubMed     Abstract available
     
     
     
321. ZAVERI S, Everidge S, FitzSullivan E, Hwang R, et al
     Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection.
     Ann Surg Oncol. 2023 Jul 17. doi: 10.1245/s10434-023-13942.
     PubMed     Abstract available
     
     
     
322. OGIYA A, Nagura N, Shimo A, Nogi H, et al
     ASO Author Reflections: Long Term Outcomes of Breast Cancer Patients with Local Recurrence After Mastectomy Undergoing Immediate Breast Reconstruction.
     Ann Surg Oncol. 2023 Jul 15. doi: 10.1245/s10434-023-13925.
     PubMed    
     
     
     
323. MANIK R, Grady CB, Elmore LC, Fieber JH, et al
     ASO Visual Abstract: Temporal Trends and Factors Associated with Receipt of Post-mastectomy Radiation After Neoadjuvant Chemotherapy in Women with cT3 Breast Cancer.
     Ann Surg Oncol. 2023 Jul 12. doi: 10.1245/s10434-023-13831.
     PubMed    
     
     
     
324. PRIDE RM, Glass CC, Nakhlis F, Laws A, et al
     Intraoperative Pathology Assessment May Lead to Overtreatment of the Axilla in Clinically Node-Negative Breast Cancer Patients Undergoing Upfront Mastectomy.
     Ann Surg Oncol. 2023 Jul 12. doi: 10.1245/s10434-023-13898.
     PubMed     Abstract available
     
     
     
325. CHUNG SH, Sachs TE
     ASO Author Reflections: Delays in Breast Cancer Treatment During the COVID Pandemic-Disparities in Delay and a Call to Action.
     Ann Surg Oncol. 2023 Jul 11. doi: 10.1245/s10434-023-13879.
     PubMed    
     
     
     
326. CEBRECOS I, Mension E, Alonso I, Castillo H, et al
     ASO Visual Abstract: Nonsentinel Axillary Lymph-Node Status in Clinically Node-Negative Early Breast Cancer After Primary Systemic Therapy and Positive Sentinel Lymph-Node-A Predictive Model Proposal.
     Ann Surg Oncol. 2023 Jul 5. doi: 10.1245/s10434-023-13325.
     PubMed    
     
     
     
327. OGIYA A, Nagura N, Shimo A, Nogi H, et al
     Long-Term Outcomes of Breast Cancer Patients with Local Recurrence After Mastectomy Undergoing Immediate Breast Reconstruction: A Retrospective Multi-institutional Study of 4153 Cases.
     Ann Surg Oncol. 2023 Jul 5. doi: 10.1245/s10434-023-13832.
     PubMed     Abstract available
     
     
     
328. NGUYEN CL, Zhou M, Easwaralingam N, Seah JL, et al
     Novel Dual Tracer Indocyanine Green and Radioisotope Versus Gold Standard Sentinel Lymph Node Biopsy in Breast Cancer: The GREENORBLUE Trial.
     Ann Surg Oncol. 2023 Jul 4. doi: 10.1245/s10434-023-13824.
     PubMed     Abstract available
     
     
     
329. MUNCK F, Jepsen P, Zeuthen P, Carstensen L, et al
     Comparing Methods for Targeted Axillary Dissection in Breast Cancer Patients: A Nationwide, Retrospective Study.
     Ann Surg Oncol. 2023 Jul 3. doi: 10.1245/s10434-023-13792.
     PubMed     Abstract available
     
     
     
330. JORDAN RM, Rivera-Sanchez L, Kelley K, O'Brien MA, et al
     ASO Visual Abstract: The Impact of an Electromagnetic Seed Localization Device Versus Wire Localization on Breast Conserving Surgery-A Matched Pair Analysis.
     Ann Surg Oncol. 2023;30:4122.
     PubMed    
     
     
     
331. STREETER SS, Zuurbier RA, diFlorio-Alexander RM, Hansberry MT, et al
     ASO Visual Abstract: Breast-Conserving Surgery Margin Guidance Using Micro-Computed Tomography-Challenges When Imaging Radiodense Resection Specimens.
     Ann Surg Oncol. 2023;30:4109-4110.
     PubMed    
     
     
     
332. CHU JJ, Tadros AB, Gallo L, Mehrara BJ, et al
     ASO Visual Abstract: Interpreting the BREAST-Q for Breast-Conserving Therapy-Minimal Important Differences and Clinical Reference Values.
     Ann Surg Oncol. 2023;30:4085-4086.
     PubMed    
     
     
     
333. KARAKATSANIS A, Eriksson S, Pistiolis L, Bagge RO, et al
     ASO Visual Abstract: Delayed Sentinel Lymph Node Dissection in Patients with a Preoperative Diagnosis of Ductal Cancer In Situ by Preoperative Injection with Superparamagnetic Iron Oxide (SPIO) Nanoparticles: The SentiNot Study.
     Ann Surg Oncol. 2023;30:4073-4074.
     PubMed    
     
     
     
334. JORDAN RM, Bleicher R
     ASO Author Reflections: Impact of Electromagnetic Seed Localization on Breast-Conserving Surgery.
     Ann Surg Oncol. 2023;30:4120-4121.
     PubMed    
     
     
     
335. MUNCK F, Andersen IS, Vejborg I, Gerlach MK, et al
     Targeted Axillary Dissection with (125)I Seed Placement Before Neoadjuvant Chemotherapy in a Danish Multicenter Cohort.
     Ann Surg Oncol. 2023;30:4135-4142.
     PubMed     Abstract available
     
     
     
336. MUNCK F, Andersen IS, Vejborg I, Gerlach MK, et al
     ASO Visual Abstract: Targeted Axillary Dissection with (125)I Seed Placement Before Neoadjuvant Chemotherapy in a Danish Multicenter Cohort.
     Ann Surg Oncol. 2023;30:4145.
     PubMed    
     
     
     
337. STREETER SS, Zuurbier RA, diFlorio-Alexander RM, Hansberry MT, et al
     Breast-Conserving Surgery Margin Guidance Using Micro-Computed Tomography: Challenges When Imaging Radiodense Resection Specimens.
     Ann Surg Oncol. 2023;30:4097-4108.
     PubMed     Abstract available
     
     
     
338. MUNCK F, Kroman N, Tvedskov THF
     ASO Author Reflections: Feasibility of (125)I Seed Targeted Axillary Dissection.
     Ann Surg Oncol. 2023;30:4143-4144.
     PubMed    
     
     
     
339. GRABENSTETTER A, Brennan SB, Sevilimedu V, Kuba MG, et al
     ASO Visual Abstract: Is Surgical Excision of Focal Atypical Ductal Hyperplasia Warranted? Experience at a Tertiary Care Center.
     Ann Surg Oncol. 2023;30:4095-4096.
     PubMed    
     
     
     
340. PATEL TA, Dee EC, Jain B, Vapiwala N, et al
     Disparities in Breast-Conserving Therapy Versus Mastectomy Among Asian American and Pacific Islander Women.
     Ann Surg Oncol. 2023;30:3894-3897.
     PubMed    
     
     
     
341. JORDAN RM, Rivera-Sanchez L, Kelley K, O'Brien MA, et al
     The Impact of an Electromagnetic Seed Localization Device Versus Wire Localization on Breast-Conserving Surgery: A Matched-Pair Analysis.
     Ann Surg Oncol. 2023;30:4111-4119.
     PubMed     Abstract available
     
     
     
342. GRABENSTETTER A, Brennan SB, Sevilimedu V, Kuba MG, et al
     Is Surgical Excision of Focal Atypical Ductal Hyperplasia Warranted? Experience at a Tertiary Care Center.
     Ann Surg Oncol. 2023;30:4087-4094.
     PubMed     Abstract available
     
     
     
343. CHU JJ, Tadros AB, Gallo L, Mehrara BJ, et al
     Interpreting the BREAST-Q for Breast-Conserving Therapy: Minimal Important Differences and Clinical Reference Values.
     Ann Surg Oncol. 2023;30:4075-4084.
     PubMed     Abstract available
     
     
     
344. KARAKATSANIS A, Eriksson S, Pistiolis L, Olofsson Bagge R, et al
     Delayed Sentinel Lymph Node Dissection in Patients with a Preoperative Diagnosis of Ductal Cancer In Situ by Preoperative Injection with Superparamagnetic Iron Oxide (SPIO) Nanoparticles: The SentiNot Study.
     Ann Surg Oncol. 2023;30:4064-4072.
     PubMed     Abstract available
     
     
     June 2023
345. LEONARD LD, de Araujo TB, Quinn C, Thomas MB, et al
     ASO Visual Abstract: De-implementation of Axillary Dissection in Women Undergoing Mastectomy for Breast Cancer.
     Ann Surg Oncol. 2023 Jun 29. doi: 10.1245/s10434-023-13803.
     PubMed    
     
     
     
346. HSU DS, Jiang SF, Habel LA, Hoodfar E, et al
     Germline Genetic Testing Among Women
     Ann Surg Oncol. 2023 Jun 29. doi: 10.1245/s10434-023-13745.
     PubMed     Abstract available
     
     
     
347. BOUGHEY JC, Yu H, Dugan CL, Piltin MA, et al
     Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial.
     Ann Surg Oncol. 2023 Jun 28. doi: 10.1245/s10434-023-13759.
     PubMed     Abstract available
     
     
     
348. VERRECK E, van Steenhoven J, van Dalen T
     ASO Author Reflections: Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy.
     Ann Surg Oncol. 2023 Jun 28. doi: 10.1245/s10434-023-13785.
     PubMed    
     
     
     
349. THALJI SZ, Cortina CS, Kong AL
     ASO Author Reflections: Extending Optimal Care for Breast Cancer to the Elderly Population.
     Ann Surg Oncol. 2023 Jun 27. doi: 10.1245/s10434-023-13776.
     PubMed    
     
     
     
350. PATEL TA, Jain B, Dee EC, Gomez SL, et al
     Delays in Time to Surgery Among Asian and Pacific Islander Women with Breast Cancer.
     Ann Surg Oncol. 2023 Jun 26. doi: 10.1245/s10434-023-13806.
     PubMed    
     
     
     
351. MIRZAEI N, Warnberg F, Zaar P, Leonhardt H, et al
     ASO Visual Abstract: Ultra-Low Dose of Superparamagnetic Iron Oxide Nanoparticles for Sentinel Lymph Node Detection in Patients with Breast Cancer.
     Ann Surg Oncol. 2023 Jun 26. doi: 10.1245/s10434-023-13801.
     PubMed    
     
     
     
352. VASILYEVA E, Hamm J, Nichol A, Isaac KV, et al
     Breast-Conserving Therapy is Associated with Improved Survival Without an Increased Risk of Locoregional Recurrence Compared with Mastectomy in Both Clinically Node-Positive and Node-Negative Breast Cancer Patients.
     Ann Surg Oncol. 2023 Jun 26. doi: 10.1245/s10434-023-13784.
     PubMed     Abstract available
     
     
     
353. LEONARD LD, de Araujo TB, Quinn C, Thomas MB, et al
     De-implementation of Axillary Dissection in Women Undergoing Mastectomy for Breast Cancer.
     Ann Surg Oncol. 2023 Jun 16. doi: 10.1245/s10434-023-13698.
     PubMed     Abstract available
     
     
     
354. VERRECK EEF, van Steenhoven JEC, Kuijer A, van Maaren MC, et al
     ASO Visual Abstract: Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy.
     Ann Surg Oncol. 2023 Jun 15. doi: 10.1245/s10434-023-13621.
     PubMed    
     
     
     
355. THALJI SZ, Cortina CS, Frebault J, Cho Y, et al
     Associations Between Hospital Volume and Overall Survival After Surgery in Older Patients with Breast Cancer.
     Ann Surg Oncol. 2023 Jun 14. doi: 10.1245/s10434-023-13725.
     PubMed     Abstract available
     
     
     
356. MIRZAEI N, Warnberg F, Zaar P, Leonhardt H, et al
     Ultra-Low Dose of Superparamagnetic Iron Oxide Nanoparticles for Sentinel Lymph Node Detection in Patients with Breast Cancer.
     Ann Surg Oncol. 2023 Jun 14. doi: 10.1245/s10434-023-13722.
     PubMed     Abstract available
     
     
     
357. CHAN VHY, Heller DR, Berger ER, Capozza S, et al
     ASO Visual Abstract: Ancillary Treatment Referrals and Visits After Breast Cancer Surgery in a Sociodemographically Diverse Population.
     Ann Surg Oncol. 2023 Jun 2. doi: 10.1245/s10434-023-13610.
     PubMed    
     
     
     
358. CHAN VHY, Heller DR, Berger ER, Capozza S, et al
     Ancillary Treatment Referrals and Visits After Breast Cancer Surgery in a Sociodemographically Diverse Population.
     Ann Surg Oncol. 2023 Jun 2. doi: 10.1245/s10434-023-13431.
     PubMed     Abstract available
     
     
     
359. NASH AL, Hwang ES
     The Landmark Series-Ductal Carcinoma in Situ: The Evolution of Treatment.
     Ann Surg Oncol. 2023;30:3206-3214.
     PubMed     Abstract available
     
     
     
360. KATAOKA A, Sawaki M, Horisawa N, Kotani H, et al
     ASO Visual Abstract: The Absence of Cancer in the Location of a Breast Tissue Marker After Neoadjuvant Chemotherapy May Predict Pathological Complete Response with High Accuracy-Results from a Phase II Trial.
     Ann Surg Oncol. 2023;30:3235-3236.
     PubMed    
     
     
     
361. SAWAKI M, Kataoka A
     ASO Author Reflections: How Can We Eliminate Breast Surgery in Patients Who Achieved Clinical Complete Response After Neoadjuvant Chemotherapy?
     Ann Surg Oncol. 2023;30:3233-3234.
     PubMed    
     
     
     
362. KATAOKA A, Sawaki M, Horisawa N, Kotani H, et al
     The Absence of Cancer in the Location of a Breast Tissue Marker After Neoadjuvant Chemotherapy may Predict Pathological Complete Response with High Accuracy: Results from a Phase II Trial.
     Ann Surg Oncol. 2023;30:3224-3232.
     PubMed     Abstract available
     
     
     
363. MOLDOVEANU D, Iny E, Theriault C, Florea A, et al
     ASO Visual Abstract: Margin Status and Local Recurrence in Phyllodes Tumors of the Breast-A Canadian Series.
     Ann Surg Oncol. 2023;30:3280.
     PubMed    
     
     
     May 2023
364. LEE J, Jung JH, Kim WW, Kang B, et al
     ASO Visual Abstract: Ten-Year Oncologic Outcomes in T1-3N1 Breast Cancer After Targeted Axillary Sampling: A Retrospective Study.
     Ann Surg Oncol. 2023 May 24. doi: 10.1245/s10434-023-13390.
     PubMed    
     
     
     
365. VERRECK EEF, van Steenhoven JEC, Kuijer A, van Maaren MC, et al
     Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy.
     Ann Surg Oncol. 2023 May 24. doi: 10.1245/s10434-023-13568.
     PubMed     Abstract available
     
     
     
366. CHUNG SH, de Geus SWL, Shewmaker G, Romatoski KS, et al
     Axillary Lymph Node Dissection is Associated with Improved Survival Among Men with Invasive Breast Cancer and Sentinel Node Metastasis.
     Ann Surg Oncol. 2023 May 19. doi: 10.1245/s10434-023-13475.
     PubMed     Abstract available
     
     
     
367. VAN HEMERT AKE, van Duijnhoven FH, Vrancken-Peeters MTFD
     ASO Author Reflections: Biopsy Guided Pathological Response Assessment in Breast Cancer is Insufficient: Additional Pathology Findings of the MICRA Trial.
     Ann Surg Oncol. 2023 May 18. doi: 10.1245/s10434-023-13546.
     PubMed    
     
     
     
368. CHUNG SH, de Geus SWL, Shewmaker G, Romatoski KS, et al
     ASO Visual Abstract: Axillary Lymph Node Dissection is Associated with Improved Survival for Men with Invasive Breast Cancer and Sentinel Node Metastasis.
     Ann Surg Oncol. 2023 May 18. doi: 10.1245/s10434-023-13574.
     PubMed    
     
     
     
369. MOON T, Bloom J, Youssef G, Gaffney K, et al
     ASO Visual Abstract: Variable Accessibility to Consumer Pricing Among Breast Cancer Operations.
     Ann Surg Oncol. 2023 May 18. doi: 10.1245/s10434-023-13597.
     PubMed    
     
     
     
370. AZAM R, Lim D, Curpen B, Mulligan AM, et al
     ASO Visual Abstract: Correlation of Mammographic Microcalcifications with Final Surgical Pathology After Neoadjuvant Chemotherapy (NAC) for Breast Cancer.
     Ann Surg Oncol. 2023 May 16. doi: 10.1245/s10434-023-13415.
     PubMed    
     
     
     
371. CHUNG SH, Cassidy MR
     ASO Author Reflections: Male Breast Cancer and Axillary Lymph Node Dissection: Time to Rethink the Algorithm?
     Ann Surg Oncol. 2023 May 16. doi: 10.1245/s10434-023-13627.
     PubMed    
     
     
     
372. CHAN VHY, Heller DR, Sanft TB
     ASO Author Reflections: Ancillary Treatment After Breast Cancer Surgery: Who are We Missing?
     Ann Surg Oncol. 2023 May 13. doi: 10.1245/s10434-023-13507.
     PubMed    
     
     
     
373. VAN HEMERT AKE, van Duijnhoven FH, van Loevezijn AA, Loo CE, et al
     ASO Visual Abstract: Biopsy-Guided Pathological Response Assessment in Breast Cancer is Insufficient-Additional Pathology Findings of the MICRA Trial.
     Ann Surg Oncol. 2023 May 9. doi: 10.1245/s10434-023-13537.
     PubMed    
     
     
     
374. CASTELO M, Sutradhar R, Faught N, Giffoni D, et al
     ASO Visual Abstract: The Association Between Surgical Axillary Staging, Adjuvant Treatment use and Survival in Older Women with Early-Stage Breast Cancer: A Population-Based Study.
     Ann Surg Oncol. 2023 May 2. doi: 10.1245/s10434-023-13488.
     PubMed    
     
     
     
375. PAWLOSKI KR, Srour MK, Moo TA, Sevilimedu V, et al
     ASO Visual Abstract: Timing of Chemotherapy and Patient-Reported Outcomes After Breast-Conserving Surgery and Mastectomy with Immediate Reconstruction.
     Ann Surg Oncol. 2023;30:2912-2913.
     PubMed    
     
     
     
376. ARMSTRONG VL, Hammond JB, Jogerst KM, Kosiorek HE, et al
     ASO Visual Abstract: Impact of Same-Day Discharge and Enhanced Recovery on Patient Quality of Life After Mastectomy with Implant Reconstruction.
     Ann Surg Oncol. 2023;30:2881-2882.
     PubMed    
     
     
     
377. PAWLOSKI KR, Tadros AB
     ASO Author Reflections: Sequencing of Breast Surgery and Chemotherapy Does Not Impact Patient-Reported Outcomes.
     Ann Surg Oncol. 2023;30:2910-2911.
     PubMed    
     
     
     
378. NGUYEN DH, Rochlin DH, Deptula PL, Zak Y, et al
     ASO Visual Abstract: A Novel Fat-Augmented Omentum-Based Construct for Unilateral and Bilateral Free Flap Breast Reconstruction in Underweight and Normal-Weight Women Receiving Nipple- or Skin-Sparing Mastectomies.
     Ann Surg Oncol. 2023;30:3060.
     PubMed    
     
     
     
379. PAWLOSKI KR, Srour MK, Moo TA, Sevilimedu V, et al
     Timing of Chemotherapy and Patient-Reported Outcomes After Breast-Conserving Surgery and Mastectomy with Immediate Reconstruction.
     Ann Surg Oncol. 2023;30:2897-2909.
     PubMed     Abstract available
     
     
     
380. ARMSTRONG VL, Hammond JB, Jogerst KM, Kosiorek HE, et al
     The Impact of Same-Day Discharge and Enhanced Recovery on Patient Quality of Life After Mastectomy with Implant Reconstruction.
     Ann Surg Oncol. 2023;30:2873-2880.
     PubMed     Abstract available
     
     
     
381. CORIDDI M, Kim LN, Haglich K, McGrath L, et al
     ASO Visual Abstract: Impact of Lymphedema on Patient-Reported Outcomes After Breast Reconstruction-A Preliminary Propensity Score-Matched Analysis.
     Ann Surg Oncol. 2023;30:3072-3073.
     PubMed    
     
     
     
382. CORIDDI M, Kim LN, Haglich K, McGrath L, et al
     The Impact of Lymphedema on Patient-Reported Outcomes After Breast Reconstruction: A Preliminary Propensity Score-Matched Analysis.
     Ann Surg Oncol. 2023;30:3061-3071.
     PubMed     Abstract available
     
     
     
383. NGUYEN DH, Rochlin DH, Deptula PL, Zak Y, et al
     ASO Author Reflections: Innovation and the Development of a New Workhorse Flap in Breast Reconstruction.
     Ann Surg Oncol. 2023;30:3058-3059.
     PubMed    
     
     
     
384. NGUYEN DH, Rochlin DH, Deptula PL, Zak Y, et al
     A Novel Fat-Augmented Omentum-Based Construct for Unilateral and Bilateral Free-Flap Breast Reconstruction in Underweight and Normal Weight Women Receiving Nipple or Skin-Sparing Mastectomies.
     Ann Surg Oncol. 2023;30:3048-3057.
     PubMed     Abstract available
     
     
     April 2023
385. VAN HEMERT AKE, van Duijnhoven FH, van Loevezijn AA, Loo CE, et al
     Biopsy-Guided Pathological Response Assessment in Breast Cancer is Insufficient: Additional Pathology Findings of the MICRA Trial.
     Ann Surg Oncol. 2023 Apr 18. doi: 10.1245/s10434-023-13476.
     PubMed     Abstract available
     
     
     
386. MOON T, Bloom J, Youssef G, Gaffney K, et al
     Variable Accessibility to Consumer Pricing Among Breast Cancer Operations.
     Ann Surg Oncol. 2023 Apr 17. doi: 10.1245/s10434-023-13520.
     PubMed     Abstract available
     
     
     
387. VAN DE VOORT EMF, Franckena M, Struik GM, Moelker A, et al
     Comment on: Cryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial.
     Ann Surg Oncol. 2023 Apr 10. doi: 10.1245/s10434-023-13335.
     PubMed    
     
     
     
388. AZAM R, Lim D, Curpen B, Mulligan AM, et al
     Correlation of Mammographic Microcalcifications with Final Surgical Pathology After Neoadjuvant Chemotherapy for Breast Cancer.
     Ann Surg Oncol. 2023 Apr 8. doi: 10.1245/s10434-023-13367.
     PubMed     Abstract available
     
     
     
389. DOWNS-CANNER S, Mittendorf EA
     Correction: Preoperative Immunotherapy Combined with Chemotherapy for Triple-Negative Breast Cancer: Perspective on the KEYNOTE-522 Study.
     Ann Surg Oncol. 2023 Apr 4. doi: 10.1245/s10434-023-13448.
     PubMed    
     
     
     
390. WEBSTER AJ, Shanno JN, Cruz HSS, Kelly BN, et al
     ASO Visual Abstract: Oncologic Safety of Nipple-Sparing Mastectomy for Breast Cancer in BRCA Gene Mutation Carriers-Outcomes at 70 Months Median Follow-up.
     Ann Surg Oncol. 2023 Apr 4. doi: 10.1245/s10434-023-13153.
     PubMed    
     
     
     
391. ZARBA MELI E, De Santis A, Cortese G, Manna E, et al
     ASO Visual Abstract: Nipple-Sparing Mastectomy After Neoadjuvant Chemotherapy: Definitive Results with a Long-Term Follow-Up.
     Ann Surg Oncol. 2023;30:2173-2174.
     PubMed    
     
     
     
392. RUBENSTEIN RN, Nelson JA, Azoury SC, Shamsunder MG, et al
     ASO Visual Abstract: Breast Surgical Oncology Epidemiologic Research-A Guide and Comparison of Four National Databases.
     Ann Surg Oncol. 2023;30:2085-2086.
     PubMed    
     
     
     
393. YOON KH, Kang E, Kim EK, Park SY, et al
     ASO Visual Abstract: Recurrence is Not Associated with Margin Status in Phyllodes Tumor.
     Ann Surg Oncol. 2023;30:2162.
     PubMed    
     
     
     
394. MEURS CJC, van Rosmalen J, Menke-Pluijmers MBE, Siesling S, et al
     ASO Visual Abstract: Predicting Lymph Node Metastases in Patients with Biopsy-Proven Ductal Carcinoma In Situ of the Breast: Development and Validation of the DCIS-met Model.
     Ann Surg Oncol. 2023;30:2152-2153.
     PubMed    
     
     
     
395. WOODWARD SG, Fayanju OM
     Optimizing Sentinel Node Biopsy After Neoadjuvant Therapy: Striving to Know What We Do Not Know.
     Ann Surg Oncol. 2023;30:1943-1944.
     PubMed    
     
     
     
396. RUBENSTEIN RN, Nelson JA, Azoury SC, Shamsunder MG, et al
     Breast Surgical Oncology Epidemiologic Research: A Guide and Comparison of Four National Databases.
     Ann Surg Oncol. 2023;30:2069-2084.
     PubMed     Abstract available
     
     
     
397. ZARBA MELI E, De Santis A, Cortese G, Manna E, et al
     Nipple-Sparing Mastectomy After Neoadjuvant Chemotherapy: Definitive Results with a Long-Term Follow-Up Evaluation.
     Ann Surg Oncol. 2023;30:2163-2172.
     PubMed     Abstract available
     
     
     
398. YOON KH, Kang E, Kim EK, Park SY, et al
     Recurrence is Not Associated with Margin Status in Phyllodes Tumor.
     Ann Surg Oncol. 2023;30:2154-2161.
     PubMed     Abstract available
     
     
     
399. WEISS A, King TA
     Local Regional Recurrence Rates Are Low Following Neoadjuvant Endocrine Therapy: What Are the Remaining Barriers to its Widespread Adoption?
     Ann Surg Oncol. 2023;30:1940-1942.
     PubMed    
     
     
     
400. SHAMMAS RL, Gordee A, Lee HJ, Sergesketter AR, et al
     ASO Visual Abstract: Complications, Costs, and Healthcare Resource Utilization After Staged, Delayed, and Immediate Free-Flap Breast Reconstruction-A Longitudinal, Claims-Based Analysis.
     Ann Surg Oncol. 2023;30:2552-2553.
     PubMed    
     
     
     
401. CROWN A, Joseph KA
     Invited Editorial on Breast Surgical Oncology Epidemiological Research: A Guide and Comparison of Four National Databases.
     Ann Surg Oncol. 2023;30:1938-1939.
     PubMed    
     
     
     
402. MEURS CJC, van Rosmalen J, Menke-Pluijmers MBE, Siesling S, et al
     Predicting Lymph Node Metastases in Patients with Biopsy-Proven Ductal Carcinoma In Situ of the Breast: Development and Validation of the DCIS-met Model.
     Ann Surg Oncol. 2023;30:2142-2151.
     PubMed     Abstract available
     
     
     
403. SHAMMAS RL, Gordee A, Lee HJ, Sergesketter AR, et al
     Complications, Costs, and Healthcare Resource Utilization After Staged, Delayed, and Immediate Free-Flap Breast Reconstruction: A Longitudinal, Claims-Based Analysis.
     Ann Surg Oncol. 2023;30:2534-2549.
     PubMed     Abstract available
     
     
     
404. SHAMMAS RL, Phillips BT
     ASO Author Reflections: Optimal Timing of Autologous Breast Reconstruction Should Incorporate Patient Perspectives When Balancing the Increased Risks of a Staged Approach.
     Ann Surg Oncol. 2023;30:2550-2551.
     PubMed    
     
     
     
405. ALSER O
     The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from the ACOSOG Z11102 (Alliance) Trial: A Comment.
     Ann Surg Oncol. 2023 Apr 1. doi: 10.1245/s10434-023-13373.
     PubMed    
     
     
     March 2023
406. MAN V, Suen D, Kwong A
     ASO Visual Abstract: Use of Superparamagnetic Iron Oxide (SPIO) Versus Conventional Technique in Sentinel Lymph Node Detection for Breast Cancer: A Randomized Controlled Trial.
     Ann Surg Oncol. 2023 Mar 30. doi: 10.1245/s10434-023-13302.
     PubMed    
     
     
     
407. LEE J, Park HY
     ASO Author Reflections: Axillary Surgery for Breast Cancer: From Back to the Future, and Beyond.
     Ann Surg Oncol. 2023 Mar 29. doi: 10.1245/s10434-023-13259.
     PubMed    
     
     
     
408. BOKKERS K, Bleiker EMA, Aalfs CM, van Dalen T, et al
     ASO Visual Abstract: Surgical Oncologists and Nurses in Breast Cancer Care are Ready to Provide Pre-Test Genetic Counseling.
     Ann Surg Oncol. 2023 Mar 27. doi: 10.1245/s10434-023-13337.
     PubMed    
     
     
     
409. BALLMAN KV, McCall L, Boughey JC, Rosenkranz KM, et al
     Reply to: "The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial: A Comment" by Alser, Osaid.
     Ann Surg Oncol. 2023 Mar 27. doi: 10.1245/s10434-023-13375.
     PubMed    
     
     
     
410. CASTELO M, Sutradhar R, Faught N, Mata DGMM, et al
     The Association Between Surgical Axillary Staging, Adjuvant Treatment Use and Survival in Older Women with Early Stage Breast Cancer: A Population-Based Study.
     Ann Surg Oncol. 2023 Mar 14. doi: 10.1245/s10434-023-13274.
     PubMed     Abstract available
     
     
     
411. DOWNS-CANNER S, Mittendorf EA
     Preoperative Immunotherapy Combined with Chemotherapy for Triple-Negative Breast Cancer: Perspective on the KEYNOTE-522 Study.
     Ann Surg Oncol. 2023 Mar 10. doi: 10.1245/s10434-023-13267.
     PubMed    
     
     
     
412. MAN V, Suen D, Kwong A
     ASO Author Reflections: Pre-Operative Injection of Superparamagnetic Iron Oxide as the Only Localizing Tracer in Sentinel Lymph Node Biopsy in Early Breast Cancer.
     Ann Surg Oncol. 2023 Mar 10. doi: 10.1245/s10434-023-13305.
     PubMed    
     
     
     
413. CIVIL YA, Jonker LW, Oei AL, van der Velde S, et al
     ASO Author Reflections: Personalized Breast Cancer Treatment Using Preoperative Partial Breast Irradiation.
     Ann Surg Oncol. 2023 Mar 9. doi: 10.1245/s10434-023-13298.
     PubMed    
     
     
     
414. CIVIL YA, Jonker LW, Groot Koerkamp MPM, Duvivier KM, et al
     Preoperative Partial Breast Irradiation in Patients with Low-Risk Breast Cancer: A Systematic Review of Literature.
     Ann Surg Oncol. 2023 Mar 3. doi: 10.1245/s10434-023-13233.
     PubMed     Abstract available
     
     
     
415. WILKERSON AD, Obi M, Ortega C, Sebikali-Potts A, et al
     ASO Visual Abstract: Young Black Women May be More Likely to have First Mammogram Cancers-A New Perspective in Breast Cancer Disparities.
     Ann Surg Oncol. 2023 Mar 2. doi: 10.1245/s10434-022-13094.
     PubMed    
     
     
     
416. ELLSWORTH BL, Settecerri DJ, Mott NM, Vastardis A, et al
     ASO Visual Abstract: Surgeon Perspectives on Determinants of Same-Day Mastectomy: A Roadmap for Implementing Change.
     Ann Surg Oncol. 2023;30:1721.
     PubMed    
     
     
     
417. CHETTRI SR, Lee CN
     ASO Author Reflections: Breast Reconstruction Decision Quality and Patient-Reported Outcomes.
     Ann Surg Oncol. 2023;30:1901.
     PubMed    
     
     
     
418. CHETTRI SR, Pignone MP, Deal AM, Sepucha KR, et al
     ASO Visual Abstract: Patient-Reported Outcomes of Breast Reconstruction: Does the Quality of Decisions Matter?
     Ann Surg Oncol. 2023;30:1902-1903.
     PubMed    
     
     
     
419. ELLSWORTH BL, Settecerri DJ, Mott NM, Vastardis A, et al
     Surgeon Perspectives on Determinants of Same-Day Mastectomy: A Roadmap for Implementing Change.
     Ann Surg Oncol. 2023;30:1712-1720.
     PubMed     Abstract available
     
     
     
420. GONZALEZ GARCIA JA, Rodriguez Alvarado EI, Gutierrez Ramirez MC, Laforga Canales JB, et al
     Magnetic-Guided Occult Lesion Localization (M-GOLL): An Exploratory Feasibility Study of Preoperative CT-Guided Puncture and Intraoperative Magnetic Seed Localization for Minimally Invasive Surgical Resection of Non-palpable Pulmonary Lesions.
     Ann Surg Oncol. 2023;30:1309-1311.
     PubMed    
     
     
     
421. INY E, Prakash I
     ASO Author Reflections: Surgical Management of Phyllodes Tumors of the Breast.
     Ann Surg Oncol. 2023;30:1710-1711.
     PubMed    
     
     
     
422. MOLDOVEANU D, Iny E, Theriault C, Florea A, et al
     Margin Status and Local Recurrence in Phyllodes Tumours of the Breast: A Canadian Series.
     Ann Surg Oncol. 2023;30:1700-1709.
     PubMed     Abstract available
     
     
     
423. CHETTRI SR, Pignone MP, Deal AM, Sepucha KR, et al
     Patient-Reported Outcomes of Breast Reconstruction: Does the Quality of Decisions Matter?
     Ann Surg Oncol. 2023;30:1891-1900.
     PubMed     Abstract available
     
     
     
424. CLARK NM, Roberts EA, Federenko C, Sun Q, et al
     ASO Visual Abstract: Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers.
     Ann Surg Oncol. 2023;30:1329-1330.
     PubMed    
     
     
     
425. ISHITOBI M, Shien T
     ASO Author Reflections: Is Nipple-Areolar Recurrence After Nipple-Sparing Mastectomy Simply a "Cosmetic Failure"?
     Ann Surg Oncol. 2023;30:1687-1688.
     PubMed    
     
     
     
426. YAMAGUCHI A, Ishitobi M, Nagura N, Shimo A, et al
     Classification of Local Recurrence After Nipple-Sparing Mastectomy Based on Location: The Features of Nipple-Areolar Recurrence Differ from Those of Other Local Recurrences.
     Ann Surg Oncol. 2023;30:1678-1686.
     PubMed     Abstract available
     
     
     
427. CLARK NM, Roberts EA, Fedorenko C, Sun Q, et al
     Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers.
     Ann Surg Oncol. 2023;30:1312-1326.
     PubMed     Abstract available
     
     
     February 2023
428. BOKKERS K, Bleiker EMA, Aalfs CM, van Dalen T, et al
     Surgical Oncologists and Nurses in Breast Cancer Care are Ready to Provide Pre-Test Genetic Counseling.
     Ann Surg Oncol. 2023 Feb 28. doi: 10.1245/s10434-023-13229.
     PubMed     Abstract available
     
     
     
429. MAN V, Suen D, Kwong A
     Use of Superparamagnetic Iron Oxide (SPIO) Versus Conventional Technique in Sentinel Lymph Node Detection for Breast Cancer: A Randomised Controlled Trial.
     Ann Surg Oncol. 2023 Feb 27. doi: 10.1245/s10434-023-13252.
     PubMed     Abstract available
     
     
     
430. BOKKERS K, Ausems MGEM
     ASO Author Reflections: The Role of Surgeons and Nurse Specialists in the Mainstreaming of Genetic Testing for Breast Cancer Patients.
     Ann Surg Oncol. 2023 Feb 24. doi: 10.1245/s10434-023-13269.
     PubMed    
     
     
     
431. MILGROM ZZ, Milgrom DP, Han Y, Hui SL, et al
     ASO Visual Abstract: Breast Cancer Screening, Diagnosis, and Surgery During the Pre- and Peri-pandemic-Experience of Patients in a Statewide Health Information Exchange.
     Ann Surg Oncol. 2023 Feb 24:1-2. doi: 10.1245/s10434-023-13183.
     PubMed    
     
     
     
432. LEE J, Jung JH, Kim WW, Kang B, et al
     Ten-Year Oncologic Outcomes in T1-3N1 Breast Cancer After Targeted Axillary Sampling: A Retrospective Study.
     Ann Surg Oncol. 2023 Feb 24. doi: 10.1245/s10434-023-13191.
     PubMed     Abstract available
     
     
     
433. RECORD SM, Plichta JK
     De-Escalation of Axillary Surgery for Older Patients with Breast Cancer: Supporting Data Continue to Accumulate.
     Ann Surg Oncol. 2023 Feb 23. doi: 10.1245/s10434-023-13299.
     PubMed    
     
     
     
434. CEBRECOS I, Mension E, Vidal M, Schettini F, et al
     ASO Author Reflections: A Perspective on Nonsentinel Axillary Lymph Node Status in Sentinel Lymph Node-Positive Early Breast Cancer After Primary Systemic Therapy and ALND-Predict.
     Ann Surg Oncol. 2023 Feb 23. doi: 10.1245/s10434-023-13297.
     PubMed    
     
     
     
435. CEBRECOS I, Mension E, Alonso I, Castillo H, et al
     Nonsentinel Axillary Lymph Node Status in Clinically Node-Negative Early Breast Cancer After Primary Systemic Therapy and Positive Sentinel Lymph Node: A Predictive Model Proposal.
     Ann Surg Oncol. 2023 Feb 21. doi: 10.1245/s10434-023-13231.
     PubMed     Abstract available
     
     
     
436. GWARK S, Kim HJ, Kim J, Chung IY, et al
     ASO Visual Abstract: Survival After Breast-Conserving Surgery Compared with that After Mastectomy in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2023 Feb 15. doi: 10.1245/s10434-023-13154.
     PubMed    
     
     
     
437. MILGROM ZZ, Milgrom DP, Han Y, Hui SL, et al
     Breast Cancer Screening, Diagnosis, and Surgery during the Pre- and Peri-pandemic: Experience of Patients in a Statewide Health Information Exchange.
     Ann Surg Oncol. 2023 Feb 7:1-12. doi: 10.1245/s10434-023-13119.
     PubMed     Abstract available
     
     
     
438. HUNT KK, Suman VJ, Wingate HF, Leitch AM, et al
     ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy - Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estro
     Ann Surg Oncol. 2023 Feb 6. doi: 10.1245/s10434-023-13149.
     PubMed    
     
     
     
439. EDEN CM, Malik M, Ju T
     ASO Author Reflections: The Asian American Breast Cancer Population: Disaggregating the Monolith.
     Ann Surg Oncol. 2023 Feb 3. doi: 10.1245/s10434-023-13177.
     PubMed    
     
     
     
440. BLOOM JA, Shah SA, Long EA, Chatterjee A, et al
     ASO Visual Abstract: Postmastectomy Tissue Expander Placement Followed by Radiation Therapy-A Cost-Effectiveness Analysis of Staged Autologous versus Implant-Based Unilateral Reconstruction.
     Ann Surg Oncol. 2023;30:1086.
     PubMed    
     
     
     
441. BLOOM JA, Shah SA, Long EA, Chatterjee A, et al
     Post-Mastectomy Tissue Expander Placement Followed by Radiation Therapy: A Cost-Effectiveness Analysis of Staged Autologous Versus Implant-Based Unilateral Reconstruction.
     Ann Surg Oncol. 2023;30:1075-1083.
     PubMed     Abstract available
     
     
     January 2023
442. MURPHY BL, Arun BK
     ASO Author Reflections: Other Cancers in Patients with Breast Cancer Who Undergo Germline Testing.
     Ann Surg Oncol. 2023 Jan 27. doi: 10.1245/s10434-022-12539.
     PubMed    
     
     
     
443. NASH AL, Ren Y, Plichta JK, Rosenberger LH, et al
     ASO Visual Abstract: Survival Benefit of Chemotherapy According to 21-Gene Recurrence Score in Young Women with Breast Cancer.
     Ann Surg Oncol. 2023 Jan 25. doi: 10.1245/s10434-022-12885.
     PubMed    
     
     
     
444. FASANO GA, Bayard S, Chen Y, Marti J, et al
     Survival Outcomes in Women with Unilateral, Triple-Negative, Breast Cancer Correlated with Contralateral Prophylactic Mastectomy.
     Ann Surg Oncol. 2023 Jan 21. doi: 10.1245/s10434-022-13056.
     PubMed     Abstract available
     
     
     
445. WILKERSON AD, Obi M, Ortega C, Sebikali-Potts A, et al
     Correction: Young Black Women May be More Likely to Have First Mammogram Cancers: A New Perspective in Breast Cancer Disparities.
     Ann Surg Oncol. 2023 Jan 19. doi: 10.1245/s10434-023-13111.
     PubMed    
     
     
     
446. HUNT KK, Suman VJ, Wingate HF, Leitch AM, et al
     Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clini
     Ann Surg Oncol. 2023 Jan 18. doi: 10.1245/s10434-022-12972.
     PubMed     Abstract available
     
     
     
447. EDEN CM, Johnson J, Syrnioti G, Malik M, et al
     The Landmark Series: The Breast Cancer Burden of the Asian American Population and the Need for Disaggregated Data.
     Ann Surg Oncol. 2023 Jan 18. doi: 10.1245/s10434-023-13103.
     PubMed     Abstract available
     
     
     
448. WU G, Cheligeer C, Brisson AM, Quan ML, et al
     ASO Visual Abstract: A New Method of Identifying Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer Patients Using a Population-Based Electronic Medical Record System.
     Ann Surg Oncol. 2023 Jan 16. doi: 10.1245/s10434-022-13023.
     PubMed    
     
     
     
449. SUN SX, Duan Z, Kuerer HM, DeSnyder SM, et al
     ASO Visual Abstract: Predictors of Emergency Room Visits After Ambulatory Breast Cancer Surgery in the Medicare Population.
     Ann Surg Oncol. 2023 Jan 9. doi: 10.1245/s10434-022-12998.
     PubMed    
     
     
     
450. NASH AL, Ren Y, Plichta JK, Rosenberger LH, et al
     Survival Benefit of Chemotherapy According to 21-Gene Recurrence Score in Young Women with Breast Cancer.
     Ann Surg Oncol. 2023 Jan 8. doi: 10.1245/s10434-022-12699.
     PubMed     Abstract available
     
     
     
451. WEBSTER AJ, Shanno JN, Santa Cruz HS, Kelly BN, et al
     Oncologic Safety of Nipple-Sparing Mastectomy for Breast Cancer in BRCA Gene Mutation Carriers: Outcomes at 70 Months Median Follow-Up.
     Ann Surg Oncol. 2023 Jan 5. doi: 10.1245/s10434-022-13006.
     PubMed     Abstract available
     
     
     
452. WILKERSON AD, Obi M, Ortega C, Sebikali-Potts A, et al
     Young Black Women May be More Likely to Have First Mammogram Cancers: A New Perspective in Breast Cancer Disparities.
     Ann Surg Oncol. 2023 Jan 5. doi: 10.1245/s10434-022-12995.
     PubMed     Abstract available
     
     
     
453. COOPEY SB
     Contralateral Prophylactic Mastectomy in Average Risk Women: Who Can Choose This Wisely?
     Ann Surg Oncol. 2023;30:4-5.
     PubMed    
     
     
     
454. OSTAPENKO E, Nixdorf L, Devyatko Y, Exner R, et al
     Prepectoral Versus Subpectoral Implant-Based Breast Reconstruction: A Systemic Review and Meta-analysis.
     Ann Surg Oncol. 2023;30:126-136.
     PubMed     Abstract available
     
     
     
455. PALMQUIST E, Tadros AB
     ASO Author Reflections: The Decision to Pursue Reconstruction After Mastectomy in cT4 Patients.
     Ann Surg Oncol. 2023;30:122-123.
     PubMed    
     
     
     
456. LAWS A, Katlin F, Hans M, Graichen M, et al
     Screening MRI Does Not Increase Cancer Detection or Result in an Earlier Stage at Diagnosis for Patients with High-Risk Breast Lesions: A Propensity Score Analysis.
     Ann Surg Oncol. 2023;30:68-77.
     PubMed     Abstract available
     
     
     
457. GLAJZER J, Castillo-Tong DC, Richter R, Vergote I, et al
     Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong S
     Ann Surg Oncol. 2023;30:35-45.
     PubMed     Abstract available
     
     
     
458. FAN B, Romatoski K, Pardo J, Valero M, et al
     Evaluating Axillary Lymph Node Yield After Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2023;30:107-111.
     PubMed     Abstract available
     
     
     
459. LEE MK, Montagna G, Pilewskie ML, Sevilimedu V, et al
     Axillary Staging Is Not Justified in Postmenopausal Clinically Node-Negative Women Based on Nodal Disease Burden.
     Ann Surg Oncol. 2023;30:92-97.
     PubMed     Abstract available
     
     
     December 2022
460. GWARK S, Kim HJ, Kim J, Chung IY, et al
     Survival After Breast-Conserving Surgery Compared with that After Mastectomy in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2022 Dec 28. doi: 10.1245/s10434-022-12993.
     PubMed     Abstract available
     
     
     
461. WU G, Cheligeer C, Brisson AM, Quan ML, et al
     A New Method of Identifying Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer Patients Using a Population-Based Electronic Medical Record System.
     Ann Surg Oncol. 2022 Dec 21. doi: 10.1245/s10434-022-12955.
     PubMed     Abstract available
     
     
     
462. SBROCCHI T, Kavanagh K, Chao AH
     ASO Visual Abstract: Optimizing the Timeliness of Surgical Therapy in Breast Cancer Patients Undergoing Immediate Breast Reconstruction.
     Ann Surg Oncol. 2022 Dec 17. doi: 10.1245/s10434-022-12914.
     PubMed    
     
     
     
463. LEE KT, Kim JH, Jeon BJ, Pyon JK, et al
     Association of Fat Graft with Breast Cancer Recurrence in Implant-Based Reconstruction: Does the Timing Matter?
     Ann Surg Oncol. 2022 Dec 10. doi: 10.1245/s10434-022-12389.
     PubMed     Abstract available
     
     
     
464. LEE KT, Kim JH, Jeon BJ, Pyon JK, et al
     ASO Visual Abstract: Association of Fat Graft in Implant-Based Reconstruction with Breast Cancer Recurrence: Does the Timing Matter?
     Ann Surg Oncol. 2022 Dec 10. doi: 10.1245/s10434-022-12602.
     PubMed    
     
     
     
465. SORAN A, Ozbas S, Ozcinar B, Isik A, et al
     Correction: Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study-IMET, Protocol MF 14-02.
     Ann Surg Oncol. 2022 Dec 9. doi: 10.1245/s10434-022-12931.
     PubMed    
     
     
     
466. KHAN SA, Schuetz S, Hosseini O
     Reply to: "Impact of Primary-Site Local Therapy in Patients with De Novo Metastatic Breast Cancer," by Makris, Eleftherios et al.
     Ann Surg Oncol. 2022 Dec 3. doi: 10.1245/s10434-022-12873.
     PubMed    
     
     
     
467. MAKRIS EA, Soran A
     Impact of Primary-Site Local Therapy for Patients with De Novo Metastatic Breast Cancer.
     Ann Surg Oncol. 2022 Dec 2. doi: 10.1245/s10434-022-12871.
     PubMed    
     
     
     
468. TESCH ME, Rosenberg SM, Collins LC, Wong JS, et al
     ASO Visual Abstract: Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ.
     Ann Surg Oncol. 2022;29:8058-8059.
     PubMed    
     
     
     
469. WILLIAMS AD, Khan AJ, Sevilimedu V, Barrio AV, et al
     ASO Visual Abstract: Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy.
     Ann Surg Oncol. 2022;29:8046-8047.
     PubMed    
     
     
     
470. WOODS AP, Papageorge MV, de Geus SWL, Alonso A, et al
     ASO Visual Abstract: Impact of Patient Primary Language upon Immediate Breast Reconstruction after Mastectomy.
     Ann Surg Oncol. 2022;29:8621-8622.
     PubMed    
     
     
     
471. TESCH ME, Rosenberg SM, Collins LC, Wong JS, et al
     Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ.
     Ann Surg Oncol. 2022;29:8048-8057.
     PubMed     Abstract available
     
     
     
472. WILLIAMS AD, Khan AJ, Sevilimedu V, Barrio AV, et al
     Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy.
     Ann Surg Oncol. 2022;29:8037-8043.
     PubMed     Abstract available
     
     
     
473. WOODS AP, Papageorge MV, de Geus SWL, Alonso A, et al
     Impact of Patient Primary Language upon Immediate Breast Reconstruction After Mastectomy.
     Ann Surg Oncol. 2022;29:8610-8618.
     PubMed     Abstract available
     
     
     
474. ROBBINS T, Hoskin TL, Day CN, Mrdutt MM, et al
     ASO Visual Abstract: Node Positivity Among Sonographically Suspicious but FNA-Negative Axillary Nodes.
     Ann Surg Oncol. 2022;29.
     PubMed    
     
     
     
475. HUANG CC, Tsai YF, Liu CY, Lien PJ, et al
     ASO Visual Abstract: Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast Cancers.
     Ann Surg Oncol. 2022;29.
     PubMed    
     
     
     
476. ABBASSI-RAHBAR S, Amin AL
     ASO Author Reflections: De-escalation of Surgical Excision for Intraductal Papilloma of the Breast.
     Ann Surg Oncol. 2022;29.
     PubMed    
     
     
     
477. LIM DW, Hong NJL
     ASO Author Reflections: Identifying pCR After Neoadjuvant Chemotherapy: The Key to Treatment De-escalation in Breast Cancer.
     Ann Surg Oncol. 2022;29.
     PubMed    
     
     
     
478. CHE BAKRI NA, Kwasnicki RM, Dhillon K, Khan N, et al
     ASO Author Reflections: Improving Management of Upper Limb Complications after Breast Cancer Treatments.
     Ann Surg Oncol. 2022;29.
     PubMed    
     
     
     
479. LEILOGLOU M, Kedrzycki MS, Elson DS, Leff DR, et al
     ASO Author Reflections: Towards Fluorescence Guided Tumor Identification for Precision Breast Conserving Surgery.
     Ann Surg Oncol. 2022;29.
     PubMed    
     
     
     
480. GARSTKA M, Smith BL
     ASO Author Reflections: Prophylactic Nipple-Sparing Mastectomy as an Effective Risk-Reducing Strategy for BRCA Mutation Carriers.
     Ann Surg Oncol. 2022;29.
     PubMed    
     
     
     
481. THOMPSON J, Wright GP
     ASO Author Reflections: Overtreatment of Older Females with Favorable-Prognosis Breast Cancer.
     Ann Surg Oncol. 2022;29.
     PubMed    
     
     
     
482. ELSHERIF A, Valente SA
     ASO Author Reflections: Is Cefazolin Enough with Implant Reconstruction? Does Retaining the Nipple Make a Difference?
     Ann Surg Oncol. 2022;29.
     PubMed    
     
     
     
483. BOUGHEY JC, Nguyen TT, Dietz JR, Wilke LG, et al
     ASO Authors Reflection: Lessons Learned from the COVID-19 Pandemic-Should We Change Surgical Management of Patients with Breast Cancer?
     Ann Surg Oncol. 2022;29.
     PubMed    
     
     
     
484. CHAGPAR AB
     ASO Author Reflections: "Right-Sizing" Radiation Therapy After Mastectomy.
     Ann Surg Oncol. 2022;29.
     PubMed    
     
     
     
485. COCCO D, Valente SA
     ASO Author Reflection: Updating our Knowledge on Invasive Lobular Breast Cancer.
     Ann Surg Oncol. 2022;29.
     PubMed    
     
     
     November 2022
486. SBROCCHI T, Kavanagh K, Chao AH
     Optimizing the Timeliness of Surgical Therapy in Patients with Breast Cancer Undergoing Immediate Breast Reconstruction.
     Ann Surg Oncol. 2022 Nov 19. doi: 10.1245/s10434-022-12835.
     PubMed     Abstract available
     
     
     
487. SUN SX, Duan Z, Kuerer HM, DeSnyder SM, et al
     Predictors of Emergency Room Visits After Ambulatory Breast Cancer Surgery in the Medicare Population.
     Ann Surg Oncol. 2022 Nov 19. doi: 10.1245/s10434-022-12836.
     PubMed     Abstract available
     
     
     
488. NAKAMURA S
     Homologous Recombination Deficiency in Triple-Negative Breast Cancer: Potential Benefit of a New Target.
     Ann Surg Oncol. 2022 Nov 18. doi: 10.1245/s10434-022-12329.
     PubMed    
     
     
     
489. CHAO AH
     ASO Author Reflections: Refining the Integration of Reconstructive Surgery into Breast Cancer Care.
     Ann Surg Oncol. 2022 Nov 18. doi: 10.1245/s10434-022-12842.
     PubMed    
     
     
     
490. KO G, Hallet J, Jerzak KJ, Chan W, et al
     ASO Visual Abstract: Low Rates of Medical Oncology Consultation for Older Women (>/= 70 Years) with Newly Diagnosed, Nonmetastatic Breast Cancer-a Population-Based Study.
     Ann Surg Oncol. 2022 Nov 14. pii: 10.1245/s10434-022-12727.
     PubMed    
     
     
     
491. OH SJ, Butler PD
     Ensuring Both Accessibility and Usability of Breast Cancer Care.
     Ann Surg Oncol. 2022 Nov 7. pii: 10.1245/s10434-022-12763.
     PubMed    
     
     
     
492. SCHWARTZ T, Marumoto AD, Giuliano AE
     ASO Visual Abstract: Surgical Management of the Axilla in Breast Cancer-Evolving but Still Necessary.
     Ann Surg Oncol. 2022 Nov 5. pii: 10.1245/s10434-022-12685.
     PubMed    
     
     
     
493. KNAPE N, Park JH, Agala CB, Spanheimer P, et al
     ASO Visual Abstract: Can We Forego Sentinel Lymph Node Biopsy in Women >/=50 Years of Age with Early-Stage Hormone Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer?
     Ann Surg Oncol. 2022 Nov 4. pii: 10.1245/s10434-022-12726.
     PubMed    
     
     
     
494. GOOIJER SA, Folkersma C, van Steenhoven JEC, de Kort J, et al
     Long-Term Outcome of Sustained Endocrine Monotherapy for Elderly Breast Cancer Patients.
     Ann Surg Oncol. 2022 Nov 3. pii: 10.1245/s10434-022-12662.
     PubMed     Abstract available
     
     
     
495. PESTANA CV, Livasy CA, Donahue EE, Neelands B, et al
     ASO Visual Abstract: Does Residual Cancer Burden Predict Local Recurrence after Neoadjuvant Chemotherapy?
     Ann Surg Oncol. 2022;29:7725.
     PubMed    
     
     
     
496. FAN B, James T
     Avoiding Axillary Management Pitfalls After Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2022;29:7265-7266.
     PubMed    
     
     
     
497. PILTIN MA, Hoskin TL, Day CN, Habermann EB, et al
     ASO Visual Abstract: Overuse of Axillary Surgery for Patients With Ductal Carcinoma In Situ: Opportunity for De-Escalation.
     Ann Surg Oncol. 2022;29:7715.
     PubMed    
     
     
     
498. KIM YS, Cho HG, Kim J, Park SJ, et al
     ASO Visual Abstract: Prediction of Implant Size Based on Breast Volume Using Mammography with Fully Automated Measurement and Breast MRI.
     Ann Surg Oncol. 2022;29:7857-7858.
     PubMed    
     
     
     
499. NICKEL KB, Myckatyn TM, Lee CN, Fraser VJ, et al
     ASO Visual Abstract: Individualized Risk Prediction Tool for Serious Wound Complications after Mastectomy with and without Immediate Reconstruction.
     Ann Surg Oncol. 2022;29:7767-7768.
     PubMed    
     
     
     
500. NICKEL KB, Myckatyn TM, Lee CN, Fraser VJ, et al
     Individualized Risk Prediction Tool for Serious Wound Complications After Mastectomy With and Without Immediate Reconstruction.
     Ann Surg Oncol. 2022;29:7751-7764.
     PubMed     Abstract available
     
     
     
501. OLSEN MA, Myckatyn TM, Lee CN
     ASO Author Reflections: Need for Individualized Risk Prediction to Facilitate Shared Decision Making in Post-mastectomy Breast Reconstruction.
     Ann Surg Oncol. 2022;29:7765-7766.
     PubMed    
     
     
     
502. PESTANA CV, Livasy CA, Donahue EE, Neelands B, et al
     Does Residual Cancer Burden Predict Local Recurrence After Neoadjuvant Chemotherapy?
     Ann Surg Oncol. 2022;29:7716-7724.
     PubMed     Abstract available
     
     
     
503. ABEL MK, Mukhtar RA
     ASO Author Reflections: Discordant Clinical and Molecular Risk in Invasive Lobular Carcinoma of the Breast: The 21-Gene Recurrence Score in the National Cancer Database by Histologic Subtype.
     Ann Surg Oncol. 2022;29:7748-7749.
     PubMed    
     
     
     
504. PILTIN MA, Hoskin TL, Day CN, Habermann EB, et al
     Overuse of Axillary Surgery in Patients with Ductal Carcinoma In Situ: Opportunity for De-escalation.
     Ann Surg Oncol. 2022;29:7705-7712.
     PubMed     Abstract available
     
     
     
505. KIM YS, Cho HG, Kim J, Park SJ, et al
     Prediction of Implant Size Based on Breast Volume Using Mammography with Fully Automated Measurements and Breast MRI.
     Ann Surg Oncol. 2022;29:7845-7854.
     PubMed     Abstract available
     
     
     
506. KIM YS, Cho HG, Kim J, Park SJ, et al
     ASO Author Reflections: Prediction of Implant Size Based on Breast Volumetry Using Mammography and Breast MRI in DTI Breast Reconstruction.
     Ann Surg Oncol. 2022;29:7855-7856.
     PubMed    
     
     
     
507. CULVER JO, Freiberg Y, Ricker C, Comeaux JG, et al
     ASO Visual Abstract: Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients.
     Ann Surg Oncol. 2022 Nov 1. pii: 10.1245/s10434-022-12712.
     PubMed    
     
     
     October 2022
508. KO G, Wright FC, Look Hong NJ
     ASO Author Reflections: Why Are Older Women with Breast Cancer Receiving Substandard Care? An Analysis of Consultation Patterns.
     Ann Surg Oncol. 2022 Oct 30. pii: 10.1245/s10434-022-12747.
     PubMed    
     
     
     
509. FAYANJU OM, Edmonds CE, Reyes SA, Arciero C, et al
     ASO Visual Abstract: Landmark Series-Addressing Disparities in Breast Cancer Screening: New Recommendations for Black Women.
     Ann Surg Oncol. 2022 Oct 30. pii: 10.1245/s10434-022-12665.
     PubMed    
     
     
     
510. KO G, Hallet J, Jerzak KJ, Chan W, et al
     Low Rates of Medical Oncology Consultation for Older Women (>/= 70 Years) with Newly Diagnosed, Non-Metastatic Breast Cancer: A Population-Based Study.
     Ann Surg Oncol. 2022 Oct 18. pii: 10.1245/s10434-022-12640.
     PubMed     Abstract available
     
     
     
511. KHAN SY, Melkus MW, Layeequr Rahman R
     ASO Author Reflections: Cryoablation Cost-Benefit Analysis: Managing Breast Cancer Through Cost-Effective Therapy.
     Ann Surg Oncol. 2022 Oct 16. pii: 10.1245/s10434-022-12669.
     PubMed    
     
     
     
512. SCHWARTZ T, Marumoto AD, Giuliano AE
     ASO Author Reflections: The Evolution of Axillary Management in Breast Cancer.
     Ann Surg Oncol. 2022 Oct 16. pii: 10.1245/s10434-022-12677.
     PubMed    
     
     
     
513. CULVER JO
     ASO Author Reflections: A Green Light for Genetic Testing in All Patients with Breast Cancer.
     Ann Surg Oncol. 2022 Oct 14. pii: 10.1245/s10434-022-12671.
     PubMed    
     
     
     
514. POSTLEWAIT LM
     Assessment of Novel Therapeutics for Individualized Breast Cancer Care in the Modern Era: The Role of Metformin in Breast Cancer Therapy.
     Ann Surg Oncol. 2022 Oct 12. pii: 10.1245/s10434-022-12627.
     PubMed    
     
     
     
515. KNAPE N, Park JH, Agala CB, Spanheimer P, et al
     Can We Forgo Sentinel Lymph Node Biopsy in Women Aged >/= 50 Years with Early-Stage Hormone-Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer?
     Ann Surg Oncol. 2022 Oct 10. pii: 10.1245/s10434-022-12626.
     PubMed     Abstract available
     
     
     
516. HASSAN AM, Offodile AC 2nd
     ASO Author Reflections: Neighborhood-Level Deprivation Impacts Patient-Reported Outcomes Following Breast Cancer Surgery.
     Ann Surg Oncol. 2022 Oct 10. pii: 10.1245/s10434-022-12521.
     PubMed    
     
     
     
517. MURPHY BL, Yi M, Barrera AG, Tripathy D, et al
     ASO Visual Abstract: Other Primary Malignancies in Patients with Breast Cancer Who Undergo Germline Panel Testing.
     Ann Surg Oncol. 2022 Oct 10. pii: 10.1245/s10434-022-12519.
     PubMed    
     
     
     
518. SAHA D, Balasubramanian A, Kannan A, Pant A, et al
     Breast Cancer Screening in Young Women with the Advent of Newer Techniques: Current Evidence and Future Considerations.
     Ann Surg Oncol. 2022 Oct 8. pii: 10.1245/s10434-022-12550.
     PubMed    
     
     
     
519. PALMQUIST E, Limberg J, Chu JJ, White C, et al
     ASO Visual Abstract: Patient-Reported Outcome Measures in Patients with Clinical T4 Breast Cancer Treated with Mastectomy With and Without Reconstruction.
     Ann Surg Oncol. 2022 Oct 7. pii: 10.1245/s10434-022-12585.
     PubMed     Abstract available
     
     
     
520. ESCOBAR N, Joseph KA
     ASO Author Reflections: Same but Different: Implications of Surgical Delays for Breast Cancer Patients Treated in NYC Public Hospitals During the COVID-19 Pandemic.
     Ann Surg Oncol. 2022 Oct 5. pii: 10.1245/s10434-022-12540.
     PubMed    
     
     
     
521. KAPP KA, Cheng AL, Bruton CM, Ahmadiyeh N, et al
     ASO Visual Abstract: Impact of COVID-19 Restrictions on Stage of Breast Cancer at Presentation and Time to Treatment at an Urban Safety-Net Hospital.
     Ann Surg Oncol. 2022 Oct 5. pii: 10.1245/s10434-022-12475.
     PubMed    
     
     
     
522. SCHWARTZ T, Marumoto AD, Giuliano AE
     Surgical Management of the Axilla in Breast Cancer: Evolving but Still Necessary.
     Ann Surg Oncol. 2022 Oct 4. pii: 10.1245/s10434-022-12605.
     PubMed    
     
     
     
523. FAYANJU OM, Edmonds CE, Reyes SA, Arciero C, et al
     The Landmark Series-Addressing Disparities in Breast Cancer Screening: New Recommendations for Black Women.
     Ann Surg Oncol. 2022 Oct 3. pii: 10.1245/s10434-022-12535.
     PubMed     Abstract available
     
     
     
524. KHAN SY, Snitman A, Habrawi Z, Crawford S, et al
     ASO Visual Abstract: The Role of Cryoablation in Breast Cancer Beyond the Oncologic Control: COST and Breast-Q Patient Reported Outcomes.
     Ann Surg Oncol. 2022 Oct 2. pii: 10.1245/s10434-022-12610.
     PubMed    
     
     
     
525. CHAKEDIS JM, Tang A, Savitz A, Lyon LL, et al
     ASO Visual Abstract: Economic Impact of Reducing Re-excision Rates After Breast-Conserving Surgery in a Large, Integrated Health System.
     Ann Surg Oncol. 2022;29:6297-6298.
     PubMed    
     
     
     
526. ABUJBARAH S, Jogerst K, Kosiorek HE, Ahmad S, et al
     ASO Visual Abstract: Postoperative Hematomas in the Era of Outpatient Mastectomy: Is Ketorolac Really to Blame?
     Ann Surg Oncol. 2022;29:6406.
     PubMed    
     
     
     
527. MARTINEZ EO, Jorns JM, Kong AL, Kijak J, et al
     ASO Visual Abstract: Primary Breast Neuroendocrine Tumors-An Analysis of the National Cancer Database.
     Ann Surg Oncol. 2022;29:6349.
     PubMed    
     
     
     
528. NANDA AD, Reifel KR, Mann MP, Lyman-Hager MM, et al
     Text-Based Intervention Increases Mammography Uptake at an Urban Safety-Net Hospital.
     Ann Surg Oncol. 2022;29:6199-6205.
     PubMed     Abstract available
     
     
     
529. MONTAGNA G, Morrow M
     ASO Author Reflections: Do We Need to Clip Metastatic Lymph Nodes at Diagnosis and Localize Them After Neoadjuvant Chemotherapy?
     Ann Surg Oncol. 2022;29:6140-6141.
     PubMed    
     
     
     
530. MILLER KN, Thomas SM, Sergesketter AR, Rosenberger LH, et al
     The Influence of Body Mass Index on the Histopathology and Outcomes of Patients Diagnosed with Atypical Breast Lesions.
     Ann Surg Oncol. 2022;29:6484-6494.
     PubMed     Abstract available
     
     
     
531. JOGERST KM, Abujbarah SM, Pockaj B
     ASO Author Reflections: Weighing the Risks and Benefits of Multimodal Analgesia Following Breast Surgery.
     Ann Surg Oncol. 2022;29:6404-6405.
     PubMed    
     
     
     
532. HIEKEN TJ, Solanki MH
     ASO Author Reflections: Standardizing Pathology Examination of Sentinel Lymph Nodes in Invasive Lobular Carcinoma: Less Is More.
     Ann Surg Oncol. 2022;29:6466-6467.
     PubMed    
     
     
     
533. OROZCO JIJ, Le J, Baker JL, Marzese DM, et al
     ASO Author Reflections: Molecular Signatures May Render Surgical Staging of the Axilla Obsolete.
     Ann Surg Oncol. 2022;29:6415-6416.
     PubMed    
     
     
     
534. MARTINS RS, Sattar AK
     ASO Author Reflections: Perioperative Antibiotic Prophylaxis for Mastectomy-Too Much or Too Little.
     Ann Surg Oncol. 2022;29:6323-6324.
     PubMed    
     
     
     
535. DIEGO EJ, Rosenberger LH, Deng X, McGuire KP, et al
     ASO Visual Abstract: Margin Management and Adjuvant Therapy for Phyllodes Tumors-Practice Patterns of the American Society of Breast Surgeons Members.
     Ann Surg Oncol. 2022;29:6162.
     PubMed    
     
     
     
536. SATTAR AK, Shahzad H, Masroor T, Martins RS, et al
     ASO Visual Abstract: Practice Patterns of Antibiotic Prophylaxis in Patients Undergoing Mastectomy-A Survey of Members of the American Society of Breast Surgeons.
     Ann Surg Oncol. 2022;29:6325-6326.
     PubMed    
     
     
     
537. CHAKEDIS JM, Tang A, Savitz A, Lyon LL, et al
     Economic Impact of Reducing Reexcision Rates after Breast-Conserving Surgery in a Large, Integrated Health System.
     Ann Surg Oncol. 2022;29:6288-6296.
     PubMed     Abstract available
     
     
     
538. SATTAR AK, Shahzad H, Masroor T, Martins RS, et al
     Practice Patterns of Antibiotic Prophylaxis in Patients Undergoing Mastectomy: A Survey of Members of the American Society of Breast Surgeons.
     Ann Surg Oncol. 2022;29:6314-6322.
     PubMed     Abstract available
     
     
     
539. DE LA CRUZ KU G, Karamchandani M, Chambergo-Michilot D, Narvaez-Rojas AR, et al
     Does Breast-Conserving Surgery with Radiotherapy have a Better Survival than Mastectomy? A Meta-Analysis of More than 1,500,000 Patients.
     Ann Surg Oncol. 2022;29:6163-6188.
     PubMed     Abstract available
     
     
     
540. SANDERS SB, Hoskin TL, Solanki MH, Stafford AP, et al
     ASO Visual Abstract: Lack of Clinical Value for Immunohistochemistry for Sentinel Lymph Node Assessment in Invasive Lobular Carcinoma.
     Ann Surg Oncol. 2022;29:6468.
     PubMed    
     
     
     
541. CRARY IL, Parker EU, Lowry KP, Patwardhan PP, et al
     ASO Visual Abstract: Risk of Lobular Neoplasia Upgrade with Synchronous Carcinoma.
     Ann Surg Oncol. 2022;29:6360.
     PubMed    
     
     
     
542. TELLER P, Nguyen TT, Tseng J, Allen L, et al
     Innovation in Breast Surgery: Practical and Ethical Considerations.
     Ann Surg Oncol. 2022;29:6144-6150.
     PubMed     Abstract available
     
     
     
543. ROBBINS T, Hoskin TL, Day CN, Mrdutt MM, et al
     Node Positivity Among Sonographically Suspicious but FNA-Negative Axillary Nodes.
     Ann Surg Oncol. 2022;29:6276-6287.
     PubMed     Abstract available
     
     
     
544. ABUJBARAH SM, Jogerst K, Kosiorek HE, Ahmad S, et al
     Postoperative Hematomas in the Era of Outpatient Mastectomy: Is Ketorolac Really to Blame?
     Ann Surg Oncol. 2022;29:6395-6403.
     PubMed     Abstract available
     
     
     
545. A DE LA CRUZ-KU G, Karamchandani M, Chambergo-Michilot D, Narvaez-Rojas AR, et al
     ASO Visual Abstract: Does Breast-Conserving Surgery with Radiotherapy Have a Better Survival Than Mastectomy? A Meta-Analysis of More Than 1,500,000 Patients.
     Ann Surg Oncol. 2022;29:6197-6198.
     PubMed    
     
     
     
546. DIEGO EJ, Rosenberger LH, Deng X, McGuire KP, et al
     Margin Management and Adjuvant Therapy for Phyllodes Tumors: Practice Patterns of the American Society of Breast Surgeons Members.
     Ann Surg Oncol. 2022;29:6151-6161.
     PubMed     Abstract available
     
     
     
547. SANDERS SB, Hoskin TL, Solanki MH, Stafford AP, et al
     Lack of Clinical Value for Immunohistochemistry for Sentinel Lymph Node Assessment in Invasive Lobular Carcinoma.
     Ann Surg Oncol. 2022;29:6458-6465.
     PubMed     Abstract available
     
     
     
548. ZHANG C, Kosiorek HE, Patel BK, Pockaj BA, et al
     Accuracy of Posttreatment Imaging for Evaluation of Residual in Breast Disease After Neoadjuvant Endocrine Therapy.
     Ann Surg Oncol. 2022;29:6207-6212.
     PubMed     Abstract available
     
     
     
549. CRARY IL, Flanagan MR
     ASO Author Reflections: Is Surgical Excision Necessary in Lobular Neoplasia with Synchronous Breast Carcinoma?
     Ann Surg Oncol. 2022;29:6359.
     PubMed    
     
     
     
550. GENTLE CK, Pratt DA
     ASO Author Reflections: It is Time to Deescalate Screening Mammography for Patients Who Do Not Benefit.
     Ann Surg Oncol. 2022;29:6367-6368.
     PubMed    
     
     
     
551. CRARY IL, Parker EU, Lowry KP, Patwardhan PP, et al
     Risk of Lobular Neoplasia Upgrade with Synchronous Carcinoma.
     Ann Surg Oncol. 2022;29:6350-6358.
     PubMed     Abstract available
     
     
     
552. MARTINEZ EO, Jorns JM, Kong AL, Kijak J, et al
     Primary Breast Neuroendocrine Tumors: An Analysis of the National Cancer Database.
     Ann Surg Oncol. 2022;29:6339-6346.
     PubMed     Abstract available
     
     
     
553. PARK HS, Lee J, Lai HW, Park JM, et al
     ASO Visual Abstract: Surgical and Oncologic Outcomes of Robotic and Conventional Nipple-Sparing Mastectomy with Immediate Reconstruction-International Multicenter Pooled Data Analysis.
     Ann Surg Oncol. 2022;29:6658-6659.
     PubMed    
     
     
     
554. PAK LM, Pawloski KR, Sevilimedu V, Kalvin HL, et al
     ASO Visual Abstract: How Much Pain Will I Have After Surgery? A Preoperative Nomogram to Predict Acute Pain Following Mastectomy.
     Ann Surg Oncol. 2022;29:6714-6715.
     PubMed    
     
     
     
555. ZAVERI S, Romanoff A
     ASO Author Reflections on "Racial Disparities in Time to Treatment Persist in the Setting of a Comprehensive Breast Center".
     Ann Surg Oncol. 2022;29:6704.
     PubMed    
     
     
     
556. JOUKAINEN S, Laaksonen E, Vanninen R, Kaarela O, et al
     Dual-Layer Rotation: A Versatile Therapeutic Mammoplasty Technique.
     Ann Surg Oncol. 2022;29:6716-6727.
     PubMed     Abstract available
     
     
     
557. FERROUM A, Wong SM
     ASO Author Reflections: Sentinel Lymph Node Biopsy in BRCA1/2 Germline Pathogenic Variant Carriers Undergoing Risk-Reducing Mastectomy.
     Ann Surg Oncol. 2022;29:6669-6670.
     PubMed    
     
     
     
558. PAK LM, Pawloski KR, Sevilimedu V, Kalvin HL, et al
     How Much Pain Will I Have After Surgery? A Preoperative Nomogram to Predict Acute Pain Following Mastectomy.
     Ann Surg Oncol. 2022;29:6706-6713.
     PubMed     Abstract available
     
     
     
559. ZAVERI S, Nevid D, Ru M, Moshier E, et al
     Racial Disparities in Time to Treatment Persist in the Setting of a Comprehensive Breast Center.
     Ann Surg Oncol. 2022;29:6692-6703.
     PubMed     Abstract available
     
     
     
560. PARK HS, Lee J, Lai HW, Park JM, et al
     Surgical and Oncologic Outcomes of Robotic and Conventional Nipple-Sparing Mastectomy with Immediate Reconstruction: International Multicenter Pooled Data Analysis.
     Ann Surg Oncol. 2022;29:6646-6657.
     PubMed     Abstract available
     
     
     September 2022
561. KHAN SY, Snitman A, Habrawi Z, Crawford S, et al
     The Role of Cryoablation in Breast Cancer Beyond the Oncologic Control: COST and Breast-Q Patient-Reported Outcomes.
     Ann Surg Oncol. 2022 Sep 28. pii: 10.1245/s10434-022-12570.
     PubMed     Abstract available
     
     
     
562. KANTOR O, Dominici L
     Recognizing Disparities in Breast Cancer Patient-Reported Outcome Measures.
     Ann Surg Oncol. 2022 Sep 27. pii: 10.1245/s10434-022-12537.
     PubMed    
     
     
     
563. ESCOBAR N, DiMaggio C, Pocock B, Pescovitz A, et al
     ASO Visual Abstract: An Analysis of COVID-19 on Surgical Delays in Breast Cancer Patients in NYC Public Hospitals-A Multicenter Study.
     Ann Surg Oncol. 2022 Sep 26. pii: 10.1245/s10434-022-12609.
     PubMed    
     
     
     
564. CULVER JO, Freiberg Y, Ricker C, Comeaux JG, et al
     Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients.
     Ann Surg Oncol. 2022 Sep 26. pii: 10.1245/s10434-022-12595.
     PubMed     Abstract available
     
     
     
565. PALMQUIST E, Limberg J, Chu JJ, White C, et al
     Patient-Reported Outcome Measures for Patients Who Have Clinical T4 Breast Cancer Treated via Mastectomy with and Without Reconstruction.
     Ann Surg Oncol. 2022 Sep 23. pii: 10.1245/s10434-022-12560.
     PubMed     Abstract available
     
     
     
566. SROUR MK, Tadros AB, Sevilimedu V, Nelson JA, et al
     Who Are We Missing: Does Engagement in Patient-Reported Outcome Measures for Breast Cancer Vary by Age, Race, or Disease Stage?
     Ann Surg Oncol. 2022 Sep 23. pii: 10.1245/s10434-022-12477.
     PubMed     Abstract available
     
     
     
567. CROWN A, Joseph KA
     ASO Author Reflections: Optimizing Breast Cancer Risk Assessment and Screening Among Black Women.
     Ann Surg Oncol. 2022 Sep 22. pii: 10.1245/s10434-022-12586.
     PubMed    
     
     
     
568. MAGNONI F, Corso G
     ASO Author Reflections: Is Breast-Conserving Surgery a Safe Treatment Option for High-Risk Breast Cancer?
     Ann Surg Oncol. 2022 Sep 20. pii: 10.1245/s10434-022-12589.
     PubMed    
     
     
     
569. HASSAN AM, Nguyen HT, Corkum JP, Liu J, et al
     ASO Visual Abstract: The Area Deprivation Index is Associated with Variation in Quality of Life and Psychosocial Well-being After Breast Cancer Surgery.
     Ann Surg Oncol. 2022 Sep 20. pii: 10.1245/s10434-022-12554.
     PubMed    
     
     
     
570. ESCOBAR N, DiMaggio C, Pocock B, Pescovitz A, et al
     Effects of COVID-19 on Surgical Delays in Patients with Breast Cancer in NYC Public Hospitals: A Multicenter Study.
     Ann Surg Oncol. 2022 Sep 15. pii: 10.1245/s10434-022-12491.
     PubMed     Abstract available
     
     
     
571. CORSO G, Magnoni F, Veronesi P
     Points to Consider Regarding De-Escalation Surgery in High-Risk Breast Cancer.
     Ann Surg Oncol. 2022 Sep 15. pii: 10.1245/s10434-022-12542.
     PubMed     Abstract available
     
     
     
572. COBB AN, Diao K, Teshome M, Lucci A, et al
     ASO Visual Abstract: Long-Term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement.
     Ann Surg Oncol. 2022 Sep 14. pii: 10.1245/s10434-022-12457.
     PubMed    
     
     
     
573. SROUR MK, Tadros AB, Sevilimedu V, Nelson JA, et al
     ASO Visual Abstract: Who Are We Missing: Does Engagement in Patient-Reported Outcome Measures for Breast Cancer Vary by Age, Race, and Disease Stage?
     Ann Surg Oncol. 2022 Sep 13. pii: 10.1245/s10434-022-12511.
     PubMed    
     
     
     
574. MURPHY BL, Yi M, Gutierrez Barrera AM, Tripathy D, et al
     Other Primary Malignancies in Patients with Breast Cancer Who Undergo Germline Panel Testing.
     Ann Surg Oncol. 2022 Sep 12. pii: 10.1245/s10434-022-12468.
     PubMed     Abstract available
     
     
     
575. HASSAN AM, Nguyen HT, Corkum JP, Liu J, et al
     Area Deprivation Index is Associated with Variation in Quality of Life and Psychosocial Well-being Following Breast Cancer Surgery.
     Ann Surg Oncol. 2022 Sep 9. pii: 10.1245/s10434-022-12506.
     PubMed     Abstract available
     
     
     
576. NAIR AG, Giannakeas V, Semple JL, Narod SA, et al
     Contemporary Trends in Breast Reconstruction Use and Impact on Survival Among Women with Inflammatory Breast Cancer.
     Ann Surg Oncol. 2022 Sep 8. pii: 10.1245/s10434-022-12408.
     PubMed     Abstract available
     
     
     
577. NAIR AG, Giannakeas V, Semple JL, Narod SA, et al
     ASO Visual Abstract: Contemporary Trends in Breast Reconstruction Use and Impact on Survival Amongst Women with Inflammatory Breast Cancer.
     Ann Surg Oncol. 2022 Sep 7. pii: 10.1245/s10434-022-12458.
     PubMed    
     
     
     
578. ASHOOR A, Lissidini G, Datta U, Bertoldi L, et al
     ASO Visual Abstract: Chyle Leak After Axillary Node Clearance in Breast Cancer Surgery: A Rare Complication and a Proposed Management Strategy from the British and Italian Experience.
     Ann Surg Oncol. 2022 Sep 4. pii: 10.1245/s10434-022-12412.
     PubMed    
     
     
     
579. SROUR MK, Tadros AB, Morrow M
     ASO Author Reflections: Engagement in Patient-Reported Outcomes for Breast Cancer.
     Ann Surg Oncol. 2022 Sep 4. pii: 10.1245/s10434-022-12481.
     PubMed    
     
     
     
580. ELDER EA, Livasy CA, Donahue EE, Neelands B, et al
     ASO Visual Abstract: Residual Cancer Burden Class Associated with Survival Outcomes in Women with Different Phenotypic Subtypes of Breast Cancer After Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2022 Sep 4. pii: 10.1245/s10434-022-12429.
     PubMed    
     
     
     
581. KIM LS, Park T, Berger ER, Golshan M, et al
     Editorial Comment on: One-Year Experience of Same-Day Mastectomy and Breast Reconstruction Protocol.
     Ann Surg Oncol. 2022;29:5361-5363.
     PubMed    
     
     
     
582. CARLETON N, Oesterreich S, Marroquin OC, Diego EJ, et al
     Is the Choosing Wisely Recommendation for Omission of Sentinel Lymph Node Biopsy Applicable for Invasive Lobular Carcinoma?
     Ann Surg Oncol. 2022;29:5379-5382.
     PubMed    
     
     
     
583. CORSO G, Robson ME, Sacchini V
     Points to Consider Regarding Risk-Reducing Mastectomy in High-, Moderate-, and Low-Penetrance Gene Carriers.
     Ann Surg Oncol. 2022;29:5821-5825.
     PubMed     Abstract available
     
     
     
584. LILLEMOE HA, Miranda RN, Nastoupil LJ, Clemens MW, et al
     Clinical Manifestations and Surgical Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Beyond the NCCN Guidelines.
     Ann Surg Oncol. 2022;29:5722-5729.
     PubMed     Abstract available
     
     
     
585. FASANO G, Bayard S, Tamimi R, An A, et al
     Postmastectomy Breast Reconstruction Patterns at an Urban Academic Hospital and the Impact of Surgeon Gender.
     Ann Surg Oncol. 2022;29:5437-5444.
     PubMed     Abstract available
     
     
     
586. KELLY BN, Liao EC, Specht MC
     ASO Author Reflections: Reducing Length of Stay and Postoperative Opioid Administration in a Same-Day Approach to Breast Reconstruction.
     Ann Surg Oncol. 2022;29:5720.
     PubMed    
     
     
     
587. SPECHT MC, Kelly BN, Tomczyk E, Ford OA, et al
     One-Year Experience of Same-Day Mastectomy and Breast Reconstruction Protocol.
     Ann Surg Oncol. 2022;29:5711-5719.
     PubMed     Abstract available
     
     
     
588. LUDWIG K, Wexelman B, Chen S, Cheng G, et al
     Home Recovery After Mastectomy: Review of Literature and Strategies for Implementation American Society of Breast Surgeons Working Group.
     Ann Surg Oncol. 2022;29:5799-5808.
     PubMed     Abstract available
     
     
     
589. LUDWIG KK, Rao R
     ASO Author Reflections: Homing in on Safety-Home Recovery After Mastectomy.
     Ann Surg Oncol. 2022;29:5809-5810.
     PubMed    
     
     
     August 2022
590. KAPP KA, Cheng AL, Bruton CM, Ahmadiyeh N, et al
     Impact of COVID-19 Restrictions on Stage of Breast Cancer at Presentation and Time to Treatment at an Urban Safety-Net Hospital.
     Ann Surg Oncol. 2022 Aug 29. pii: 10.1245/s10434-022-12139.
     PubMed     Abstract available
     
     
     
591. SCHERMERHORN MC, Grunvald MW, O'Donoghue CM, Rao RD, et al
     ASO Visual Abstract: Mediating Factors of Racial/Ethnic Disparities in Delayed Treatment of Breast Cancer.
     Ann Surg Oncol. 2022 Aug 29. pii: 10.1245/s10434-022-12265.
     PubMed    
     
     
     
592. FARLEY CR, Irwin S, Adesoye T, Sun SX, et al
     ASO Visual Abstract: Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment.
     Ann Surg Oncol. 2022 Aug 27. pii: 10.1245/s10434-022-12337.
     PubMed    
     
     
     
593. KUERER HM
     Moving Forward with Omission of Breast Cancer Surgery Following Neoadjuvant Systemic Therapy.
     Ann Surg Oncol. 2022 Aug 24. pii: 10.1245/s10434-022-12455.
     PubMed    
     
     
     
594. CHICHURA A, Attai DJ, Kuchta K, Nicholson K, et al
     ASO Visual Abstract: Male Breast Cancer Patients and Surgeon Experience: The Male WhySurg Study.
     Ann Surg Oncol. 2022 Aug 24. pii: 10.1245/s10434-022-12218.
     PubMed    
     
     
     
595. KLIMBERG VS
     ASO Video Abstract: Keynote Address at the ASBrS 2022 Annual Meeting. Low-Risk Breast Cancer-When Is Local Therapy Enough?
     Ann Surg Oncol. 2022 Aug 22. pii: 10.1245/s10434-022-12205.
     PubMed    
     
     
     
596. FLANAGAN MR, Doody DR, Voutsinas J, Wu Q, et al
     ASO Visual Abstract: Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen Receptor-Positive Breast Cancer.
     Ann Surg Oncol. 2022 Aug 18. pii: 10.1245/s10434-022-12411.
     PubMed    
     
     
     
597. ELDER EA, Livasy CA, Donahue EE, Neelands B, et al
     Residual Cancer Burden Class Associated with Survival Outcomes in Women with Different Phenotypic Subtypes of Breast Cancer After Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2022 Aug 18. pii: 10.1245/s10434-022-12300.
     PubMed     Abstract available
     
     
     
598. WILLIAMS AD, Mamtani A
     ASO Author Reflections: Avoiding Overtreatment: Benefits of Selective Use of Frozen Sections Among cN0 Breast Cancer Patients Having Upfront Mastectomy.
     Ann Surg Oncol. 2022 Aug 16. pii: 10.1245/s10434-022-12333.
     PubMed    
     
     
     
599. SHAO Y, Yu Y, Luo Z, Guan H, et al
     ASO Visual Abstract: Clinical, Pathological Complete Response, and Prognosis Characteristics of HER2-Low Breast Cancer in the Neoadjuvant Chemotherapy Setting-A Retrospective Analysis.
     Ann Surg Oncol. 2022 Aug 16. pii: 10.1245/s10434-022-12420.
     PubMed    
     
     
     
600. HUYNH V, Vemuru S, Hampanda K, Pettigrew J, et al
     ASO Visual Abstract: No One-Size-Fits-All: Sexual Health Education Preferences in Patients with Breast Cancer.
     Ann Surg Oncol. 2022 Aug 13. pii: 10.1245/s10434-022-12209.
     PubMed    
     
     
     
601. UHLMANN RA, Mott SL, Curry M, Phadke S, et al
     ASO Visual Abstract: Analysis of Breast Cancer Patients' Understanding and Worry About Lymphedema.
     Ann Surg Oncol. 2022 Aug 12. pii: 10.1245/s10434-022-12244.
     PubMed    
     
     
     
602. MONTAGNA G, Lee MK, Sevilimedu V, Barrio AV, et al
     ASO Visual Abstract: Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy?
     Ann Surg Oncol. 2022 Aug 12. pii: 10.1245/s10434-022-12326.
     PubMed    
     
     
     
603. SWAMI N, Nguyen T, Dee EC, Franco I, et al
     Disparities in Primary Breast Cancer Stage at Presentation Among Hispanic Subgroups.
     Ann Surg Oncol. 2022 Aug 11. pii: 10.1245/s10434-022-12302.
     PubMed     Abstract available
     
     
     
604. PEIFER HG, Raker C, Pesek S, Edmonson D, et al
     Breast-Specific Sensuality in Breast Cancer Survivors: Sexually Active or Not.
     Ann Surg Oncol. 2022 Aug 11. pii: 10.1245/s10434-022-12196.
     PubMed     Abstract available
     
     
     
605. OROZCO JIJ, Fancher CE, Grumley JG
     ASO Author Reflections: Breast-Conserving Therapy: A Safe Option in Young Patients with Early-Stage Breast Cancer.
     Ann Surg Oncol. 2022 Aug 10. pii: 10.1245/s10434-022-12299.
     PubMed    
     
     
     
606. PEIFER HG, Gass JS
     ASO Author Reflections: Breast-Specific Sensuality in the Sexually Inactive Breast Cancer Survivor.
     Ann Surg Oncol. 2022 Aug 9. pii: 10.1245/s10434-022-12341.
     PubMed    
     
     
     
607. WILLIAMS AD, Barrio AV
     ASO Author Reflections: Is It Worth the Risk? The Benefit of Neoadjuvant Chemotherapy in Elderly Patients with Breast Cancer.
     Ann Surg Oncol. 2022 Aug 8. pii: 10.1245/s10434-022-12324.
     PubMed    
     
     
     
608. MITTENDORF EA, Kantor O, Weiss A, Richardson E, et al
     Nodal Positivity in Early-Stage Triple-Negative Breast Cancer: Implications for Preoperative Immunotherapy.
     Ann Surg Oncol. 2022 Aug 8. pii: 10.1245/s10434-022-12357.
     PubMed     Abstract available
     
     
     
609. KENNARD K, Wang O, Ciocca R, Sabol J, et al
     ASO Author Reflection: Outcomes of Abbreviated MRI for Women of Any Breast Cancer Risk and Breast Density.
     Ann Surg Oncol. 2022 Aug 8. pii: 10.1245/s10434-022-12323.
     PubMed    
     
     
     
610. DRAPALIK LM, Hue JJ, Simpson A, Freyvogel M, et al
     Guideline-Consistent Treatment for Inflammatory Breast Cancer Provides Associated Survival Benefit Independent of Age.
     Ann Surg Oncol. 2022 Aug 8. pii: 10.1245/s10434-022-12237.
     PubMed     Abstract available
     
     
     
611. SORAN A, Ozbas S, Ozcinar B, Isik A, et al
     ASO Visual Abstract: Intervention for Hepatic and Pulmonary METastases in Breast Cancer Patients-Prospective, Multi-Institutional Registry Study: IMET; Protocol MF 14-02.
     Ann Surg Oncol. 2022 Aug 6. pii: 10.1245/s10434-022-12320.
     PubMed    
     
     
     
612. SHAO Y, Yu Y, Luo Z, Guan H, et al
     Clinical, Pathological Complete Response, and Prognosis Characteristics of HER2-Low Breast Cancer in the Neoadjuvant Chemotherapy Setting: A Retrospective Analysis.
     Ann Surg Oncol. 2022 Aug 6. pii: 10.1245/s10434-022-12369.
     PubMed     Abstract available
     
     
     
613. SWAMI N, Nguyen T, Dee EC, Franco I, et al
     ASO Visual Abstract: Disparities in Primary-Stage Breast Cancer at Presentation Among Hispanic Subgroups.
     Ann Surg Oncol. 2022 Aug 6. pii: 10.1245/s10434-022-12375.
     PubMed    
     
     
     
614. DRAPALIK LM, Amin AL, Miller ME
     ASO Author Reflections: Inflammatory Breast Cancer: The Exception to De-escalation of Care for Older Women?
     Ann Surg Oncol. 2022 Aug 5. pii: 10.1245/s10434-022-12338.
     PubMed    
     
     
     
615. LI C, Lu N, He Z, Tan Y, et al
     ASO Visual Abstract: A Noninvasive Tool Based on Magnetic Resonance Imaging Radiomics for the Preoperative Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
     Ann Surg Oncol. 2022 Aug 4. pii: 10.1245/s10434-022-12078.
     PubMed    
     
     
     
616. FISHER CS
     Neoadjuvant Chemotherapy for Breast Cancer: The Ultimate "Spy".
     Ann Surg Oncol. 2022 Aug 4. pii: 10.1245/s10434-022-12153.
     PubMed    
     
     
     
617. DRAPALIK LM, Hue JJ, Simpson A, Freyvogel M, et al
     ASO Visual Abstract: Guideline-Consistent Treatment for Inflammatory Breast Cancer Provides Associated Survival Benefit Independent of Age.
     Ann Surg Oncol. 2022 Aug 4. pii: 10.1245/s10434-022-12318.
     PubMed    
     
     
     
618. TOLLAN CJ, Pantiora E, Valachis A, Karakatsanis A, et al
     ASO Visual Abstract: A Systematic Review and Meta-analysis on the Role of Repeat Breast-Conserving Surgery for the Management of Ipsilateral Breast Cancer Recurrence.
     Ann Surg Oncol. 2022 Aug 3. pii: 10.1245/s10434-022-12325.
     PubMed    
     
     
     
619. GENTLE CK, Alkhatib H, Valente SA, Tu C, et al
     ASO Visual Abstract: Stage IV Non-Breast Cancer Patients and Screening Mammography: It is Time to Stop.
     Ann Surg Oncol. 2022 Aug 2. pii: 10.1245/s10434-022-12214.
     PubMed    
     
     
     
620. PORTERHOUSE MD, Paul S, Lieberenz JL, Stempel LR, et al
     ASO Visual Abstract: Black Women Are Less Likely to Be Classified as High Risk for Breast Cancer Using Tyrer-Cuzick 8 Model.
     Ann Surg Oncol. 2022 Aug 2. pii: 10.1245/s10434-022-12243.
     PubMed    
     
     
     
621. PILEWSKIE M, Sevilimedu V, Eroglu I, Le T, et al
     ASO Visual Abstract: How Often Do Sentinel Lymph Node Biopsy Results Affect Adjuvant Therapy Decisions Among Postmenopausal Women with Early-Stage HR(+)/HER2(-) Breast Cancer in the Post-RxPONDER Era?
     Ann Surg Oncol. 2022 Aug 2. pii: 10.1245/s10434-022-12246.
     PubMed    
     
     
     
622. SHUBECK S, Sevilimedu V, Berger E, Robson M, et al
     Comparison of Outcomes Between BRCA Pathogenic Variant Carriers Undergoing Breast-Conserving Surgery Versus Mastectomy.
     Ann Surg Oncol. 2022;29:4706-4713.
     PubMed     Abstract available
     
     
     
623. NELSON JA, Allen RJ Jr
     ASO Author Reflections: Deeper Understanding of Patient-Reported Outcomes in Breast Reconstruction Patients Not Requiring Radiation Therapy: Harnessing Propensity Matching Methodology.
     Ann Surg Oncol. 2022;29:5276-5277.
     PubMed    
     
     
     
624. STAFFORD AP, Hoskin TL, Day CN, Sanders SB, et al
     ASO Author Reflections: Axillary Management in Mastectomy Patients with Limited Nodal Burden.
     Ann Surg Oncol. 2022;29:4750-4751.
     PubMed    
     
     
     
625. ARDON AE, George JE 3rd, Gupta K, O'Rourke MJ, et al
     The Use of Pectoralis Blocks in Breast Surgery: A Practice Advisory and Narrative Review from the Society for Ambulatory Anesthesia (SAMBA).
     Ann Surg Oncol. 2022;29:4777-4786.
     PubMed     Abstract available
     
     
     
626. DINOME ML, Marzese DM
     ASO Author Reflections: Entering the Era of Biomarker-Driven Management of the Axilla.
     Ann Surg Oncol. 2022;29:4725-4726.
     PubMed    
     
     
     
627. NELSON JA, Chu JJ, McCarthy CM, Stern CS, et al
     BREAST-Q REACT: Clinical Reference Values for the BREAST-Q in Post-mastectomy Breast Reconstruction Patients.
     Ann Surg Oncol. 2022;29:5280-5293.
     PubMed     Abstract available
     
     
     
628. ARDON AE, George JE 3rd, Gupta K, O'Rourke MJ, et al
     ASO Author Reflections: SAMBA's Practice Advisory for the Use of Pectoralis Blocks in Breast Surgery: Overview and Lingering Questions.
     Ann Surg Oncol. 2022;29:4787-4788.
     PubMed    
     
     
     
629. NELSON JA, Shamsunder MG, Myers PL, Polanco TO, et al
     Matched Preliminary Analysis of Patient-Reported Outcomes following Autologous and Implant-Based Breast Reconstruction.
     Ann Surg Oncol. 2022;29:5266-5275.
     PubMed     Abstract available
     
     
     
630. NELSON JA, Shamsunder MG, Myers PL, Polanco TO, et al
     A Matched Preliminary Analysis of Patient-Reported Outcomes After Autologous and Implant-Based Breast Reconstruction.
     Ann Surg Oncol. 2022;29:5278-5279.
     PubMed    
     
     
     
631. CHU JJ, Nelson JA
     ASO Author Reflections: Patient-Reported Outcomes for Breast Reconstruction Clinical Practice.
     Ann Surg Oncol. 2022;29:5294-5295.
     PubMed    
     
     
     
632. HUYNH V, Vemuru S, Hampanda K, Pettigrew J, et al
     No One-Size-Fits-All: Sexual Health Education Preferences in Patients with Breast Cancer.
     Ann Surg Oncol. 2022 Aug 1. pii: 10.1245/s10434-022-12126.
     PubMed     Abstract available
     
     
     
633. CO LMB, Dee EC, Eala MAB, Ang SD, et al
     Access to Surgical Treatment for Breast Cancer in the Philippines.
     Ann Surg Oncol. 2022 Aug 1. pii: 10.1245/s10434-022-12311.
     PubMed     Abstract available
     
     
     
634. UHLMANN RA, Mott SL, Curry M, Phadke S, et al
     Analysis of the Understanding and Worry about Lymphedema of Patients with Breast Cancer.
     Ann Surg Oncol. 2022 Aug 1. pii: 10.1245/s10434-022-12189.
     PubMed     Abstract available
     
     
     
635. BAYARD S, Bea VJ
     Disparities in Time to Treatment for Breast Cancer: Shifting Focus to the Root Cause.
     Ann Surg Oncol. 2022 Aug 1. pii: 10.1245/s10434-022-11948.
     PubMed    
     
     
     July 2022
636. KLIMBERG VS
     Keynote Address at the ASBrS 2022 Annual Meeting Low-Risk Breast Cancer: When Is Local Therapy Enough?
     Ann Surg Oncol. 2022 Jul 30. pii: 10.1245/s10434-022-12125.
     PubMed     Abstract available
     
     
     
637. NAKHLIS F
     ASO Visual Abstract: Inflammatory Breast Cancer-Is There a Role for De-escalation of Surgery?
     Ann Surg Oncol. 2022 Jul 30. pii: 10.1245/s10434-022-12217.
     PubMed    
     
     
     
638. CHEN JC, Li Y, Fisher JL, Bhattacharyya O, et al
     ASO Visual Abstract: Modified Radical Mastectomy in De Novo Stage IV Inflammatory Breast Cancer.
     Ann Surg Oncol. 2022 Jul 29. pii: 10.1245/s10434-022-12183.
     PubMed    
     
     
     
639. PEIFER HG, Raker C, Pesek S, Edmonson D, et al
     ASO Visual Abstract: Breast-Specific Sensuality in Breast Cancer Survivors - Sexually Active or Not.
     Ann Surg Oncol. 2022 Jul 29. pii: 10.1245/s10434-022-12249.
     PubMed    
     
     
     
640. TASOULIS MK, Karakatsanis A
     ASO Author Reflections: Surgical De-escalation for the Management of Ipsilateral Breast Cancer Recurrence in the Modern Era of Multimodality Treatment.
     Ann Surg Oncol. 2022 Jul 29. pii: 10.1245/s10434-022-12310.
     PubMed    
     
     
     
641. KANTOR O, Burstein HJ, King TA, Shak S, et al
     ASO Visual Abstract: Expanding Staging Criteria in T1-2N0 Hormone Receptor-Positive Breast Cancer Patients Enrolled in TAILORx.
     Ann Surg Oncol. 2022 Jul 28. pii: 10.1245/s10434-022-12294.
     PubMed    
     
     
     
642. WILLIAMS AD, Dang CT, Sevilimedu V, Morrow M, et al
     ASO Visual Abstract: Neoadjuvant Chemotherapy for Breast Cancer in the Elderly-Are We Accomplishing Our Treatment Goals?
     Ann Surg Oncol. 2022 Jul 28. pii: 10.1245/s10434-022-12282.
     PubMed    
     
     
     
643. BAYARD S, Bea VJ
     ASO Author Reflections: Racial Disparities in Time to Breast Cancer Treatment-A Call to Action.
     Ann Surg Oncol. 2022 Jul 28. pii: 10.1245/s10434-022-11981.
     PubMed    
     
     
     
644. MONTAGNA G, Lee MK, Sevilimedu V, Barrio AV, et al
     Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy?
     Ann Surg Oncol. 2022 Jul 28. pii: 10.1245/s10434-022-12240.
     PubMed     Abstract available
     
     
     
645. KANTOR O, Burstein HJ, King TA, Shak S, et al
     Expanding the Staging Criteria for T1-2N0 Hormone-Receptor Positive Breast Cancer Patients Enrolled in TAILORx.
     Ann Surg Oncol. 2022 Jul 27. pii: 10.1245/s10434-022-12225.
     PubMed     Abstract available
     
     
     
646. OROZCO JIJ, Keller JK, Chang SC, Fancher CE, et al
     ASO Visual Abstract: Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer Undergoing Upfront Surgery.
     Ann Surg Oncol. 2022 Jul 27. pii: 10.1245/s10434-022-12279.
     PubMed    
     
     
     
647. OROZCO JIJ, Keller JK, Chang SC, Fancher CE, et al
     Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer undergoing Upfront Surgery.
     Ann Surg Oncol. 2022 Jul 27. pii: 10.1245/s10434-022-12190.
     PubMed     Abstract available
     
     
     
648. CHICHURA A, Attai DJ, Kuchta K, Nicholson K, et al
     Male Breast Cancer Patient and Surgeon Experience: The Male WhySurg Study.
     Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12135.
     PubMed     Abstract available
     
     
     
649. KENNARD K, Wang O, Kjelstrom S, Larson S, et al
     ASO Visual Abstract: Outcomes of Abbreviated MRI (Ab-MRI) for Women of Any Breast Cancer Risk and Breast Density in a Community Academic Setting.
     Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12247.
     PubMed    
     
     
     
650. BOUGHEY JC, Hoskin TL, Day CN, Goetz MP, et al
     Nodal Pathologic Complete Response Rates in Luminal Breast Cancer Vary by Genomic Risk.
     Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12191.
     PubMed     Abstract available
     
     
     
651. SANDERS SB, Hoskin TL, Stafford AP, Boughey JC, et al
     ASO Visual Abstract: Factors Influencing Non-Sentinel Lymph Node Involvement in Patients with Positive Sentinel Lymph Node(s) After Neoadjuvant Chemotherapy for Breast Cancer.
     Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12270.
     PubMed    
     
     
     
652. SORAN A, Ozbas S, Ozcinar B, Isik A, et al
     Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study-IMET, Protocol MF 14-02.
     Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12239.
     PubMed     Abstract available
     
     
     
653. WILLIAMS AD, Dang CT, Sevilimedu V, Morrow M, et al
     Neoadjuvant Chemotherapy for Breast Cancer In the Elderly: Are We Accomplishing Our Treatment Goals?
     Ann Surg Oncol. 2022 Jul 24. pii: 10.1245/s10434-022-12206.
     PubMed     Abstract available
     
     
     
654. BOUGHEY JC, Hoskin TL, Day CN, Goetz MP, et al
     ASO Visual Abstract: Nodal Pathologic Complete Response Rates in Luminal Breast Cancer Vary by Genomic Risk.
     Ann Surg Oncol. 2022 Jul 24. pii: 10.1245/s10434-022-12278.
     PubMed    
     
     
     
655. NAKHLIS F, Katlin FD, Grossmith SC, DiPasquale A, et al
     ASO Visual Abstract: The Presence of Non-classic LCIS is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS.
     Ann Surg Oncol. 2022 Jul 21. pii: 10.1245/s10434-022-12272.
     PubMed    
     
     
     
656. KENNARD K, Wang O, Kjelstrom S, Larson S, et al
     Outcomes of Abbreviated MRI (Ab-MRI) for Women of any Breast Cancer Risk and Breast Density in a Community Academic Setting.
     Ann Surg Oncol. 2022 Jul 20. pii: 10.1245/s10434-022-12194.
     PubMed     Abstract available
     
     
     
657. FARLEY CR, Irwin S, Adesoye T, Sun SX, et al
     Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment.
     Ann Surg Oncol. 2022 Jul 19. pii: 10.1245/s10434-022-12142.
     PubMed     Abstract available
     
     
     
658. TOLLAN CJ, Pantiora E, Valachis A, Karakatsanis A, et al
     A Systematic Review and Meta-Analysis on the Role of Repeat Breast-Conserving Surgery for the Management of Ipsilateral Breast Cancer Recurrence.
     Ann Surg Oncol. 2022 Jul 18. pii: 10.1245/s10434-022-12197.
     PubMed     Abstract available
     
     
     
659. ASHOOR A, Lissidini G, Datta U, Bertoldi L, et al
     Chyle Leak After Axillary Node Clearance in Breast Cancer Surgery-A Rare Complication and a Proposed Management Strategy from the British and Italian Experience.
     Ann Surg Oncol. 2022 Jul 18. pii: 10.1245/s10434-022-12094.
     PubMed     Abstract available
     
     
     
660. PILEWSKIE M, Sevilimedu V, Eroglu I, Le T, et al
     How Often Do Sentinel Lymph Node Biopsy Results Affect Adjuvant Therapy Decisions Among Postmenopausal Women with Early-Stage HR(+)/HER2(-) Breast Cancer in the Post-RxPONDER Era?
     Ann Surg Oncol. 2022 Jul 18. pii: 10.1245/s10434-022-12193.
     PubMed     Abstract available
     
     
     
661. GENTLE CK, Alkhatib H, Valente SA, Tu C, et al
     Stage IV Non-breast Cancer Patients and Screening Mammography: It is Time to Stop.
     Ann Surg Oncol. 2022 Jul 18. pii: 10.1245/s10434-022-12132.
     PubMed     Abstract available
     
     
     
662. OROZCO JIJ, Le J, Ensenyat-Mendez M, Baker JL, et al
     ASO Visual Abstract: Machine Learning-Based Epigenetic Classifiers for Axillary Staging of Patients with ER-Positive Early-Stage Breast Cancer.
     Ann Surg Oncol. 2022 Jul 18. pii: 10.1245/s10434-022-12245.
     PubMed    
     
     
     
663. COBB AN, Sun SX
     ASO Author Reflections: Inflammatory Breast Cancer with Supraclavicular Nodal Involvement-Favorable Long-Term Outcomes can be Achieved.
     Ann Surg Oncol. 2022 Jul 16. pii: 10.1245/s10434-022-12235.
     PubMed    
     
     
     
664. OROZCO JIJ, Le J, Ensenyat-Mendez M, Baker JL, et al
     Machine Learning-Based Epigenetic Classifiers for Axillary Staging of Patients with ER-Positive Early-Stage Breast Cancer.
     Ann Surg Oncol. 2022 Jul 16. pii: 10.1245/s10434-022-12143.
     PubMed     Abstract available
     
     
     
665. AMLICKE MJ, Park J, Agala CB, Casey DL, et al
     ASO Visual Abstract: Prevalence of Pathologic N2/N3 Disease in Postmenopausal Women with Clinical N0 ER+/HER2- Breast Cancer.
     Ann Surg Oncol. 2022 Jul 16. pii: 10.1245/s10434-022-12163.
     PubMed    
     
     
     
666. NAKHLIS F
     Inflammatory Breast Cancer: Is There a Role for Deescalation of Surgery?
     Ann Surg Oncol. 2022 Jul 15. pii: 10.1245/s10434-022-12138.
     PubMed     Abstract available
     
     
     
667. SU GH, Jiang L, Xiao Y, Zheng RC, et al
     ASO Visual Abstract: A Multiomics Signature Highlights Alterations Underlying Homologous Recombination Deficiency in Triple-Negative Breast Cancer.
     Ann Surg Oncol. 2022 Jul 15. pii: 10.1245/s10434-022-12010.
     PubMed    
     
     
     
668. COBB AN, Diao K, Teshome M, Lucci A, et al
     Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement.
     Ann Surg Oncol. 2022 Jul 14. pii: 10.1245/s10434-022-12144.
     PubMed     Abstract available
     
     
     
669. SANDERS SB, Hoskin TL, Stafford AP, Boughey JC, et al
     Factors Influencing Non-sentinel Lymph Node Involvement in Patients with Positive Sentinel Lymph Node(s) After Neoadjuvant Chemotherapy for Breast Cancer.
     Ann Surg Oncol. 2022 Jul 13. pii: 10.1245/s10434-022-12064.
     PubMed     Abstract available
     
     
     
670. AMLICKE MJ, Spanheimer PM
     ASO Author Reflections: Can Genomic Recurrence Score Replace SLNB in Postmenopausal Women with ER+/HER2- Breast Cancer?
     Ann Surg Oncol. 2022 Jul 13. pii: 10.1245/s10434-022-12175.
     PubMed    
     
     
     
671. LAWS A, Pastorello R, Dey T, Grossmith S, et al
     ASO Visual Abstract: Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I-III Breast Cancer.
     Ann Surg Oncol. 2022 Jul 13. pii: 10.1245/s10434-022-12165.
     PubMed    
     
     
     
672. FLANAGAN MR, Sharifi N, Gadi VK
     ASO Author Reflections: Inheritance of Adrenal Permissive HSD3B1 Genotype Negatively Impacts Outcomes in Hormone Receptor-Positive Postmenopausal Breast Cancer.
     Ann Surg Oncol. 2022 Jul 11. pii: 10.1245/s10434-022-12091.
     PubMed    
     
     
     
673. GUTNIK LA, Fish LJ, Gallagher J, Greenup RA, et al
     'At All Costs': Breast Cancer Patient Responses to Cost Transparency and Communication.
     Ann Surg Oncol. 2022 Jul 9. pii: 10.1245/s10434-022-12160.
     PubMed    
     
     
     
674. KANTOR O, Weiss A, Burstein HJ, Mittendorf EA, et al
     ASO Visual Abstract: Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer with 1-3 Positive Sentinel Lymph Nodes.
     Ann Surg Oncol. 2022 Jul 9. pii: 10.1245/s10434-022-12081.
     PubMed    
     
     
     
675. ASHOOR A, Lissidini G, Datta U, Bertoldi L, et al
     ASO Author Reflections: Chyle Leak after Axillary Node Clearance in Breast Cancer Surgery, a Successful Management Approach from Leading Centres.
     Ann Surg Oncol. 2022 Jul 9. pii: 10.1245/s10434-022-12122.
     PubMed    
     
     
     
676. LAWS A, Pastorello R, Dey T, Grossmith S, et al
     Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I-III Breast Cancer.
     Ann Surg Oncol. 2022 Jul 9. pii: 10.1245/s10434-022-12054.
     PubMed     Abstract available
     
     
     
677. ABEL MK, Shui AM, Chien AJ, Rugo HS, et al
     The 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database Study.
     Ann Surg Oncol. 2022 Jul 9. pii: 10.1245/s10434-022-12065.
     PubMed     Abstract available
     
     
     
678. WONG SM, Ferroum A, Apostolova C, Alhassan B, et al
     ASO Visual Abstract: Incidence of Occult Breast Cancer in Carriers of BRCA1/2 and Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy-When is Sentinel Lymph Node Biopsy Indicated?
     Ann Surg Oncol. 2022 Jul 8. pii: 10.1245/s10434-022-12011.
     PubMed    
     
     
     
679. ABEL MK, Shui AM, Chien AJ, Rugo HS, et al
     ASO Visual Abstract: The 21-Gene Recurrence Score in Clinically High Risk Lobular and Ductal Breast Cancer-A National Cancer Database Study.
     Ann Surg Oncol. 2022 Jul 7. pii: 10.1245/s10434-022-12120.
     PubMed    
     
     
     
680. HIEKEN TJ, Hoskin TL
     ASO Author Reflections: Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy.
     Ann Surg Oncol. 2022 Jul 7. pii: 10.1245/s10434-022-12181.
     PubMed    
     
     
     
681. COOPEY SB
     Supraclavicular and Contralateral Axillary Lymph Node Involvement in Breast Cancer Patients.
     Ann Surg Oncol. 2022 Jul 6. pii: 10.1245/s10434-022-12134.
     PubMed     Abstract available
     
     
     
682. PILTIN MA, Boughey JC
     ASO Author Reflections: In an Era of De-escalation, Are We Still Doing Too Much for Stage 0 Breast Cancer?
     Ann Surg Oncol. 2022 Jul 6. pii: 10.1245/s10434-022-12169.
     PubMed    
     
     
     
683. PORTERHOUSE MD, Paul S, Lieberenz JL, Stempel LR, et al
     Black Women Are Less Likely to Be Classified as High-Risk for Breast Cancer Using the Tyrer-Cuzick 8 Model.
     Ann Surg Oncol. 2022 Jul 5. pii: 10.1245/s10434-022-12140.
     PubMed     Abstract available
     
     
     
684. MARTINEZ EO, Jorns JM, Kong AL, Cortina CS, et al
     ASO Author Reflections: Rare Breast Cancer Subtypes and the Role for Precision Oncology.
     Ann Surg Oncol. 2022 Jul 5. pii: 10.1245/s10434-022-12137.
     PubMed    
     
     
     
685. SCHERMERHORN MC, Grunvald MW, O'Donoghue CM, Rao RD, et al
     ASO Author Reflections: Applying the Counterfactual Approach to Disparities in Breast Cancer Treatment Delays.
     Ann Surg Oncol. 2022 Jul 4. pii: 10.1245/s10434-022-12069.
     PubMed    
     
     
     
686. BOUGHEY JC, Hoskin TL, Goetz MP
     ASO Visual Abstract: Neoadjuvant Chemotherapy and Nodal Response Rates in Luminal Breast Cancer-Effects of Age and Tumor Ki67.
     Ann Surg Oncol. 2022 Jul 1. pii: 10.1245/s10434-022-12004.
     PubMed    
     
     
     
687. FLANAGAN MR, Doody DR, Voutsinas J, Wu Q, et al
     Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen-Receptor-Positive Breast Cancer.
     Ann Surg Oncol. 2022 Jul 1. pii: 10.1245/s10434-022-12088.
     PubMed     Abstract available
     
     
     June 2022
688. NAKHLIS F, Katlin FD, Grossmith SC, DiPasquale A, et al
     Presence of Non-classic LCIS Is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS.
     Ann Surg Oncol. 2022 Jun 30. pii: 10.1245/s10434-022-12066.
     PubMed     Abstract available
     
     
     
689. HIEKEN TJ, Boughey JC, Degnim AC, Glazebrook KN, et al
     Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy.
     Ann Surg Oncol. 2022 Jun 30. pii: 10.1245/s10434-022-12037.
     PubMed    
     
     
     
690. LI C, Lu N, He Z, Tan Y, et al
     A Noninvasive Tool Based on Magnetic Resonance Imaging Radiomics for the Preoperative Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
     Ann Surg Oncol. 2022 Jun 30. pii: 10.1245/s10434-022-12034.
     PubMed     Abstract available
     
     
     
691. KANTOR O, Weiss A, Burstein HJ, Mittendorf EA, et al
     Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer with One to Three Positive Sentinel Lymph Nodes.
     Ann Surg Oncol. 2022 Jun 28. pii: 10.1245/s10434-022-12032.
     PubMed     Abstract available
     
     
     
692. AMLICKE MJ, Park J, Agala CB, Casey DL, et al
     Prevalence of Pathologic N2/N3 Disease in Postmenopausal Women with Clinical N0 ER+/HER2- Breast Cancer.
     Ann Surg Oncol. 2022 Jun 25. pii: 10.1245/s10434-022-12056.
     PubMed     Abstract available
     
     
     
693. SCHERMERHORN MC, Grunvald MW, O'Donoghue CM, Rao RD, et al
     Factors Mediating Racial/Ethnic Disparities in Delayed Treatment of Breast Cancer.
     Ann Surg Oncol. 2022 Jun 24. pii: 10.1245/s10434-022-12001.
     PubMed     Abstract available
     
     
     
694. KUS T, Aktas G
     Correction to : Should We Completely Exclude Locoregional Therapy for the Primary Tumor from Our Clinical Practice in De Novo Metastatic Breast Cancer?
     Ann Surg Oncol. 2022 Jun 22. pii: 10.1245/s10434-022-12072.
     PubMed    
     
     
     
695. MCGUIRE KP, Arthur DW, Mamounas EP
     Updates on Management of Hereditary Breast Cancer: New Data on PARP Inhibitors Change Recommendations Regarding the Multidisciplinary Care of Breast Cancer Patients with BRCA Mutations.
     Ann Surg Oncol. 2022 Jun 18. pii: 10.1245/s10434-022-12048.
     PubMed    
     
     
     
696. HUANG X, Luo Z, Fu DY
     ASO Author Reflections: Simplified Nomogram Predictive of Survival for Young Breast Cancer Patients.
     Ann Surg Oncol. 2022 Jun 17. pii: 10.1245/s10434-022-11966.
     PubMed    
     
     
     
697. SU GH, Jiang L, Xiao Y, Zheng RC, et al
     A Multiomics Signature Highlights Alterations Underlying Homologous Recombination Deficiency in Triple-Negative Breast Cancer.
     Ann Surg Oncol. 2022 Jun 16. pii: 10.1245/s10434-022-11958.
     PubMed     Abstract available
     
     
     
698. CHEN JC, Bazan JG, Obeng-Gyasi S
     ASO Author Reflections: Surgical Management Should be Considered in Patients with De Novo Stage IV Inflammatory Breast Cancer.
     Ann Surg Oncol. 2022 Jun 14. pii: 10.1245/s10434-022-12016.
     PubMed    
     
     
     
699. TINTERRI C, Gentile D, Gatzemeier W, Sagona A, et al
     ASO Visual Abstract: Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting 1-2 Metastatic Sentinel Lymph Nodes: The Multicenter Randomized Clinical Trial SINODAR-ONE.
     Ann Surg Oncol. 2022 Jun 12. pii: 10.1245/s10434-022-11908.
     PubMed    
     
     
     
700. CHEN JC, Li Y, Fisher JL, Bhattacharyya O, et al
     Modified Radical Mastectomy in De Novo Stage IV Inflammatory Breast Cancer.
     Ann Surg Oncol. 2022 Jun 8. pii: 10.1245/s10434-022-11975.
     PubMed     Abstract available
     
     
     
701. KHAN SA, Schuetz S, Hosseini O
     Correction to: Primary-Site Local Therapy for Patients with De Novo Metastatic Breast Cancer: An Educational Review.
     Ann Surg Oncol. 2022 Jun 8. pii: 10.1245/s10434-022-11995.
     PubMed    
     
     
     
702. CROWN A, Muhsen S, Sevilimedu V, Kelvin J, et al
     Fertility Preservation in Young Women with Breast Cancer: Impact on Treatment and Outcomes.
     Ann Surg Oncol. 2022 Jun 7. pii: 10.1245/s10434-022-11910.
     PubMed     Abstract available
     
     
     
703. EISENBERG ER, Weiss A, Prakash I, Skamene S, et al
     Surgical Management and Contralateral Breast Cancer Risk in Women with History of Radiation Therapy for Hodgkin Lymphoma: Results from a Population-Based Cohort.
     Ann Surg Oncol. 2022 Jun 6. pii: 10.1245/s10434-022-11947.
     PubMed     Abstract available
     
     
     
704. HUANG X, Luo Z, Liang W, Xie G, et al
     ASO Visual Abstract: Survival Nomogram for Young Breast Cancer Patients Based on the SEER Database and an External Validation Cohort.
     Ann Surg Oncol. 2022 Jun 5. pii: 10.1245/s10434-022-11968.
     PubMed    
     
     
     
705. KUS T, Aktas G
     Should We Completely Exclude Locoregional Therapy for the Primary Tumor from Our Clinical Practice in De Novo Metastatic Breast Cancer?
     Ann Surg Oncol. 2022 Jun 4. pii: 10.1245/s10434-022-11979.
     PubMed     Abstract available
     
     
     
706. HUANG X, Luo Z, Liang W, Xie G, et al
     Survival Nomogram for Young Breast Cancer Patients Based on the SEER Database and an External Validation Cohort.
     Ann Surg Oncol. 2022 Jun 3. pii: 10.1245/s10434-022-11911.
     PubMed     Abstract available
     
     
     
707. MAIMONE S, Morozov AP, Li Z, Craver EC, et al
     ASO Visual Abstract: Additional Work-Ups Recommended During Preoperative Breast MRI, Methods to Gain Efficiency and Limit Confusion.
     Ann Surg Oncol. 2022;29:3851-3852.
     PubMed    
     
     
     
708. MARTINS MAIA C, Siderides C, Jaffer S, Weltz C, et al
     ASO Visual Abstract: Mastectomy or Margin Reexcision? A Nomogram for Close/Positive Margins after Lumpectomy for DCIS.
     Ann Surg Oncol. 2022;29:3749.
     PubMed    
     
     
     
709. MITSUEDA R, Gen A, Fujiki Y, Gondo N, et al
     ASO Visual Abstract: Satisfaction of Patients Who Received Breast-Conserving Surgery Using the Suture Scaffold Technique: A Single-Institution, Cross-Sectional Study.
     Ann Surg Oncol. 2022;29:3838.
     PubMed    
     
     
     
710. WEISS A, King C, Grossmith S, Portnow L, et al
     ASO Visual Abstract: How Often Does Retrieval of a Clipped Lymph Node Change Adjuvant Therapy Recommendations? A Prospective Consecutive Patient Cohort Study.
     Ann Surg Oncol. 2022;29:3774-3775.
     PubMed    
     
     
     
711. MITSUEDA R, Gen A, Fujiki Y, Gondo N, et al
     Satisfaction of Patients Who Received Breast-Conserving Surgery Using the Suture Scaffold Technique: A Single-Institution, Cross-Sectional Study.
     Ann Surg Oncol. 2022;29:3829-3835.
     PubMed     Abstract available
     
     
     
712. MITSUEDA R, Gen A, Fujiki Y, Gondo N, et al
     ASO Author Reflections: Patients' Satisfaction After Breast Conserving Surgery Using the Suture Scaffold Technique.
     Ann Surg Oncol. 2022;29:3836-3837.
     PubMed    
     
     
     
713. MAIMONE S, Morozov AP, Li Z, Craver EC, et al
     Additional Workups Recommended During Preoperative Breast MRI: Methods to Gain Efficiency and Limit Confusion.
     Ann Surg Oncol. 2022;29:3839-3848.
     PubMed     Abstract available
     
     
     
714. MAIMONE S, McLaughlin SA
     ASO Author Reflections: Optimizing Additional Workups from Preoperative Breast MRI.
     Ann Surg Oncol. 2022;29:3849-3850.
     PubMed    
     
     
     
715. MORARASU S, Clancy C, Ghetu N, Musina AM, et al
     ASO Visual Abstract: Impact of Quilting Sutures on Surgical Outcomes After Mastectomy: A Systematic Review and Meta-Analysis.
     Ann Surg Oncol. 2022;29:3799.
     PubMed    
     
     
     
716. LIANG DH, Black D, Yi M, Luo CK, et al
     Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of Non-palpable Breast Lesions.
     Ann Surg Oncol. 2022;29:3822-3828.
     PubMed     Abstract available
     
     
     
717. HUANG CC, Tsai YF, Liu CY, Lien PJ, et al
     Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast Cancers.
     Ann Surg Oncol. 2022;29:3578-3590.
     PubMed     Abstract available
     
     
     
718. SILVERSTEIN MJ, Epstein MS, Chen P, Lin K, et al
     ASO Visual Abstract: Recurrence and Survival Rates for 1400 Early Breast Tumors Treated with Intraoperative Radiation Therapy (IORT).
     Ann Surg Oncol. 2022;29:3739.
     PubMed    
     
     
     
719. REDFERN RE, Shermis RB
     ASO Visual Abstract: Initial Experience Using Magseed for Breast Lesion Localization Compared to Wire-Guided Localization-Analysis of Volume and Margin Clearance Rates.
     Ann Surg Oncol. 2022;29:3784.
     PubMed    
     
     
     
720. MORARASU S, Clancy C, Ghetu N, Musina AM, et al
     Impact of Quilting Sutures on Surgical Outcomes After Mastectomy: A Systematic Review and Meta-Analysis.
     Ann Surg Oncol. 2022;29:3785-3797.
     PubMed     Abstract available
     
     
     
721. REDFERN RE, Shermis RB
     Initial Experience Using Magseed for Breast Lesion Localization Compared With Wire-Guided Localization: Analysis of Volume and Margin Clearance Rates.
     Ann Surg Oncol. 2022;29:3776-3783.
     PubMed     Abstract available
     
     
     
722. SILVERSTEIN MJ, Epstein MS, Chen P, Lin K, et al
     Recurrence and Survival Rates for 1400 Early Breast Tumors Treated with Intraoperative Radiation Therapy (IORT).
     Ann Surg Oncol. 2022;29:3726-3736.
     PubMed     Abstract available
     
     
     
723. MARTINS MAIA C, Siderides C, Jaffer S, Weltz C, et al
     Mastectomy or Margin Re-excision? A Nomogram for Close/Positive Margins After Lumpectomy for DCIS.
     Ann Surg Oncol. 2022;29:3740-3748.
     PubMed     Abstract available
     
     
     
724. WEISS A, King C, Grossmith S, Portnow L, et al
     How Often Does Retrieval of a Clipped Lymph Node Change Adjuvant Therapy Recommendations? A Prospective, Consecutive, Patient Cohort Study.
     Ann Surg Oncol. 2022;29:3764-3771.
     PubMed     Abstract available
     
     
     
725. KOPKASH K, Novak K, Murphy R, Deliere A, et al
     ASO Visual Abstract: Improving the Breast Surgeon's Ergonomic Workload for Nipple-Sparing Mastectomies Using Exercise and an Operating Room Positioning Protocol.
     Ann Surg Oncol. 2022;29:3863.
     PubMed    
     
     
     
726. CORTINA CS, Kong AL
     ASO Author Reflections: The Evolving Multidisciplinary Management of the Axilla in Mastectomy Patients.
     Ann Surg Oncol. 2022;29:3853-3854.
     PubMed    
     
     
     
727. JU T, Momeni A, Wapnir I
     ASO Author Reflections: Preventing Nipple Loss by Surgical Delay in Nipple-Sparing Mastectomy.
     Ann Surg Oncol. 2022;29:3855-3856.
     PubMed    
     
     
     May 2022
728. SU GH, Jiang L, Xiao Y, Zheng RC, et al
     ASO Author Reflections: Deeper Insight into Therapeutic Implications and Non-invasive Detection of Homologous Recombination Deficiency in Triple-Negative Breast Cancer: Results from a Multi-omics Cohort Study.
     Ann Surg Oncol. 2022 May 29. pii: 10.1245/s10434-022-11960.
     PubMed    
     
     
     
729. WONG SM, Ferroum A, Apostolova C, Alhassan B, et al
     Incidence of Occult Breast Cancer in Carriers of BRCA1/2 or Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy: When is Sentinel Lymph Node Biopsy Indicated?
     Ann Surg Oncol. 2022 May 26. pii: 10.1245/s10434-022-11916.
     PubMed     Abstract available
     
     
     
730. KHAN SA, Schuetz S, Husseini O
     Primary-Site Local Therapy for Patients with De Novo Metastatic Breast Cancer: An Educational Review.
     Ann Surg Oncol. 2022 May 24. pii: 10.1245/s10434-022-11900.
     PubMed     Abstract available
     
     
     
731. ZIPKIN RJ, Schaefer A, Wang C, Loehrer AP, et al
     Rural-Urban Differences in Breast Cancer Surgical Delays in Medicare Beneficiaries.
     Ann Surg Oncol. 2022 May 24. pii: 10.1245/s10434-022-11834.
     PubMed     Abstract available
     
     
     
732. RELATION T, Bhattacharyya O, Oppong BA
     ASO Author Reflections: Surgery Refusal in Breast Cancer Has a Disproportionate Impact on Black and Hispanic Women.
     Ann Surg Oncol. 2022 May 17. pii: 10.1245/s10434-022-11906.
     PubMed    
     
     
     
733. BOUGHEY JC, Blair SL, Subhedar PD, Edge SB, et al
     The EA2108 Clinical Trial and Real-World Data: A Cautionary Tale in Stage IV Breast Cancer.
     Ann Surg Oncol. 2022 May 16. pii: 10.1245/s10434-022-11899.
     PubMed    
     
     
     
734. BOUGHEY JC, Hoskin TL, Goetz MP
     Neoadjuvant Chemotherapy and Nodal Response Rates in Luminal Breast Cancer: Effects of Age and Tumor Ki67.
     Ann Surg Oncol. 2022 May 15. pii: 10.1245/s10434-022-11871.
     PubMed     Abstract available
     
     
     
735. TINTERRI C, Gentile D, Gatzemeier W, Sagona A, et al
     Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial.
     Ann Surg Oncol. 2022 May 12. pii: 10.1245/s10434-022-11866.
     PubMed     Abstract available
     
     
     
736. HUGHES KS, Yin K
     A Woman Needs to Know She Is a BRCA Carrier Before She Develops Breast Cancer.
     Ann Surg Oncol. 2022 May 12. pii: 10.1245/s10434-022-11860.
     PubMed    
     
     
     
737. ZIPKIN RJ, Schaefer A, Wang C, Loehrer AP, et al
     ASO Visual Abstract: Rural-Urban Differences in Breast Cancer Surgical Delays in Medicare Beneficiaries.
     Ann Surg Oncol. 2022 May 12. pii: 10.1245/s10434-022-11877.
     PubMed    
     
     
     
738. RADOSA JC, Solomayer EF, Deeken M, Minko P, et al
     ASO Visual Abstract: Preoperative Sonographic Prediction of Limited Axillary Disease in Patients with Primary Breast Cancer Meeting the Z0011 Criteria: An Alternative to Sentinel-Node-Biopsy?
     Ann Surg Oncol. 2022 May 12. pii: 10.1245/s10434-022-11876.
     PubMed    
     
     
     
739. BREDBECK BC, Mott NM, Wang T, Sinco BR, et al
     ASO Visual Abstract: Facility-Level Variation of Low-Value Breast Cancer Treatments in Older Women with Early-Stage Breast Cancer: Analysis of a Statewide Claims Registry.
     Ann Surg Oncol. 2022 May 9. pii: 10.1245/s10434-022-11743.
     PubMed    
     
     
     
740. RELATION T, Ndumele A, Bhattacharyya O, Fisher JL, et al
     Surgery Refusal Among Black and Hispanic Women with Non-Metastatic Breast Cancer.
     Ann Surg Oncol. 2022 May 5. pii: 10.1245/s10434-022-11832.
     PubMed     Abstract available
     
     
     
741. MATAR R, Sevilimedu V, Gemignani ML, Morrow M, et al
     ASO Visual Abstract: Impact of Endocrine Therapy Adherence on Outcomes in Elderly Women With Early-Stage Breast Cancer Undergoing Lumpectomy Without Radiotherapy.
     Ann Surg Oncol. 2022 May 2. pii: 10.1245/s10434-022-11795.
     PubMed    
     
     
     
742. VERBUS EA, Khan TM, Hernandez JM, Kulkarni S, et al
     Evaluating the Effects of a Tissue Selective Estrogen Complex (TSEC) in Women with Newly Diagnosed Ductal Carcinoma In Situ.
     Ann Surg Oncol. 2022;29:2769-2770.
     PubMed    
     
     
     April 2022
743. RADOSA JC, Solomayer EF, Deeken M, Minko P, et al
     Preoperative Sonographic Prediction of Limited Axillary Disease in Patients with Primary Breast Cancer Meeting the Z0011 Criteria: an Alternative to Sentinel Node Biopsy?
     Ann Surg Oncol. 2022 Apr 29. pii: 10.1245/s10434-022-11829.
     PubMed     Abstract available
     
     
     
744. RADOSA JC, Solomayer EF, Deeken M, Minko P, et al
     ASO Author Reflections: An Alternative to Sentinel-Node Biopsy? Preoperative Sonographic Prediction of Limited Axillary Disease in Breast Cancer Patients Meeting the Z0011 Criteria.
     Ann Surg Oncol. 2022 Apr 29. pii: 10.1245/s10434-022-11845.
     PubMed    
     
     
     
745. STAFFORD AP, Hoskin TL, Day CN, Sanders SB, et al
     ASO Visual Abstract: Contemporary Axillary Management in cT1-2N0 Breast Cancer with 1-2 Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database.
     Ann Surg Oncol. 2022 Apr 28. pii: 10.1245/s10434-022-11818.
     PubMed    
     
     
     
746. BURKBAUER L, Goldbach M, Hoffman DI, Giannakou A, et al
     ASO Visual Abstract: Preoperative MRI and Its Impact on Surgical Outcomes in Patients with Triple Negative Breast Cancer Treated with Primary Surgery: Did New Margin Guidelines or Cavity Shave Margins Practice Diminish the Role of Preoperative MRI?
     Ann Surg Oncol. 2022 Apr 28. pii: 10.1245/s10434-022-11608.
     PubMed    
     
     
     
747. KARZAI S, Port E, Siderides C, Valente C, et al
     ASO Visual Abstract: Impact of Screening Mammography on Treatment in Young Women Diagnosed with Breast Cancer.
     Ann Surg Oncol. 2022 Apr 27. pii: 10.1245/s10434-022-11636.
     PubMed    
     
     
     
748. COLLIN LJ, Ross-Driscoll K, Nash R, Miller-Kleinhenz JM, et al
     ASO Visual Abstract: Time to Surgical Treatment and Facility Characteristics as Potential Drivers of Racial Disparities in Breast Cancer Mortality: Delay, Facilities, and Breast Cancer Mortality.
     Ann Surg Oncol. 2022 Apr 26. pii: 10.1245/s10434-022-11794.
     PubMed    
     
     
     
749. SONG JH, Kantor O, Mittendorf EA, King TA, et al
     ASO Visual Abstract: Race and Site of Care Impact Treatment Delays for Older Women with Non-Metastatic Breast Cancer.
     Ann Surg Oncol. 2022 Apr 26. pii: 10.1245/s10434-022-11593.
     PubMed    
     
     
     
750. ADESOYE T, Sun SX, Schaverien MV, Woodward WA, et al
     Immediate Breast Reconstruction in Inflammatory Breast Cancer: Are We There Yet?
     Ann Surg Oncol. 2022 Apr 26. pii: 10.1245/s10434-022-11788.
     PubMed    
     
     
     
751. MATAR R, Sevilimedu V, Gemignani ML, Morrow M, et al
     Impact of Endocrine Therapy Adherence on Outcomes in Elderly Women with Early-Stage Breast Cancer Undergoing Lumpectomy Without Radiotherapy.
     Ann Surg Oncol. 2022 Apr 24. pii: 10.1245/s10434-022-11728.
     PubMed     Abstract available
     
     
     
752. STAFFORD AP, Hoskin TL, Day CN, Sanders SB, et al
     Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database.
     Ann Surg Oncol. 2022 Apr 22. pii: 10.1245/s10434-022-11759.
     PubMed     Abstract available
     
     
     
753. MATAR R, Morrow M
     ASO Author Reflections: Undertreatment of Early-Stage Breast Cancer in Elderly Women Undergoing Lumpectomy Without Radiotherapy Increases the Risk of Locoregional Recurrence.
     Ann Surg Oncol. 2022 Apr 22. pii: 10.1245/s10434-022-11769.
     PubMed    
     
     
     
754. WHITWORTH P, Beitsch PD, Pellicane JV, Baron PL, et al
     ASO Visual Abstract: Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer.
     Ann Surg Oncol. 2022 Apr 19. pii: 10.1245/s10434-022-11711.
     PubMed    
     
     
     
755. COLLIN LJ, Ross-Driscoll K, Nash R, Miller-Kleinhenz JM, et al
     Time to Surgical Treatment and Facility Characteristics as Potential Drivers of Racial Disparities in Breast Cancer Mortality.
     Ann Surg Oncol. 2022 Apr 18. pii: 10.1245/s10434-022-11720.
     PubMed     Abstract available
     
     
     
756. SCHWARTZ T
     Personal Systemic Therapy Decision-Making has Officially Arrived for Node-Positive Breast Cancer.
     Ann Surg Oncol. 2022 Apr 16. pii: 10.1245/s10434-022-11689.
     PubMed    
     
     
     
757. ENSENYAT-MENDEZ M, Runger D, Orozco JIJ, Le J, et al
     ASO Visual Abstract: Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen-Receptor-Positive, Clinically Node-Positive Disease.
     Ann Surg Oncol. 2022 Apr 16. pii: 10.1245/s10434-022-11744.
     PubMed    
     
     
     
758. MINAMI CA, Jin G, Schonberg MA, Freedman RA, et al
     ASO Visual Abstract: Variation in Deescalated Axillary Surgical Practices in Older Women with Early-Stage Breast Cancer.
     Ann Surg Oncol. 2022 Apr 16. pii: 10.1245/s10434-022-11778.
     PubMed    
     
     
     
759. ENSENYAT-MENDEZ M, Runger D, Orozco JIJ, Le J, et al
     Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen Receptor-Positive, Clinically Node-Positive Disease.
     Ann Surg Oncol. 2022 Apr 9. pii: 10.1245/s10434-022-11684.
     PubMed     Abstract available
     
     
     
760. HUANG CC, Tseng LM
     ASO Author Reflections: Broaden the Targeted Population of Synthetic Lethality for Taiwanese Breast Cancer.
     Ann Surg Oncol. 2022 Apr 7. pii: 10.1245/s10434-022-11407.
     PubMed     Abstract available
     
     
     
761. MINAMI CA, Jin G, Schonberg MA, Freedman RA, et al
     Variation in Deescalated Axillary Surgical Practices in Older Women with Early-Stage Breast Cancer.
     Ann Surg Oncol. 2022 Apr 6. pii: 10.1245/s10434-022-11677.
     PubMed     Abstract available
     
     
     
762. CROWN A, Ramiah K, Siegel B, Joseph KA, et al
     ASO Visual Abstract: The Role of Safety Net Hospitals in Reducing Disparities in Breast Cancer Care.
     Ann Surg Oncol. 2022 Apr 6. pii: 10.1245/s10434-022-11694.
     PubMed    
     
     
     
763. BREDBECK BC, Mott NM, Wang T, Sinco BR, et al
     Facility-Level Variation of Low-Value Breast Cancer Treatments in Older Women with Early-Stage Breast Cancer: Analysis of a Statewide Claims Registry.
     Ann Surg Oncol. 2022 Apr 5. pii: 10.1245/s10434-022-11631.
     PubMed     Abstract available
     
     
     
764. WHITWORTH P, Beitsch PD, Pellicane JV, Baron PL, et al
     Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer.
     Ann Surg Oncol. 2022 Apr 4. pii: 10.1245/s10434-022-11666.
     PubMed     Abstract available
     
     
     
765. GUI Y, Chen Q, Li S, Yang X, et al
     ASO Visual Abstract: Safety and feasibility of Minimally Invasive (Laparoscopic/Robotic-Assisted) Nipple-Sparing Mastectomy Combined with Prosthesis Breast Reconstruction in Breast Cancer-A Single-Center Retrospective Study.
     Ann Surg Oncol. 2022 Apr 3. pii: 10.1245/s10434-022-11449.
     PubMed    
     
     
     
766. LE BLANC J, Golshan M, Lannin D, Greenup R, et al
     Association of Medicaid Expansion with Post-mastectomy Reconstruction Rates.
     Ann Surg Oncol. 2022;29:2181-2189.
     PubMed     Abstract available
     
     
     
767. REGIS C, Le Deley MC, Bogart E, Leguillette C, et al
     Functional Cerebral MRI Evaluation of Integration of Breast Reconstruction into the Body Schema.
     Ann Surg Oncol. 2022;29:2652-2661.
     PubMed     Abstract available
     
     
     
768. MOHAN SC, Tseng J, Marumoto A, Angarita S, et al
     Upstaging of Fibroepithelial Lesions: A Single-Institution Experience.
     Ann Surg Oncol. 2022;29:2193-2199.
     PubMed     Abstract available
     
     
     
769. KARZAI S, Port E, Siderides C, Valente C, et al
     Impact of Screening Mammography on Treatment in Young Women Diagnosed with Breast Cancer.
     Ann Surg Oncol. 2022 Apr 1. pii: 10.1245/s10434-022-11581.
     PubMed     Abstract available
     
     
     
770. MOHAN SC, Tseng J, Marumoto A, Angarita S, et al
     ASO Visual Abstract: Upstaging of Fibroepithelial Lesions-A Single-Institution Experience.
     Ann Surg Oncol. 2022;29:2201.
     PubMed    
     
     
     
771. LE BLANC J, Park T, Lannin D
     ASO Author Reflections: Despite Medicaid Expansion, Large Disparities in Breast Reconstruction Persist.
     Ann Surg Oncol. 2022;29:2190.
     PubMed    
     
     
     March 2022
772. CROWN A, Ramiah K, Siegel B, Joseph KA, et al
     The Role of Safety-Net Hospitals in Reducing Disparities in Breast Cancer Care.
     Ann Surg Oncol. 2022 Mar 31. pii: 10.1245/s10434-022-11576.
     PubMed     Abstract available
     
     
     
773. CROWN A, Joseph KA
     ASO Author Reflections: Reinforcing the Safety Net: Supporting Safety-Net Hospitals in Mitigating Breast Cancer Disparities.
     Ann Surg Oncol. 2022 Mar 30. pii: 10.1245/s10434-022-11640.
     PubMed    
     
     
     
774. SONG JH, Kantor O, Mittendorf EA, King TA, et al
     Race and Site of Care Impact Treatment Delays in Older Women with Non-Metastatic Breast Cancer.
     Ann Surg Oncol. 2022 Mar 30. pii: 10.1245/s10434-022-11543.
     PubMed     Abstract available
     
     
     
775. BURKBAUER L, Goldbach M, Hoffman DI, Giannakou A, et al
     Preoperative MRI and Its Impact on Surgical Outcomes in Patients with Triple Negative Breast Cancer Treated with Primary Surgery: Did New Margin Guidelines or Cavity Shave Margins Practice Diminish the Role of Preoperative MRI?
     Ann Surg Oncol. 2022 Mar 18. pii: 10.1245/s10434-022-11545.
     PubMed     Abstract available
     
     
     
776. FRIEDMAN-ELDAR O, Ozmen T, El Haddi SJ, Goel N, et al
     Axillary Response to Neoadjuvant Therapy in Node-Positive, Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: Predictors and Oncologic Outcomes.
     Ann Surg Oncol. 2022 Mar 18. pii: 10.1245/s10434-022-11473.
     PubMed     Abstract available
     
     
     
777. FRIEDMAN-ELDAR O, Ozmen T, Haddi SJE, Goel N, et al
     ASO Visual Abstract: Axillary Response to Neoadjuvant Therapy in Node-Positive ER+/HER2- Breast Cancer Patients-Predictors and Oncologic Outcomes.
     Ann Surg Oncol. 2022 Mar 14. pii: 10.1245/s10434-022-11531.
     PubMed    
     
     
     
778. RING A, Campo D, Porras TB, Kaur P, et al
     Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.
     Ann Surg Oncol. 2022 Mar 8. pii: 10.1245/s10434-022-11589.
     PubMed    
     
     
     
779. VERDIAL FC, Mamtani A, Pawloski KR, Sevilimedu V, et al
     The Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer.
     Ann Surg Oncol. 2022 Mar 5. pii: 10.1245/s10434-022-11367.
     PubMed     Abstract available
     
     
     
780. JIWA N, Kumar S, Gandhewar R, Chauhan H, et al
     Diagnostic Accuracy of Nipple Discharge Fluid Cytology: A Meta-Analysis and Systematic Review of the Literature.
     Ann Surg Oncol. 2022;29:1774-1786.
     PubMed     Abstract available
     
     
     
781. VICINI E, Leonardi MC, Fontana SKR, Pagan E, et al
     How to Perform Repeat Sentinel Node Biopsy Safely After a Previous Mastectomy: Technical Features and Oncologic Outcomes.
     Ann Surg Oncol. 2022;29:1750-1760.
     PubMed     Abstract available
     
     
     
782. ESGUEVA AJ, Noordhoek I, Kranenbarg EM, Espinosa-Bravo M, et al
     Health-Related Quality of Life After Nipple-Sparing Mastectomy: Results From the INSPIRE Registry.
     Ann Surg Oncol. 2022;29:1722-1734.
     PubMed     Abstract available
     
     
     
783. MATAR R, Sevilimedu V, Park A, King TA, et al
     Comparison of Outcomes for Classic-Type Lobular Carcinoma In Situ Managed with Surgical Excision After Core Biopsy Versus Observation.
     Ann Surg Oncol. 2022;29:1670-1679.
     PubMed     Abstract available
     
     
     
784. WILLIAMS AD, Chang C, Sigurdson ER, Wang CH, et al
     Neoadjuvant Endocrine Therapy and Delays in Surgery for Ductal Carcinoma in Situ: Implications for the Coronavirus Pandemic.
     Ann Surg Oncol. 2022;29:1683-1691.
     PubMed     Abstract available
     
     
     
785. WANG W, Shen Z, Zhang J, Chen H, et al
     A Novel Criterion for Lymph Nodes Dissection in Distal Pancreatectomy for Ductal Adenocarcinoma: A Population Study of the US SEER Database.
     Ann Surg Oncol. 2022;29:1533-1539.
     PubMed     Abstract available
     
     
     
786. LAWS A, Katlin F, Nakhlis F, Chikarmane SA, et al
     Atypical Lobular Hyperplasia and Classic Lobular Carcinoma In Situ Can Be Safely Managed Without Surgical Excision.
     Ann Surg Oncol. 2022;29:1660-1667.
     PubMed     Abstract available
     
     
     
787. SOEGAARD BALLESTER JM, Goodsell KE, Ermer JP, Karakousis GC, et al
     New Operative Reporting Standards: Where We Stand Now and Opportunities for Innovation.
     Ann Surg Oncol. 2022;29:1797-1804.
     PubMed     Abstract available
     
     
     
788. JIWA N, Leff D
     ASO Authors Reflection: Diagnostic Accuracy of Nipple Discharge Fluid Cytology: A Meta-Analysis and Systematic Review of the Literature.
     Ann Surg Oncol. 2022;29:1787-1788.
     PubMed    
     
     
     
789. VICINI E, Fontana SKR, Leonardi MC, Veronesi P, et al
     ASO Author Reflections: Value of Sentinel Node Biopsy for Chest Wall Recurrence After Mastectomy.
     Ann Surg Oncol. 2022;29:1761-1762.
     PubMed    
     
     
     
790. PAWLOSKI KR, Moo TA
     ASO Author Reflection: Pain Control Can Be Optimized with Surgeon-Administered Local Anesthesia in Patients Undergoing Lumpectomy and Sentinel Lymph Node Biopsy with Multimodal Analgesia.
     Ann Surg Oncol. 2022;29:1746-1747.
     PubMed    
     
     
     
791. MATAR R, Pilewskie M
     ASO Author Reflections: Observation After a Core Biopsy Diagnosis of Classic-Type LCIS Is a Safe Standard of Practice.
     Ann Surg Oncol. 2022;29:1680-1681.
     PubMed    
     
     
     
792. WANG W, Shen B
     ASO Author Reflections: Lymphadenectomy in Distal Pancreatectomy for Ductal Adenocarcinoma: How to Do Better?
     Ann Surg Oncol. 2022;29:1540-1541.
     PubMed    
     
     
     
793. ROSSI AJ, Verbus EA, Horst K, De Martini W, et al
     Surgical Excision Versus Neoadjuvant Radiotherapy Followed by Delayed Surgical Excision of Ductal Carcinoma In Situ (NORDIS).
     Ann Surg Oncol. 2022;29:1528-1529.
     PubMed    
     
     
     February 2022
794. DUMITRU D, Ghanakumar S, Provenzano E, Benson JR, et al
     ASO Visual Abstract: A Prospective Study Evaluating the Accuracy of Indocyanine Green (ICG) Fluorescence Compared with Radioisotope for Sentinel Lymph Node (Sln) Detection in Early Breast Cancer.
     Ann Surg Oncol. 2022 Feb 21. pii: 10.1245/s10434-021-11313.
     PubMed    
     
     
     
795. VERDIAL FC, Mamtani A, Pawloski KR, Sevilimedu V, et al
     ASO Visual Abstract: Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer.
     Ann Surg Oncol. 2022 Feb 20. pii: 10.1245/s10434-022-11425.
     PubMed    
     
     
     
796. GUI Y, Chen Q, Chen L
     ASO Author Reflections: Minimally Invasive Nipple-Sparing Mastectomy Combined with Prosthesis Breast Reconstruction for Early Breast Cancer.
     Ann Surg Oncol. 2022 Feb 18. pii: 10.1245/s10434-022-11422.
     PubMed    
     
     
     
797. GUI Y, Chen Q, Li S, Yang X, et al
     Safety and Feasibility of Minimally Invasive (Laparoscopic/Robotic-Assisted) Nipple-Sparing Mastectomy Combined with Prosthesis Breast Reconstruction in Breast Cancer: A Single-Center Retrospective Study.
     Ann Surg Oncol. 2022 Feb 16. pii: 10.1245/s10434-022-11420.
     PubMed     Abstract available
     
     
     
798. CARMONA CA, Yee S, Seminsky M, Glass K, et al
     ASO Visual Abstract: Surgeon and Patient Reports of Fertility Preservation Referral and Uptake in a Prospective Pan-Canadian Study of Young Women with Breast Cancer.
     Ann Surg Oncol. 2022 Feb 15. pii: 10.1245/s10434-022-11340.
     PubMed    
     
     
     
799. COBB AN, Adesoye T, Teshome M
     Progress and Persistent Challenges in Improving Care for Low-Income Women with Breast Cancer.
     Ann Surg Oncol. 2022 Feb 12. pii: 10.1245/s10434-022-11343.
     PubMed    
     
     
     
800. MATAR R, Barrio AV, Sevilimedu V, Le T, et al
     ASO Visual Abstract: Can We Successfully Deescalate Axillary Surgery in Women Aged >/= 70 Years with Ductal Carcinoma In Situ or Early-Stage Breast Cancer Undergoing Mastectomy?
     Ann Surg Oncol. 2022 Feb 3. pii: 10.1245/s10434-021-11305.
     PubMed    
     
     
     
801. BAE J, Jeon BJ, Mun GH, Bang SI, et al
     Predictors for Implant Rupture in Two-Stage Tissue Expander-Based Breast Reconstruction: A Retrospective Cohort Study.
     Ann Surg Oncol. 2022;29:1100-1108.
     PubMed     Abstract available
     
     
     
802. MAMTANI A, Sevilimedu V, Vincent A, Morrow M, et al
     Local Recurrence is Frequent After Heroic Mastectomy for Classically Inoperable Breast Cancers.
     Ann Surg Oncol. 2022;29:1043-1048.
     PubMed     Abstract available
     
     
     
803. KELLY BN, Faulkner HR, Smith BL, Korotkin JE, et al
     Nipple-Sparing Mastectomy versus Skin-Sparing Mastectomy: Does Saving the Nipple Impact Short- and Long-Term Patient Satisfaction?
     Ann Surg Oncol. 2022;29:1033-1040.
     PubMed     Abstract available
     
     
     
804. ERDRICH J, Cordova-Marks F, Monetathchi AR, Wu M, et al
     Disparities in Breast-Conserving Therapy for Non-Hispanic American Indian/Alaska Native Women Compared with Non-Hispanic White Women.
     Ann Surg Oncol. 2022;29:1019-1030.
     PubMed     Abstract available
     
     
     
805. KANTOR O, Means J, Grossmith S, Dey T, et al
     Optimizing Axillary Management in Clinical T1-2N0 Mastectomy Patients with Positive Sentinel Lymph Nodes.
     Ann Surg Oncol. 2022;29:972-980.
     PubMed     Abstract available
     
     
     
806. SHAMMAS RL, Fish LJ, Sergesketter AR, Offodile AC 2nd, et al
     Dissatisfaction After Post-Mastectomy Breast Reconstruction: A Mixed-Methods Study.
     Ann Surg Oncol. 2022;29:1109-1119.
     PubMed     Abstract available
     
     
     
807. ERDRICH J
     ASO Author Reflections: Mastectomy Versus Lumpectomy: Are There Surgical Disparities for Native American Women Compared with White Women?
     Ann Surg Oncol. 2022;29:1031-1032.
     PubMed    
     
     
     
808. MAMTANI A, Morrow M
     ASO Author Reflections: Heroic Mastectomy for Chemoresistant Disease: A Complex Decision.
     Ann Surg Oncol. 2022;29:1049-1050.
     PubMed    
     
     
     
809. MONTAGNA G, Weber WP, Geroldinger A, Fitzal F, et al
     ASO Author Reflections: Impact of Resection Volume on Risk of Local Recurrence-The OPBC-01/iTOP2 Study.
     Ann Surg Oncol. 2022;29:1071-1072.
     PubMed    
     
     
     
810. SHAMMAS RL, Greenup RA, Hollenbeck ST
     ASO Author Reflections: Decision Support Tools Are Needed to Address Dissatisfaction Among Women Seeking Post-Mastectomy Breast Reconstruction.
     Ann Surg Oncol. 2022;29:1120-1121.
     PubMed    
     
     
     January 2022
811. KHAN SY, Melkus MW, Rasha F, Castro M, et al
     Tumor-Infiltrating Lymphocytes (TILs) as a Biomarker of Abscopal Effect of Cryoablation in Breast Cancer: A Pilot Study.
     Ann Surg Oncol. 2022 Jan 29. pii: 10.1245/s10434-021-11157.
     PubMed     Abstract available
     
     
     
812. MATHEW AT, Jain B, Dee EC, Johnson J, et al
     Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers.
     Ann Surg Oncol. 2022 Jan 29. pii: 10.1245/s10434-022-11349.
     PubMed    
     
     
     
813. KHAN SY, Melkus MW, Rasha F, Castro M, et al
     ASO Visual Abstract: Tumor-Infiltrating Lymphocytes (TILs) as a Biomarker of Abscopal Effect of Cryoablation in Breast Cancer-A Pilot Study.
     Ann Surg Oncol. 2022 Jan 25. pii: 10.1245/s10434-021-11240.
     PubMed    
     
     
     
814. NAFFOUJE SA, Barker V, Lee MC, Hoover SJ, et al
     ASO Visual Abstract: Surgical Management of the Axilla of Triple-Negative Breast Cancer in the Z1071 Era-A Propensity-Score Matched Analysis of the National Cancer Database.
     Ann Surg Oncol. 2022 Jan 25. pii: 10.1245/s10434-021-11281.
     PubMed    
     
     
     
815. TONNESON JE, Hoskin TL, Day CN, Durgan DM, et al
     ASO Visual Abstract: Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis, Presentation, and Patient Management.
     Ann Surg Oncol. 2022 Jan 21. pii: 10.1245/s10434-021-11178.
     PubMed    
     
     
     
816. DUCHESNEAU ED, An SJ, Strassle PD, Reeder-Hayes KE, et al
     Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer.
     Ann Surg Oncol. 2022 Jan 17. pii: 10.1245/s10434-021-11260.
     PubMed     Abstract available
     
     
     
817. GUAY E, Cordeiro E, Roberts A
     ASO Visual Abstract: Young Women with Breast Cancer: Chemotherapy or Surgery First? An Evaluation of Time to Treatment for Invasive Breast Cancer.
     Ann Surg Oncol. 2022 Jan 16. pii: 10.1245/s10434-021-11246.
     PubMed    
     
     
     
818. LUDWIGSON A, Huynh V, Myers S, Hampanda K, et al
     ASO Visual Abstract: Patient Perceptions of Changes in Breast Cancer Care and Well-Being During COVID-19: A Mixed-Methods Study.
     Ann Surg Oncol. 2022 Jan 16. pii: 10.1245/s10434-021-11256.
     PubMed    
     
     
     
819. CADILI L, DeGirolamo K, Ma CS, Chen L, et al
     ASO Visual Abstract: The Breast Cancer Patient Experience of Telemedicine During COVID-19.
     Ann Surg Oncol. 2022 Jan 14. pii: 10.1245/s10434-021-11183.
     PubMed    
     
     
     
820. LIN SQ, Vo NP, Yen YC, Tam KW, et al
     ASO Visual Abstract: Outcomes of Sentinel Node Biopsy in Women with Breast Cancer Following Neoadjuvant Therapy-Systematic Review and Meta-Analysis of Real-World Data.
     Ann Surg Oncol. 2022 Jan 13. pii: 10.1245/s10434-021-11306.
     PubMed    
     
     
     
821. DUCHESNEAU ED, An SJ, Strassle PD, Reeder-Hayes K, et al
     ASO Visual Abstract: Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer.
     Ann Surg Oncol. 2022 Jan 12. pii: 10.1245/s10434-021-11312.
     PubMed    
     
     
     
822. KONISHI T, Fujiogi M, Sato A, Michihata N, et al
     ASO Visual Abstract: Short-Term Outcomes Following Breast Cancer Surgery With and Without Neoadjuvant Chemotherapy: A Nationwide Administrative Database Study in Japan.
     Ann Surg Oncol. 2022 Jan 11. pii: 10.1245/s10434-021-11272.
     PubMed    
     
     
     
823. LIN SQ, Vo NP, Yen YC, Tam KW, et al
     Outcomes of Sentinel Node Biopsy for Women with Breast Cancer After Neoadjuvant Therapy: Systematic Review and Meta-Analysis of Real-World Data.
     Ann Surg Oncol. 2022 Jan 11. pii: 10.1245/s10434-021-11297.
     PubMed     Abstract available
     
     
     
824. NAFFOUJE SA, Barker V, Lee MC, Hoover SJ, et al
     Surgical Management of Axilla of Triple-Negative Breast Cancer in the Z1071 Era: A Propensity Score-Matched Analysis of the National Cancer Database.
     Ann Surg Oncol. 2022 Jan 10. pii: 10.1245/s10434-021-11194.
     PubMed     Abstract available
     
     
     
825. CARMONA CA, Yee S, Seminsky M, Glass K, et al
     Surgeon and Patient Reports of Fertility Preservation Referral and Uptake in a Prospective, Pan-Canadian Study of Young Women with Breast Cancer.
     Ann Surg Oncol. 2022 Jan 9. pii: 10.1245/s10434-021-11254.
     PubMed     Abstract available
     
     
     
826. OBENG-GYASI S, Rose J, Dong W, Kim U, et al
     ASO Visual Abstract: Is Medicaid Expansion Narrowing Gaps in Surgical Disparities for Low-Income Breast Cancer Patients?
     Ann Surg Oncol. 2022 Jan 9. pii: 10.1245/s10434-021-11172.
     PubMed    
     
     
     
827. RING A, Campo D, Porras TB, Kaur P, et al
     Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.
     Ann Surg Oncol. 2022 Jan 9. pii: 10.1245/s10434-021-11135.
     PubMed     Abstract available
     
     
     
828. DUMITRU D, Ghanakumar S, Provenzano E, Benson JR, et al
     A Prospective Study Evaluating the Accuracy of Indocyanine Green (ICG) Fluorescence Compared with Radioisotope for Sentinel Lymph Node (SLN) Detection in Early Breast Cancer.
     Ann Surg Oncol. 2022 Jan 8. pii: 10.1245/s10434-021-11255.
     PubMed     Abstract available
     
     
     
829. KONISHI T, Fujiogi M, Tanabe M, Seto Y, et al
     ASO Author Reflections: Neoadjuvant Chemotherapy Does Not Affect Short-Term Outcomes After Breast Cancer Surgery.
     Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11277.
     PubMed    
     
     
     
830. KONISHI T, Fujiogi M, Sato A, Michihata N, et al
     Short-Term Outcomes Following Breast Cancer Surgery With and Without Neoadjuvant Chemotherapy: A Nationwide Administrative Database Study in Japan.
     Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11212.
     PubMed     Abstract available
     
     
     
831. MOORMAN AM, Rutgers EJT, Kouwenhoven EA
     ASO Visual Abstract: Omitting SLNB in Breast Cancer: Is a Nomogram the Answer?
     Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11130.
     PubMed    
     
     
     
832. MATAR R, Barrio AV, Sevilimedu V, Le T, et al
     Can We Successfully De-Escalate Axillary Surgery in Women Aged >/= 70 Years with Ductal Carcinoma in Situ or Early-Stage Breast Cancer Undergoing Mastectomy?
     Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11140.
     PubMed     Abstract available
     
     
     
833. MATAR R, Crown A, Sevilimedu V, Goldfarb SB, et al
     ASO Visual Abstract: Timing of Presentation and Outcomes of Women with Stage IV Pregnancy-Associated Breast Cancer (PABC).
     Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-10971.
     PubMed    
     
     
     
834. TAMIRISA N, Hunt KK
     Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.
     Ann Surg Oncol. 2022 Jan 6. pii: 10.1245/s10434-021-11223.
     PubMed    
     
     
     
835. CARMONA C, Warner E
     ASO Author Reflections: Referring Young Breast Cancer Patients for Fertility Preservation: Significant Progress but Still Room for Improvement.
     Ann Surg Oncol. 2022 Jan 6. pii: 10.1245/s10434-021-11288.
     PubMed    
     
     
     
836. PLICHTA JK
     Circulating Tumor Cells and Breast Cancer: The Long and Winding Road Behind and Before Us.
     Ann Surg Oncol. 2022 Jan 4. pii: 10.1245/s10434-021-11301.
     PubMed    
     
     
     
837. RING A, Campo D, Porras TB, Kaur P, et al
     ASO Visual Abstract: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.
     Ann Surg Oncol. 2022 Jan 4. pii: 10.1245/s10434-021-11216.
     PubMed    
     
     
     
838. CORDEIRO E, Guay E, Roberts A
     ASO Author Reflections: Improving Efficiency of Care for Young Women with Breast Cancer.
     Ann Surg Oncol. 2022 Jan 4. pii: 10.1245/s10434-021-11164.
     PubMed    
     
     
     
839. DIETZ JR
     Editorial: Impact of the Covid-19 Pandemic on Breast Cancer Treatment and Patient Experience.
     Ann Surg Oncol. 2022 Jan 2. pii: 10.1245/s10434-021-11227.
     PubMed    
     
     
     
840. DE LORENZI F, Borelli F, Pagan E, Bagnardi V, et al
     Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis.
     Ann Surg Oncol. 2022;29:427-436.
     PubMed     Abstract available
     
     
     
841. GANESH KUMAR N, Berlin NL, Hawley ST, Jagsi R, et al
     Financial Toxicity in Breast Reconstruction: A National Survey of Women Who have Undergone Breast Reconstruction After Mastectomy.
     Ann Surg Oncol. 2022;29:535-544.
     PubMed     Abstract available
     
     
     
842. GURAM S, Covelli AM, O'Neill AC, Shultz DB, et al
     Multidisciplinary Intervention in Radiation-Associated Angiosarcoma of the Breast: Patterns of Recurrence and Response to Treatment.
     Ann Surg Oncol. 2022;29:522-532.
     PubMed     Abstract available
     
     
     
843. BOGACH J, Shakeel S, Wright FC, Hong NJL, et al
     Phyllodes Tumors: A Scoping Review of the Literature.
     Ann Surg Oncol. 2022;29:446-459.
     PubMed     Abstract available
     
     
     
844. SAHAKYAN MA, Verbeke CS, Tholfsen T, Ignjatovic D, et al
     Prognostic Impact of Resection Margin Status in Distal Pancreatectomy for Ductal Adenocarcinoma.
     Ann Surg Oncol. 2022;29:366-375.
     PubMed     Abstract available
     
     
     
845. DE LORENZI F, Borelli F
     ASO Author Reflections: The Safety of Oncoplastic Surgery for Multicentric and Multifocal Breast Tumors.
     Ann Surg Oncol. 2022;29:437.
     PubMed    
     
     
     
846. MATROS E, Offodile AC 2nd
     Financial Toxicity Following Post-Mastectomy Reconstruction: Consideration for a Novel Outcome Measure.
     Ann Surg Oncol. 2022;29:25-27.
     PubMed    
     
     
     
847. GANESH KUMAR N, Momoh AO
     ASO Author Reflections: Characterizing Financial Toxicity in Post-mastectomy Breast Reconstruction: A Need for Additional Perspectives.
     Ann Surg Oncol. 2022;29:545-546.
     PubMed    
     
     
     
848. SUN SX, Suk R, Kuerer HM, Cantor SB, et al
     No Treatment Versus Partial Mastectomy Plus Radiation for Ductal Carcinoma In Situ.
     Ann Surg Oncol. 2022;29:39-41.
     PubMed    
     
     
     
849. COVELLI AM, Gladdy RA
     ASO Author Reflections: Rethinking Radiation Associated Angiosarcoma of the Breast-Secondary Malignancies That Require Expert Care for Improved Outcomes.
     Ann Surg Oncol. 2022;29:533-534.
     PubMed    
     
     
     
850. SAHAKYAN MA, Labori KJ, Edwin B
     ASO Author Reflections: Resection Margins in Distal Pancreatectomy for Ductal Adenocarcinoma-Does Surgery Tell the Whole Story?
     Ann Surg Oncol. 2022;29:376-377.
     PubMed    
     
     
     December 2021
851. LUDWIGSON A, Huynh V, Myers S, Hampanda K, et al
     Patient Perceptions of Changes in Breast Cancer Care and Well-Being During COVID-19: A Mixed Methods Study.
     Ann Surg Oncol. 2021 Dec 20. pii: 10.1245/s10434-021-11209.
     PubMed     Abstract available
     
     
     
852. KING CA, Bartholomew AJ, Sosin M, Avila A, et al
     A Critical Appraisal of Late Complications of Prepectoral versus Subpectoral Breast Reconstruction Following Nipple-Sparing Mastectomy.
     Ann Surg Oncol. 2021;28:9150-9158.
     PubMed     Abstract available
     
     
     
853. ZHANG X, Liu W, Hai T, Li F, et al
     Upgrade Rate and Predictive Factors for Breast Benign Intraductal Papilloma Diagnosed at Biopsy: A Meta-Analysis.
     Ann Surg Oncol. 2021;28:8643-8650.
     PubMed     Abstract available
     
     
     
854. MURPHY BM, Hoskin TL, Degnim AC, Boughey JC, et al
     Surgical Management of Axilla Following Neoadjuvant Endocrine Therapy.
     Ann Surg Oncol. 2021;28:8729-8739.
     PubMed     Abstract available
     
     
     
855. JAMES TA, Fan B
     ASO Author Reflections: National Analysis of Breast Surgery Malpractice Cases: A Teachable Moment?
     Ann Surg Oncol. 2021;28:8116-8117.
     PubMed    
     
     
     
856. LEE SE, Kim HY, Yoon JH, Kim EK, et al
     Chronological Trends of Breast Ductal Carcinoma In Situ: Clinical, Radiologic, and Pathologic Perspectives.
     Ann Surg Oncol. 2021;28:8699-8709.
     PubMed     Abstract available
     
     
     
857. HUYNH V, Yang J, Bronsert M, Ludwigson A, et al
     Choosing Between Mastectomy and Breast-Conserving Therapy: Is Patient Distress an Influencing Factor?
     Ann Surg Oncol. 2021;28:8679-8687.
     PubMed     Abstract available
     
     
     
858. FAN B, Pardo J, Yu-Moe CW, Janes M, et al
     Malpractice Cases in Breast Surgery: An Assessment of Litigation Involving Surgeons.
     Ann Surg Oncol. 2021;28:8109-8115.
     PubMed     Abstract available
     
     
     
859. RING A, Lang JE
     ASO Author Reflections: Advancing Circulating Tumor Cells as Liquid Biopsies to Efficiently Target Metastatic Breast Cancer.
     Ann Surg Oncol. 2021 Dec 1. pii: 10.1245/s10434-021-11139.
     PubMed    
     
     
     
860. ZHANG X, Liu W, Hai T, Li F, et al
     ASO Visual Abstract: Upgrade Rate and Predictive Factors for Breast Benign Intraductal Papilloma Diagnosed at Biopsy: A Meta-analysis.
     Ann Surg Oncol. 2021;28.
     PubMed     Abstract available
     
     
     
861. BOGACH J, Shakeel S, Wright FC, Hong NJL, et al
     ASO Visual Abstract: Phyllodes Tumors: A Scoping Review of the Literature.
     Ann Surg Oncol. 2021;28.
     PubMed    
     
     
     
862. HUYNH V, Yang J, Bronsert M, Ludwigson A, et al
     ASO Visual Abstract: Choosing Between Mastectomy and Breast-Conserving Therapy-Is Patient Distress an Influencing Factor?
     Ann Surg Oncol. 2021;28.
     PubMed    
     
     
     
863. STAHL K, Wong W, Dodge D, Brooks A, et al
     ASO Visual Abstract: Benefits of Surgical Treatment in Stage IV Breast Cancer in Patients with Known Hormone Receptor and HER2 Status.
     Ann Surg Oncol. 2021;28.
     PubMed    
     
     
     
864. ROSENBERGER LH, Quintana LM, Thomas SM, Nimbkar SN, et al
     ASO Visual Abstract: Limited Reporting of Histopathologic Details in a Multi-Institutional Academic Cohort of Phyllodes Tumors: Time for Standardization.
     Ann Surg Oncol. 2021;28.
     PubMed    
     
     
     
865. LIZARRAGA IM, Schroeder MC, Jatoi I, Sugg SL, et al
     ASO Visual Abstract: Surgical decision-making surrounding contralateral prophylactic mastectomy-- Comparison of treatment goals, preferences, and psychosocial outcomes from a multi-center survey of breast cancer patients.
     Ann Surg Oncol. 2021;28.
     PubMed     Abstract available
     
     
     
866. PAWLOSKI KR, El-Tamer M
     Reply to Significance of 21-Gene Nonconcordant Recurrence Scores in Patients with Multifocal or Multicentric Breast Carcinomas.
     Ann Surg Oncol. 2021;28.
     PubMed    
     
     
     
867. SORSCHER S
     Significance of 21-Gene Non-Concordant Recurrence Scores in Patients with Multifocal or Multicentric Breast Carcinomas.
     Ann Surg Oncol. 2021;28.
     PubMed    
     
     
     
868. ALTUNDAG K
     Specific Histological Subgroups in Invasive Lobular Carcinoma Might Affect Management Strategy in Invasive Lobular Carcinoma of the Breast.
     Ann Surg Oncol. 2021;28.
     PubMed    
     
     
     
869. MCCORMICK PJ, Assel M, Van Zee KJ, Vickers AJ, et al
     Reply to: "Ketorolac Following Mastectomy: Is There an Increased Risk of Reoperation?"
     Ann Surg Oncol. 2021;28.
     PubMed    
     
     
     
870. LI L, Zhao X, Xiang B, Tang X, et al
     Ketorolac following Mastectomy: Is There an Increased Risk of Reoperation?
     Ann Surg Oncol. 2021;28.
     PubMed    
     
     
     
871. GIULIANO AE, Vane M
     Reply to Comment on: "Women Could Avoid Axillary Lymph Node Dissection by Choosing Breast-Conserving Therapy Instead of Mastectomy".
     Ann Surg Oncol. 2021;28.
     PubMed    
     
     
     
872. CORTINA CS, Kong AL
     Comment on "Women Could Avoid Axillary Lymph Node Dissection by Choosing Breast-Conserving Therapy Instead of Mastectomy".
     Ann Surg Oncol. 2021;28.
     PubMed    
     
     
     
873. JAMES TA, Zhang JQ
     ASO Author Reflections: Addressing the Early Onset of Clinical Practice Distress in Breast Surgery.
     Ann Surg Oncol. 2021;28.
     PubMed    
     
     
     
874. CORSO G
     Second Reply to: "Metaplastic Breast Carcinoma and Other Triple-Negative Subtype Breast Cancers: Which is the Worst?"
     Ann Surg Oncol. 2021;28.
     PubMed    
     
     
     November 2021
875. TONNESON JE, Boughey JC
     ASO Author Reflections: How COVID-19 Impacted Breast Cancer Presentation and Management.
     Ann Surg Oncol. 2021 Nov 30. pii: 10.1245/s10434-021-11098.
     PubMed    
     
     
     
876. OBENG-GYASI S, Rose J, Koroukian S
     ASO Author Reflections: Medicaid Expansion is Key in Mitigating Surgical Disparities in Low-Income Breast Cancer Patients.
     Ann Surg Oncol. 2021 Nov 27. pii: 10.1245/s10434-021-11138.
     PubMed    
     
     
     
877. OBENG-GYASI S, Rose J, Dong W, Kim U, et al
     Is Medicaid Expansion Narrowing Gaps in Surgical Disparities for Low-Income Breast Cancer Patients?
     Ann Surg Oncol. 2021 Nov 27. pii: 10.1245/s10434-021-11137.
     PubMed     Abstract available
     
     
     
878. GUAY E, Cordeiro E, Roberts A
     Young Women with Breast Cancer: Chemotherapy or Surgery First? An Evaluation of Time to Treatment for Invasive Breast Cancer.
     Ann Surg Oncol. 2021 Nov 26. pii: 10.1245/s10434-021-11102.
     PubMed     Abstract available
     
     
     
879. KOELBEL V, Pfob A, Schaefgen B, Sinn P, et al
     ASO Visual Abstract: Vacuum-Assisted Breast Biopsy After Neoadjuvant Systemic Treatment to Reliably Exclude Residual Cancer in Breast Cancer Patients.
     Ann Surg Oncol. 2021 Nov 26. pii: 10.1245/s10434-021-10958.
     PubMed    
     
     
     
880. MITTAL A, Deo S, Gogia A, Batra A, et al
     ASO Visual Abstract: Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center.
     Ann Surg Oncol. 2021 Nov 25. pii: 10.1245/s10434-021-10967.
     PubMed    
     
     
     
881. CADILI L, DeGirolamo K, Ma CS, Chen L, et al
     The Breast Cancer Patient Experience of Telemedicine During COVID-19.
     Ann Surg Oncol. 2021 Nov 24. pii: 10.1245/s10434-021-11103.
     PubMed     Abstract available
     
     
     
882. LUEHMANN N, Ascha M, Chwa E, Hackenberger P, et al
     ASO Visual Abstract: A Single Center Study of Adherence to Breast Cancer Screening Mammography Guidelines by Transgender and Non-Binary Patients.
     Ann Surg Oncol. 2021 Nov 23. pii: 10.1245/s10434-021-11038.
     PubMed    
     
     
     
883. TONNESON JE, Hoskin TL, Day CN, Durgan DM, et al
     Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis, Presentation, and Patient Management.
     Ann Surg Oncol. 2021 Nov 23. pii: 10.1245/s10434-021-11088.
     PubMed     Abstract available
     
     
     
884. FU M, Chen Q, Zeng L, Hong T, et al
     Prognosis Comparison Between Nipple-Sparing Mastectomy and Total Mastectomy in Breast Cancer: A Case-Control Study After Propensity Score Matching.
     Ann Surg Oncol. 2021 Nov 20. pii: 10.1245/s10434-021-11044.
     PubMed     Abstract available
     
     
     
885. MATAR R, Gemignani ML
     ASO Author Reflections: Stage IV Pregnancy-Associated Breast Cancer: A Continuum of Disease.
     Ann Surg Oncol. 2021 Nov 19. pii: 10.1245/s10434-021-11018.
     PubMed    
     
     
     
886. VERBUS EA, Rossi AJ, Clark AS, Taunk NK, et al
     Preoperative Use of a Radiation Boost to Enhance Effectiveness of Immune Checkpoint Blockade Therapy in Operable Breast Cancer.
     Ann Surg Oncol. 2021 Nov 16. pii: 10.1245/s10434-021-10987.
     PubMed    
     
     
     
887. SARIDAKIS A, Berger ER, Greenup R, Golshan M, et al
     ASO Author Reflections: Apocrine Breast Cancer: More Questions than Answers.
     Ann Surg Oncol. 2021 Nov 6. pii: 10.1245/s10434-021-10649.
     PubMed    
     
     
     
888. ELMORE LC, Kuerer HM, Barcenas CH, Smith BD, et al
     ASO Visual Abstract: Clinical Course of Breast Cancer Patients with Local Regional Progression During Neoadjuvant Systemic Therapy.
     Ann Surg Oncol. 2021 Nov 6. pii: 10.1245/s10434-021-10579.
     PubMed    
     
     
     
889. ADESOYE T, Babayemi O, Postlewait LM, DeSnyder SM, et al
     ASO Visual Abstract: Inflammatory Breast Cancer at the Extremes of Age.
     Ann Surg Oncol. 2021 Nov 6. pii: 10.1245/s10434-021-10586.
     PubMed    
     
     
     
890. MOORMAN AM, Rutgers EJT, Kouwenhoven EA
     Omitting SLNB in Breast Cancer: Is a Nomogram the Answer?
     Ann Surg Oncol. 2021 Nov 5. pii: 10.1245/s10434-021-11007.
     PubMed     Abstract available
     
     
     
891. BHUTIANI N, Holland MM, Mercer MK, Donaldson M, et al
     Effect of the Ductal Carcinoma In Situ Margin Consensus Guideline Implementation on Re-Excision Rates, Satisfaction, and Cost.
     Ann Surg Oncol. 2021;28:7432-7438.
     PubMed     Abstract available
     
     
     
892. KLASSEN AF, Kaur MN, Tsangaris E, de Vries CEE, et al
     Development and Psychometric Validation of BREAST-Q Scales Measuring Cancer Worry, Fatigue, and Impact on Work.
     Ann Surg Oncol. 2021;28:7410-7420.
     PubMed     Abstract available
     
     
     
893. ROSENBERGER LH, Quintana LM, Thomas SM, Nimbkar SN, et al
     Limited Reporting of Histopathologic Details in a Multi-Institutional Academic Cohort of Phyllodes Tumors: Time for Standardization.
     Ann Surg Oncol. 2021;28:7404-7409.
     PubMed     Abstract available
     
     
     
894. TSANGARIS E, Klassen AF, Kaur MN, Voineskos S, et al
     Development and Psychometric Validation of the BREAST-Q Sensation Module for Women Undergoing Post-Mastectomy Breast Reconstruction.
     Ann Surg Oncol. 2021;28:7842-7853.
     PubMed     Abstract available
     
     
     
895. LAI HW
     ASO Author Reflections: Oncologic Outcome of Endoscopic-Assisted Breast Surgery Compared with the Conventional Approach in Breast Cancers.
     Ann Surg Oncol. 2021;28:7381-7382.
     PubMed    
     
     
     
896. BHUTIANI N, Ajkay N
     ASO Author Reflections: The Broad Impact of the Margin Consensus Guidelines for Breast-Conserving Surgery in DCIS.
     Ann Surg Oncol. 2021;28:7439-7440.
     PubMed    
     
     
     
897. CHAGPAR AB
     Guide to Enhanced Recovery for Cancer Patients Undergoing Breast Surgery and Reconstruction.
     Ann Surg Oncol. 2021;28:6943-6946.
     PubMed    
     
     
     
898. SATYANANDA V, Oshi M, Endo I, Takabe K, et al
     ASO Author Reflections: High BRCA2 Gene Expression is Associated with Aggressive and Highly Proliferative Breast Cancer.
     Ann Surg Oncol. 2021;28:7366-7367.
     PubMed    
     
     
     
899. YUAN Q, Wu G
     ASO Author Reflections: Clinical Prediction Nomogram for Breast Cancer-Related Lymphedema.
     Ann Surg Oncol. 2021;28:7329-7330.
     PubMed    
     
     
     October 2021
900. MYERS SP, Ahrendt GM, Lee JS, Steiman J, et al
     ASO Visual Abstract: Association of Tumor Molecular Subtype and Stage with Breast and Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer.
     Ann Surg Oncol. 2021 Oct 29. pii: 10.1245/s10434-021-10255.
     PubMed    
     
     
     
901. MILLEN EC, Cavalcante FP, Zerwes F, Novita G, et al
     ASO Visual Abstract: The Attitudes of Brazilian Breast Surgeons on Axillary Management in Early Breast Cancer 10 Years After the ACOSOG Z0011 Trial First Publication.
     Ann Surg Oncol. 2021 Oct 28. pii: 10.1245/s10434-021-10939.
     PubMed    
     
     
     
902. MATAR R, Crown A, Sevilimedu V, Goldfarb SB, et al
     Timing of Presentation and Outcomes of Women with Stage IV Pregnancy-Associated Breast Cancer (PABC).
     Ann Surg Oncol. 2021 Oct 28. pii: 10.1245/s10434-021-10901.
     PubMed     Abstract available
     
     
     
903. ASCHA M, Felt D, Beach LB, Kulkarni SA, et al
     ASO Author Reflections: Constructing a Transgender and Nonbinary Cohort to Analyze Breast Cancer Screening.
     Ann Surg Oncol. 2021 Oct 27. pii: 10.1245/s10434-021-10978.
     PubMed    
     
     
     
904. HERBERT C, Paro A, Diaz A, Pawlik TM, et al
     ASO Visual Abstract: Association of Community Economic Distress and Breast and Colorectal Cancer Screening, Incidence, and Mortality Rates Among U.S. Counties.
     Ann Surg Oncol. 2021 Oct 27. pii: 10.1245/s10434-021-10942.
     PubMed    
     
     
     
905. LUEHMANN N, Ascha M, Chwa E, Hackenberger P, et al
     A Single-Center Study of Adherence to Breast Cancer Screening Mammography Guidelines by Transgender and Non-Binary Patients.
     Ann Surg Oncol. 2021 Oct 26. pii: 10.1245/s10434-021-10932.
     PubMed     Abstract available
     
     
     
906. FITZAL F, Bolliger M, Dunkler D, Geroldinger A, et al
     ASO Visual Abstract: Retrospective Multicenter Analysis Comparing Conventional with Oncoplastic Breast-Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study.
     Ann Surg Oncol. 2021 Oct 21. pii: 10.1245/s10434-021-10898.
     PubMed    
     
     
     
907. KHAN TM, Rossi AJ, Suman V, Haffty B, et al
     Is Axillary Radiation not Inferior to Axillary Dissection for Sentinel Lymph Node-Positive Breast Cancer After Neoadjuvant Chemotherapy?
     Ann Surg Oncol. 2021 Oct 20. pii: 10.1245/s10434-021-10830.
     PubMed    
     
     
     
908. STAHL K, Dodge D, Shen C
     Surgery of the Primary Tumor in De Novo Metastatic Breast Cancer Confers No Survival Benefit: Author's Reply.
     Ann Surg Oncol. 2021 Oct 18. pii: 10.1245/s10434-021-10906.
     PubMed    
     
     
     
909. HERREMANS KM, Cribbin MP, Riner AN, Neal DW, et al
     ASO Visual Abstract: A 5-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast Cancer.
     Ann Surg Oncol. 2021 Oct 16. pii: 10.1245/s10434-021-10648.
     PubMed    
     
     
     
910. MITTAL A, Pramanik R
     ASO Author Reflections: Germline Testing for All Patients With Breast Cancer: Has the Time Finally Come?
     Ann Surg Oncol. 2021 Oct 15. pii: 10.1245/s10434-021-10880.
     PubMed     Abstract available
     
     
     
911. FITZAL F, Bolliger M, Dunkler D, Geroldinger A, et al
     Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study.
     Ann Surg Oncol. 2021 Oct 13. pii: 10.1245/s10434-021-10809.
     PubMed     Abstract available
     
     
     
912. MURALI-NANAVATI S, Nair NS, Badwe R
     Surgery of the Primary Tumor in De Novo Metastatic Breast Cancer Confers No Survival Benefit.
     Ann Surg Oncol. 2021 Oct 11. pii: 10.1245/s10434-021-10887.
     PubMed    
     
     
     
913. DESNYDER SM, Yi M, Boccardo F, Feldman S, et al
     ASO Visual Abstract: American Society of Breast Surgeons Practice Patterns for Patients At-risk and Affected by Breast Cancer-Related Lymphedema.
     Ann Surg Oncol. 2021 Oct 9. pii: 10.1245/s10434-021-10608.
     PubMed    
     
     
     
914. DELIERE A, Attai D, Victorson D, Kuchta K, et al
     ASO Visual Abstract: Decision Regret About Breast Cancer Surgery-The WhySurg Study: Patients Undergoing Bilateral Mastectomy and Breast-Conserving Surgery Found to Have Lowest Levels of Regret.
     Ann Surg Oncol. 2021 Oct 6. pii: 10.1245/s10434-021-10591.
     PubMed    
     
     
     
915. OROZCO JIJ, Grumley JG
     ASO Author Reflections: Molecular Testing in Breast Cancer: Is Core Biopsy Equivalent to Surgical Specimen?
     Ann Surg Oncol. 2021 Oct 4. pii: 10.1245/s10434-021-10604.
     PubMed    
     
     
     
916. MITTAL A, Deo SVS, Gogia A, Batra A, et al
     Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center.
     Ann Surg Oncol. 2021 Oct 2. pii: 10.1245/s10434-021-10870.
     PubMed     Abstract available
     
     
     
917. BUTLER PD, Morris MP, Momoh AO
     Persistent Disparities in Postmastectomy Breast Reconstruction and Strategies for Mitigation.
     Ann Surg Oncol. 2021;28:6099-6108.
     PubMed     Abstract available
     
     
     
918. BYUN DJ, Wu SP, Nagar H, Gerber NK, et al
     Ductal Carcinoma in Situ in Young Women: Increasing Rates of Mastectomy and Variability in Endocrine Therapy Use.
     Ann Surg Oncol. 2021;28:6083-6096.
     PubMed     Abstract available
     
     
     
919. MOO TA, Saccarelli CR, Sutton EJ, Sevilimedu V, et al
     Tumor-Nipple Distance of >/= 1 cm Predicts Negative Nipple Pathology After Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2021;28:6024-6029.
     PubMed     Abstract available
     
     
     
920. SHAH C, Bremer T, Cox C, Whitworth P, et al
     The Clinical Utility of DCISionRT((R)) on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery.
     Ann Surg Oncol. 2021;28:5974-5984.
     PubMed     Abstract available
     
     
     
921. GORDON NT, Alberty-Oller JJ, Fei K, Greco G, et al
     Association of Insulin Resistance and Higher Oncotype DX Recurrence Score.
     Ann Surg Oncol. 2021;28:5941-5947.
     PubMed     Abstract available
     
     
     
922. VAN LA PARRA RFD, Clough KB, Thygesen HH, Levy E, et al
     Oncological Safety of Oncoplastic Level II Mammoplasties After Neoadjuvant Chemotherapy for Large Breast Cancers: A Matched-Cohort Analysis.
     Ann Surg Oncol. 2021;28:5920-5928.
     PubMed     Abstract available
     
     
     
923. HILLS N, Leslie M, Davis R, Crowell M, et al
     Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma.
     Ann Surg Oncol. 2021;28:5895-5905.
     PubMed     Abstract available
     
     
     
924. MUKHTAR RA, Hoskin TL, Habermann EB, Day CN, et al
     Changes in Management Strategy and Impact of Neoadjuvant Therapy on Extent of Surgery in Invasive Lobular Carcinoma of the Breast: Analysis of the National Cancer Database (NCDB).
     Ann Surg Oncol. 2021;28:5867-5877.
     PubMed     Abstract available
     
     
     
925. RELATION T, Obeng-Gyasi S, Bhattacharyya O, Li Y, et al
     Racial Differences in Response to Neoadjuvant Chemotherapy: Impact on Breast and Axillary Surgical Management.
     Ann Surg Oncol. 2021;28:6489-6497.
     PubMed     Abstract available
     
     
     
926. ILES K, Downs-Canner S
     ASO Author Reflections: Use of Axillary Staging Surgery Before Systemic Therapy in Breast Cancer Highlights a Need for Implementation Science in Surgery.
     Ann Surg Oncol. 2021 Oct 1. pii: 10.1245/s10434-021-10747.
     PubMed    
     
     
     
927. MOO TA, Sacchini V
     ASO Author Reflections: Tumor-Nipple Distance of >/= 1 cm on Pre- or Post-Neoadjuvant Chemotherapy Imaging can be used to Determine Eligibility for Nipple-Sparing Mastectomy.
     Ann Surg Oncol. 2021;28:6030-6031.
     PubMed    
     
     
     
928. WEISS A, Golshan M, Ollila DW
     ASO Author Reflections: Accurately Predicting Nodal pCR Holds the Key to Axillary Surgery De-escalation Strategies.
     Ann Surg Oncol. 2021;28:5972-5973.
     PubMed    
     
     
     
929. GORDON N, Alberty-Oller J
     Genomic Assays and the Great Unknown: The Oncotype DX May Miss the Mark in Certain Populations.
     Ann Surg Oncol. 2021;28:5948-5949.
     PubMed    
     
     
     
930. SCHWARTZ T
     Just Say No: The Case Against Opioid-Based Postoperative Pain Management Regimens Following Breast Surgery.
     Ann Surg Oncol. 2021;28:5799-5800.
     PubMed    
     
     
     
931. ELDREDGE-HINDY H
     ASO Author Reflections: Five-Fraction Whole-Breast Radiation: Let's Make Adjuvant Therapy Accessible.
     Ann Surg Oncol. 2021;28:5893-5894.
     PubMed    
     
     
     
932. MUKHTAR RA, Boughey JC
     ASO Author Reflections: Changes in Primary Treatment Strategy for Invasive Lobular Carcinoma Highlight the Need for Better Predictors of Therapy Response.
     Ann Surg Oncol. 2021;28:5878-5879.
     PubMed    
     
     
     
933. HILLS N, Leslie M, Davis R, Crowell M, et al
     ASO Author Reflections: Does Prompt Breast-Conserving Surgery Matter?
     Ann Surg Oncol. 2021;28:5906.
     PubMed    
     
     
     
934. HERBERT C, Paro A, Diaz A, Pawlik TM, et al
     ASO Author Reflections: Association of Community Economic Distress and Breast and Colorectal Cancer Screening, Incidence, and Mortality Rates among U.S. Counties.
     Ann Surg Oncol. 2021 Oct 1. pii: 10.1245/s10434-021-10864.
     PubMed    
     
     
     September 2021
935. BREDBECK BC, Dossett LA
     ASO Author Reflections: Adding up the Costs of Low-Value Breast Cancer Care.
     Ann Surg Oncol. 2021 Sep 29. pii: 10.1245/s10434-021-10863.
     PubMed    
     
     
     
936. GONZALEZ L, Sun C, Loscalzo M, Clark K, et al
     A Cross-Sectional Study of Distress Levels in Patients with Newly Diagnosed Breast Cancer: The Impact of Race, Ethnicity, and Language Preference.
     Ann Surg Oncol. 2021 Sep 28. pii: 10.1245/s10434-021-10561.
     PubMed     Abstract available
     
     
     
937. KOELBEL V, Pfob A, Schaefgen B, Sinn P, et al
     Vacuum-Assisted Breast Biopsy After Neoadjuvant Systemic Treatment for Reliable Exclusion of Residual Cancer in Breast Cancer Patients.
     Ann Surg Oncol. 2021 Sep 28. pii: 10.1245/s10434-021-10847.
     PubMed     Abstract available
     
     
     
938. MILLEN EC, Cavalcante FP, Zerwes F, Novita G, et al
     The Attitudes of Brazilian Breast Surgeons on Axillary Management in Early Breast Cancer-10 Years after the ACOSOG Z0011 Trial First Publication.
     Ann Surg Oncol. 2021 Sep 27. pii: 10.1245/s10434-021-10812.
     PubMed     Abstract available
     
     
     
939. MILLEN EC, Cavalcante FP
     ASO Author Reflections: Positive Sentinel Lymph Node in Breast Cancer Surgery.
     Ann Surg Oncol. 2021 Sep 24. pii: 10.1245/s10434-021-10836.
     PubMed    
     
     
     
940. ASGEIRSSON KS, Dixon JM, Darrigues L, Sarfati B, et al
     Multicenter Evaluation of Hydrodissection-Assisted Mastectomy (HAM).
     Ann Surg Oncol. 2021;28:4780-4781.
     PubMed    
     
     
     
941. SCHAVERIEN MV, Chang EI
     Discussion: "Development and Psychometric Validation of a Patient-Reported Outcome Measure for Arm Lymphedema: LYMPH-Q Upper Extremity Module".
     Ann Surg Oncol. 2021;28:4767-4768.
     PubMed    
     
     
     
942. TUTTLE TM, Burke EE, Hui JYC
     Genetic Testing and De-escalation of Contralateral Prophylactic Mastectomy.
     Ann Surg Oncol. 2021;28:4764-4766.
     PubMed    
     
     
     
943. MCCORMICK PJ, Simon BA
     ASO Author Reflections: We No Longer Give Ketorolac During Mastectomy. Should You?
     Ann Surg Oncol. 2021;28:5141.
     PubMed    
     
     
     
944. FRIEDRICH AU, Lannin DR
     ASO Author Reflections: Breast Angiosarcoma-A Rare Disease with a Lot of Uncertainty.
     Ann Surg Oncol. 2021;28:5119-5120.
     PubMed    
     
     
     
945. TADROS AB, Sevilimedu V, Plitas G
     Reply to: Metaplastic Breast Carcinoma and Other Triple-Negative Subtype Breast Cancers: Which is the Worst?
     Ann Surg Oncol. 2021;28:5440-5441.
     PubMed    
     
     
     
946. CORSO G
     Metaplastic Breast Carcinoma and Other Triple-Negative Subtype Breast Cancers: Which Is Worst?
     Ann Surg Oncol. 2021;28:5438-5439.
     PubMed